Third Coast Bancshares (TCBX) 10-K15 Mar 232022 FY Annual reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
Document and Entity Information - USD ($) $ in Millions	Dec. 31, 2022	Mar. 10, 2023	Jun. 30, 2022
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Entity Registrant Name	THIRD COAST BANCSHARES, INC.
Entity Central Index Key	0001781730
Current Fiscal Year End Date	--12-31
Entity Voluntary Filers	No
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Title of 12(b) Security	Common Stock, par value $1.00 per share
Trading Symbol	TCBX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Well-known Seasoned Issuer	No
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	TX
Entity File Number	001-41028
Entity Tax Identification Number	46-2135597
Entity Address, Address Line One	20202 Highway 59 North
Entity Address, Address Line Two	Suite 190
Entity Address, City or Town	Humble
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77338
City Area Code	281
Local Phone Number	446-7000
Document Annual Report	true
Document Transition Report	false
Entity Public Float			$ 278.2
Entity Common Stock, Shares Outstanding		13,579,498
Documents Incorporated by Reference	Documents Incorporated by Reference Portions of the registrant's Definitive Proxy Statement relating to the 2023 Annual Meeting of Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K.
Auditor Name	Whitley Penn LLP
Auditor Location	Dallas, Texas
Auditor Firm ID	726

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Cash and cash equivalents:
Cash and due from banks	$ 329,864,000	$ 326,733,000
Federal funds sold	2,150,000	292,000
Total cash and cash equivalents	332,014,000	327,025,000
Interest bearing time deposits in other banks		131,000
Investment securities available for sale	176,067,000	26,432,000
Loans, net of allowance for loan loss of $30,351 and $19,295 at December 31, 2022 and 2021, respectively	3,077,200,000	2,049,429,000
Accrued interest receivable	18,340,000	10,228,000
Premises and equipment, net	28,662,000	19,045,000
Other real estate owned		1,676,000
Bank-owned life insurance	60,761,000	26,528,000
Non-marketable equity securities, at cost	15,405,000	7,527,000
Deferred tax asset, net	6,303,000	4,123,000
Fair value hedge assets	9,213,000	389,000
Right-of-use asset - operating leases	17,872,000
Core Deposit Intangible, net	1,131,000	1,292,000
Goodwill	18,034,000	18,034,000
Other assets	12,146,000	7,553,000
Total assets	3,773,148,000	2,499,412,000
Deposits:
Noninterest bearing	486,114,000	531,401,000
Interest bearing	2,750,032,000	1,609,798,000
Total deposits	3,236,146,000	2,141,199,000
Accrued interest payable	2,545,000	437,000
Fair value hedge liabilities	9,221,000	389,000
Lease liability - operating leases	18,209,000
Other liabilities	14,024,000	7,380,000
FHLB advances		50,000,000
Line of credit - Senior Debt	30,875,000	1,000,000
Note payable - Subordinated Debt, net	80,348,000
Total liabilities	3,391,368,000	2,200,405,000
Shareholders' equity:
Series A Convertible Non-Cumulative Preferred Stock, $1 par value; 69,400 shares authorized; 69,400 outstanding at December 31, 2022 and no shares outstanding at December 31, 2021	69,000
Common stock, $1 par value; 50,000,000 shares authorized; 13,610,198 and 13,481,786 issued; and 13,531,736 and 13,403,324 outstanding at December 31, 2022 and 2021, respectively	13,610,000	13,482,000
Additional paid-in capital	318,033,000	249,202,000
Retained earnings	53,270,000	36,029,000
Accumulated other comprehensive income	(2,103,000)	1,393,000
Treasury stock: at cost; 78,462 shares at December 31, 2022 and 2021, respectively	(1,099,000)	(1,099,000)
Total shareholders' equity	381,780,000	299,007,000
Total liabilities & shareholders' equity	$ 3,773,148,000	$ 2,499,412,000

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Preferred stock, par value	$ 1
Preferred stock, shares authorized	1,000,000
Loans, net of allowance for loan loss	$ 30,351	$ 19,295
Common stock, par value	$ 1	$ 1
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	13,610,198	13,481,786
Common stock, shares outstanding	13,531,736	13,403,324
Treasury stock, shares	78,462	78,462
Series A Convertible Non-cumulative Preferred Stock
Preferred stock, par value	$ 1	$ 1
Preferred stock, shares authorized	69,400	69,400
Preferred stock, shares outstanding	69,400	0
Series B Convertible Perpetual Preferred Stock
Preferred stock, par value	$ 1	$ 1
Preferred stock, shares authorized	69,400	69,400
Preferred stock, shares outstanding	0	0

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Thousands	12 Months Ended
Consolidated Statements of Income - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Interest income:
Loans, including fees	$ 146,425	$ 98,886	$ 80,791
Investment securities available-for-sale	3,925	1,043	297
Federal funds sold and other	3,596	686	1,153
Total interest income	153,946	100,615	82,241
Interest expense:
Deposit accounts	30,696	8,526	12,302
FHLB advances and notes payable	6,796	1,536	2,058
Total interest expense	37,492	10,062	14,360
Net interest income	116,454	90,553	67,881
Provision for loan losses	12,200	9,923	7,550
Net interest income after provision for loan losses	104,254	80,630	60,331
Noninterest income:
Services charges and fees	2,714	2,367	1,709
Gain on sales of SBA loans	950	586	266
Earnings on bank-owned life insurance	1,312	567	354
Derivative fees	1,259	820
Other	988	538	353
Total noninterest income	7,223	4,878	2,682
Noninterest expense:
Salaries and employee benefits	56,510	48,642	29,262
Data processing and network expense	3,947	3,060	3,184
Occupancy and equipment expense	8,526	5,367	4,127
Legal and professional	6,987	5,293	3,962
Loan operations and other real estate owned expense	988	1,963	1,369
Advertising and marketing	1,912	1,889	1,326
Telephone and communications	496	595	605
Software purchases and maintenance	1,012	852	420
Regulatory assessments	3,464	1,101	1,303
Loss on sale of other real estate owned	350	344
Other	4,117	1,919	1,845
Total noninterest expense	88,309	71,025	47,403
Net income before income tax expense	23,168	14,483	15,610
Income tax expense	4,509	3,059	3,495
Net income	18,659	11,424	12,115
Preferred stock dividends declared	(1,418)
Net income available to common shareholders	$ 17,241	$ 11,424	$ 12,115
Earnings per common share:
Basic earnings per share	$ 1.28	$ 1.45	$ 1.94
Diluted earnings per share	$ 1.25	$ 1.40	$ 1.91

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Other Comprehensive Income [Abstract]
Net income	$ 18,659	$ 11,424	$ 12,115
Other comprehensive income (loss):
Unrealized holding (loss) gain arising during the period	(7,049)	861	137
Income tax benefit (expense)	1,480	(181)	(29)
Other comprehensive (loss) income on securities	(5,569)	680	108
Unrealized gain on derivatives:
Unrealized holding (loss) gain arising during the period		(216)	216
Gain on termination of derivative instruments	3,025	945
Reclassification adjustment for accretion recorded in interest expense during the period	(401)	(180)
Income tax expense	(551)	(115)	(45)
Other comprehensive income on derivatives	2,073	434	171
Total other comprehensive (loss) income	(3,496)	1,114	279
Total comprehensive income	$ 15,163	$ 12,538	$ 12,394

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Less: ESOP-Owned Shares	Initial Public Offering	Initial Public Offering Common Stock	Initial Public Offering Additional Paid in Capital	Private Placement Offering	Private Placement Offering Common Stock	Private Placement Offering Additional Paid in Capital	Series A Preferred Stock	Series A Preferred Stock Retained Earnings	Series A Preferred Stock Preferred Stock	Series A Preferred Stock Private Placement Offering Preferred Stock
Balance at Dec. 31, 2019	$ 56,521	$ 3,923	$ 41,832	$ 12,490		$ (941)	$ (783)
Net income	12,115			12,115
Share-based compensation	275		275
Stock options exercised	385	32	353
Common stock issued for acquisition of Heritage Bancorp, Inc.	50,861	2,363	48,498
Issuance of common stock to ESOP	(1)	32	504				(537)
Net change in fair value of ESOP shares	18						18
Net redemption of treasury stock	(37)					(37)
Other comprehensive income (loss), net of tax	279				$ 279
Balance at Dec. 31, 2020	120,416	6,350	91,462	24,605	279	(978)	(1,302)
Net income	11,424			11,424
Share-based compensation	659		659
Warrants exercised	19	2	17
Stock options exercised	995	83	912
Stock issued from initial public offering and private placement offering								$ 92,043	$ 4,025	$ 88,018	$ 70,509	$ 2,938	$ 67,571
Issuance of common stock to ESOP		34	613				(647)
Terminated ESOP put option	2,266						2,266
Restricted stock grants		50	(50)
Net change in fair value of ESOP shares	(317)						$ (317)
Net redemption of treasury stock	(121)					(121)
Other comprehensive income (loss), net of tax	1,114				1,114
Balance at Dec. 31, 2021	299,007	13,482	249,202	36,029	1,393	(1,099)
Net income	18,659			18,659
Share-based compensation	1,275		1,275
Stock options exercised	672	47	625
Stock issued from initial public offering and private placement offering											$ 66,225		$ 66,156				$ 69
Issuance of common stock to ESOP	856	36	820
Restricted stock grants		45	(45)
Other comprehensive income (loss), net of tax	(3,496)				(3,496)
Preferred dividends declared - Series A $20.44 per share														$ (1,418)	$ (1,418)
Balance at Dec. 31, 2022	$ 381,780	$ 13,610	$ 318,033	$ 53,270	$ (2,103)	$ (1,099)										$ 69

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Shareholders' Equity (Parenthetical)	Dec. 31, 2022 $ / shares
Statement of Stockholders' Equity [Abstract]
Preferred dividends declared per share - Series A	$ 20.44

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income	$ 18,659	$ 11,424	$ 12,115
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Provision for loan losses	12,200	9,923	7,550
Changes in deferred tax asset, net	(1,250)	(380)	(1,708)
Share based compensation expense	1,275	659	275
Gain on sale of SBA loans	(950)	(586)	(266)
Writedown of other real estate owned			10
Loss on sale of other real estate owned	350	344
Loss on disposal of fixed assets			7
Amortization of premium on securities, net	392	34	60
Accretion of gain on terminated cash flow hedges	(401)	(180)
Accretion of SBA Paycheck Protection Program fees	(2,039)	(19,249)	(10,223)
Amortization of subordinated debt origination costs	154
Depreciation, amortization and accretion	(479)	(270)	78
Earnings on bank-owned life insurance	(1,312)	(567)	(354)
Originations of loans held for sale			(5,003)
Proceeds from sale of loans held for sale		2,346	3,840
Net change in operating leases	337
Net change in fair value hedge assets and liabilities	8
Changes in operating assets and liabilities:
Accrued interest receivable and other assets	(12,707)	749	(9,699)
Accrued interest payable and other liabilities	7,554	337	(336)
Net cash provided by (used in) operating activities	21,791	4,584	(3,654)
Cash flows from investing activities:
Net decrease (increase) in interest bearing deposits in other banks	131	(2)
Increase in non-marketable equity securities	(7,878)	(3,120)	(987)
Investment securities available-for-sale activity:
Purchases	(2,159,237)	(1,997,000)	(1,923,756)
Maturities, calls and principal paydowns	2,002,160	1,996,989	1,902,560
Proceeds from termination of derivative instruments	3,025	945
Net originations on loans held for investment	(1,033,947)	(493,601)	(482,413)
Net additions to bank premises and equipment	(12,189)	(5,620)	(1,354)
Proceeds from disposal of fixed assets	1,326		59
Construction additions on foreclosed assets			(230)
Proceeds from sales of foreclosed assets		1,347
Purchase of bank owned life insurance	(32,921)		(10,000)
Net cash acquired from acquisition of Heritage Bancorp, Inc.			16,112
Net cash used in investing activities	(1,239,530)	(500,062)	(500,009)
Cash flows from financing activities:
Net increase in deposits	1,095,127	507,726	566,774
Net (repayment of) proceeds from issuance of FHLB Advances	(50,000)	(20,000)	40,000
Net proceeds from subordinated debt issuance	80,194
Net (repayment of) proceeds from subordinated notes payable - related party		(13,000)	5,000
Net proceeds from (repayment of) line of credit -senior debt	29,875	(19,875)	(1,500)
Proceeds from stock warrants exercised		19
Proceeds from stock options exercised	672	995	385
Dividends paid on Series A preferred stock	(221)
Net redemption of treasury stock		(121)	(38)
Net cash provided by financing activities	1,222,728	618,943	611,158
Increase in cash and cash equivalents	4,989	123,465	107,495
Cash and cash equivalents at beginning of period	327,025	203,560	96,065
Cash and cash equivalents at end of period	332,014	327,025	203,560
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	35,384	10,840	14,891
Cash paid for income taxes, net of $144 refund in 2020	7,065	6,525	2,656
Supplemental Disclosure of Noncash Investing and Financing Activities:
Loans transferred to other real estate owned, net			1,380
Right of use lease assets obtained in exchange for operating lease liabilities	19,211
Net (increase) decrease in fair value of ESOP-owned shares		(317)	18
Terminated ESOP put option		2,266
2021 Private Placement Offering
Cash flows from financing activities:
Proceeds from issuance of common stock		70,509
2022 Private Placement Offering
Cash flows from financing activities:
Net proceeds from issuance of preferred stock	66,225
Initial Public Offering
Cash flows from financing activities:
Proceeds from issuance of common stock		92,043
ESOP Contributions
Cash flows from financing activities:
Proceeds from issuance of common stock	$ 856	$ 647	537
Heritage Bancorp, Inc.
Supplemental Disclosure of Noncash Investing and Financing Activities:
Common stock issued for acquisition of Heritage Bancorp, Inc.			$ 50,861

Consolidated Statements of Ca_2

Consolidated Statements of Cash Flows (Parenthetical) $ in Thousands	12 Months Ended
	Dec. 31, 2020 USD ($)
Statement of Cash Flows [Abstract]
Income tax refunds	$ 144

Nature of Operations and Summar

Nature of Operations and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Nature of Operations and Summary of Significant Accounting Policies	1. Nature of Operations and Summary of Significant Accounting Policies Nature of Operations Third Coast Bancshares, Inc. (“Bancshares”), through its subsidiary, Third Coast Bank, SSB, a Texas state savings bank (the “Bank”), and the Bank’s subsidiary, Third Coast Commercial Capital, Inc. (“TCCC”), (collectively known as the “Company”), provide general consumer and commercial banking services through fifteen branch offices in the Greater Houston, Dallas-Fort Worth and Austin-San Antonio markets, and one branch in Detroit, Texas. Branch locations include: Humble, Kingwood, Houston-Galleria, Conroe, Pearland, Lake Jackson, Beaumont, Port Arthur, Dallas, Fort Worth, Plano, La Vernia, Nixon, San Antonio, Georgetown, and Detroit. The Bank is engaged in traditional community banking activities, which include commercial and retail lending, deposit gathering, and investment and liquidity management activities. The Bank’s primary deposit products are demand deposits, money market accounts and certificates of deposit; its primary lending products are commercial business and real estate, residential-construction, real estate mortgage and consumer loans. TCCC engages in accounts receivable factoring activities. The Company is subject to the regulations of certain government agencies and undergoes periodic examinations by those regulatory authorities. Basis of Presentation The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and with reporting practices prescribed by the financial services industry. The accompanying consolidated financial statements include the accounts of Bancshares, the Bank, and TCCC. All significant intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all adjustments that were recurring in nature and considered necessary have been included for fair presentation of the Company’s financial position and results of operations. The Company has evaluated subsequent events for potential recognition and/or disclosure through the date the consolidated financial statements were issued. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates. Estimates subject to significant changes include the allowance for loan and lease losses, the expected cash flows and collateral values associated with impaired loans, the carrying value of other real estate owned (“OREO”), the fair value of financial instruments, business combination fair value computations, the valuation of goodwill and other intangible assets, stock-based compensation and deferred income tax assets. Cash and Cash Equivalents Cash and cash equivalents include cash, deposits with other financial institutions that have initial maturities of less than 90 days when acquired by the Company and federal funds sold. Interest Bearing Time Deposits in Other Banks Interest bearing time deposits in other banks are carried at cost and generally mature between 90 days to one year from purchase date. Investment Securities Available-For-Sale Investment securities available-for-sale consist of bonds, notes, and debentures that are not classified as trading securities or held-to-maturity securities. Investment securities available-for-sale are held for indefinite periods of time and carried at fair value, with the unrealized holding gains and losses reported as a component of other comprehensive income (loss), net of tax. Management determines the appropriate classification of investment securities at the time of purchase. Loans and Allowance for Loan Losses Loans are stated at the amount of unpaid principal, reduced by unearned income and an allowance for loan losses (“ALLL”). Interest on loans is recognized using the effective interest method and includes amortization of deferred loan origination fees and costs over the life of the loans. A loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due (both principal and interest) according to the terms of the loan agreement. Reserves on impaired loans are primarily measured based on the fair value of the underlying collateral. Impaired loans, or portions thereof, are charged off when deemed uncollectible. The accrual of interest on loans is discontinued when there is a clear indication that the borrower’s cash flow may not be sufficient to meet payments as they become due, which is generally when a loan is 90 days past due. When a loan is placed on non-accrual status, all previously accrued and unpaid interest is reversed. Interest income is subsequently recognized on a cash basis as long as the remaining book balance of the asset is deemed to be collectible. If collectability is questionable, then cash payments are applied to principal. A loan is placed back on accrual status when both principal and interest are current and it is probable that the Company will be able to collect all amounts due (both principal and interest) according to the terms of the loan agreement. The allowance for loan losses is established through a provision for loan losses charged against income. The allowance for loan losses includes specific reserves for impaired loans and an estimate of losses inherent in the loan portfolio at the balance sheet date, but not yet identified with specific loans. Loans deemed to be uncollectible are charged against the allowance when management believes that the collectability of the principal is unlikely and subsequent recoveries, if any, are credited to the allowance. Management’s periodic evaluation of the adequacy of the allowance is based on an assessment of the current loan portfolio, including known inherent risks, adverse situations that may affect the borrowers’ ability to repay, the estimated value of any underlying collateral and current economic conditions. From time to time, the Company modifies its loan agreement with a borrower. A modified loan is considered a troubled debt restructuring when two conditions are met: (i) the borrower is experiencing financial difficulty and (ii) concessions are made by the Company that would not otherwise be considered for a borrower with similar credit risk characteristics. Modifications to loan terms may include a lower interest rate, a reduction of principal, or a longer term to maturity. At the time of restructuring, the Company evaluates the economic and business conditions and collection efforts, and should the collection of interest be doubtful, the loan is placed on non-accrual. Each of these loans is evaluated for impairment and a specific reserve is recorded, as necessary, based on probable losses, taking into consideration the related collateral and modified loan terms and cash flow. The Company has certain lending policies and procedures in place that are designed to maximize loan income with an acceptable level of risk. Management reviews and approves these policies and procedures on a regular basis and makes changes as appropriate. Management receives frequent reports related to loan originations, quality, concentrations, delinquencies, non-performing, and potential problem loans. Diversification in the loan portfolio is a means of managing risk associated with fluctuations in economic conditions, both by type of loan and geography. Commercial loans are underwritten after evaluating and understanding the borrower’s ability to operate profitably and effectively. Underwriting standards are designed to determine whether the borrower possesses sound business ethics and practices and to evaluate current and projected cash flows to determine the ability of the borrower to repay their obligations as agreed. Commercial loans are primarily made based on the identified cash flows of the borrower and, secondarily, on the underlying collateral provided by the borrower. Most commercial loans are secured by the assets being financed or other business assets, such as accounts receivable or inventory, and include personal guarantees. Real estate loans are also subject to underwriting standards and processes similar to commercial and agricultural loans. These loans are underwritten primarily based on projected cash flows and, secondarily, as loans secured by real estate. The repayment of real estate loans is generally largely dependent on the successful operation of the property securing the loans or the business conducted on the property securing the loan. Real estate loans may be more adversely affected by conditions in the real estate markets or in the general economy. The properties securing the Company’s real estate portfolio are generally diverse in terms of type and geographic location primarily throughout the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio metropolitan areas. This diversity helps reduce the exposure to adverse economic events that affect any single market or industry. Generally, real estate loans are owner occupied which further reduces the Company’s risk. Agricultural loans are subject to underwriting standards and processes similar to commercial loans. Agricultural loans are primarily made based on the identified cash flows of the borrower and, secondarily, on the underlying collateral provided by the borrower. Most agricultural loans are secured by the agriculture related assets being financed, such as farmland, cattle, or equipment, and include personal guarantees. The Company utilizes methodical credit standards and analysis to supplement its policies and procedures in underwriting consumer loans. The Company’s loan policy addresses types of consumer loans that may be originated and the collateral, if secured, which must be perfected. The relatively smaller individual dollar amounts of consumer loans that are spread over numerous individual borrowers also minimizes the Company’s risk. Certain Acquired Loans Acquired loans purchased from third parties are recorded at their estimated fair value at the acquisition date and are initially classified as either purchased credit impaired (“PCI”) loans (i.e., loans that reflect credit deterioration since origination and it is probable at acquisition that the Company will be unable to collect all contractually required payments) or purchased non-impaired loans (“acquired performing loans”). Acquired performing loans are accounted for under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 310-20. Performance of certain loans may be monitored and based on management’s assessment of the cash flows and other facts available, portions of the accretable difference may be delayed or suspended if management deems appropriate. The Company’s policy for determining when to discontinue accruing interest on acquired performing loans and the subsequent accounting for such loans is essentially the same as the policy for originated loans described above. An ALLL is calculated using a methodology similar to that described for originated loans. Acquired performing loans are subsequently evaluated for any required allowance at each reporting date. Such required allowance for each loan is compared to the remaining fair value discount for that loan. If greater, the excess is recognized as an addition to the allowance through a provision for loan losses. If less than the discount, no additional allowance is recorded. Charge-offs and losses first reduce any remaining fair value discount for the loan and once the discount is depleted, losses are applied against the allowance established for that loan. PCI loans are accounted for under the accounting guidance for loans and debt securities acquired with deteriorated credit quality, found in FASB ASC Topic 310-30, Receivables—Loans and Debt Securities Acquired with Deteriorated Credit Quality . The Company estimates the amount and timing of expected principal, interest and other cash flows for each loan meeting the criteria above and determines the excess of the loan’s scheduled contractual principal and contractual interest payments over all cash flows expected to be collected at acquisition as an amount that should not be accreted. These credit discounts (“nonaccretable marks”) are included in the determination of the initial fair value for acquired loans; therefore, an allowance for loan losses is not recorded at the acquisition date. Differences between the estimated fair values and expected cash flows of acquired loans at the acquisition date that are not credit-based (“accretable marks”) are subsequently accreted to interest income over the estimated life of the loans using a method that approximates a level yield method if the timing and amount of the future cash flows is reasonably estimable. Subsequent to the acquisition date for PCI loans, increases in cash flows over those expected at the acquisition date result in a move of the discount from nonaccretable to accretable. Decreases in expected cash flows after the acquisition date are recognized through the provision for loan losses. For PCI loans after acquisition, cash flows expected to be collected are recast for each loan periodically as determined appropriate by management. If the present value of expected cash flows for a loan is less than its carrying value, impairment is reflected by an increase in the ALLL and a charge to the provision for loan losses. If the present value of the expected cash flows for a loan is greater than its carrying value, any previously established ALLL is reversed and any remaining difference increases the accretable yield, which will be taken into income over the remaining life of the loan. Loan dispositions may include sales of loans, receipt of payments in full from the borrower, or foreclosure. Write-downs are not recorded on the PCI loan until actual losses exceed the remaining non-accretable difference. To date, no write-downs have been recorded for the PCI loans held by the Company. Loans that were considered troubled debt restructurings by the third party prior to the acquisition date are not required to be classified as troubled debt restructurings in the Company’s consolidated financial statements unless or until such loans would subsequently meet criteria to be classified as such, since acquired loans were recorded at their estimated fair values at the time of the acquisition. Servicing Assets Certain Small Business Administration (“SBA”) loans are originated and intended for sale in the secondary market. They are carried at the lower of cost or estimated fair value in the aggregate. Net unrealized losses, if any, are recognized through a valuation allowance by charges to income. Gains or losses recognized upon the sale of loans are determined on a specific identification basis and are included in non-interest income. SBA loan transfers are accounted for as sales when control over the loan has been surrendered. Control over such loans is deemed to be surrendered when (i) the assets have been isolated from the Company, (ii) the transferee obtains the right (free of conditions that constrain it from taking advantage of that right) to pledge or exchange the transferred assets, and (iii) the Company does not maintain effective control over the transferred assets through an agreement to repurchase them before their maturity. The Company has adopted guidance issued by the FASB that clarifies the accounting and reporting standards for transfers and servicing of financial assets and extinguishments of liabilities, in which, after a transfer of financial assets, an entity recognizes the financial and servicing assets it controls and liabilities it has incurred, derecognizes financial assets when control has been surrendered, and derecognizes liabilities when extinguished. To calculate the gain or loss on sale of loans, the Company’s investment in the loan is allocated among the retained portion of the loan, the servicing retained, the interest-only strip and the sold portion of the loan, based on the relative fair value of each portion. The gain or loss on the sold portion of the loan is recognized based on the difference between the sale proceeds and the allocated investment. As a result of the relative fair value allocation, the carrying value of the retained portion is discounted, with the discount accreted to interest income over the life of the loan. Servicing assets are amortized over an estimated life using a method that is in proportion to the estimated future servicing income. In the event future prepayments exceed management’s estimates and future cash flows are inadequate to cover the servicing asset, additional amortization would be recognized. The portion of servicing fees in excess of the contracted servicing fees is reflected as interest-only strips receivable, which are classified as available for sale and are carried at fair value. At December 31, 2022 and 2021, the Company was servicing loans previously sold of approxima tely $ 8.3 million and $ 3.8 million, respectively. The related servicing assets receivable were not material to the consolidated financial statements at December 31, 2022 and 2021. Premises and Equipment Buildings, leasehold improvements, furniture and fixtures, and equipment are carried at cost, less accumulated depreciation, computed principally by the straight-line method based on the estimated useful lives of the related asset. Land is not depreciated. Major replacements and betterments are capitalized while maintenance and repairs are charged to expense when incurred. Gains or losses on dispositions are reflected in income as incurred. A small portion of building floor space is currently leased out to tenants and recognized in income when earned. Operating Leases The Company leases certain office space and stand-alone buildings which are recognized as operating lease right-of-use assets and operating lease liabilities in the consolidated balance sheets. Lease liabilities represent the Company's liability to make lease payments under these leases on a discounted basis and are amortized on a straight-line basis over the lease term for each related lease agreement. Right-of-use assets represent the Company's right to use, or control the use of, leased assets for their lease term and are amortized over the lease term of the related lease agreement. See further discussion of Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842) below. The Company does not recognize short-term operating leases on the consolidated balance sheets. A short-term lease has a term of 12 months or less and does not have a purchase option that is likely to be exercised. Other Real Estate Owned Other real estate owned represents properties acquired through or in lieu of loan foreclosure and are initially recorded at fair value less estimated costs to sell. Any write-down to fair value at the time of transfer to other real estate owned is charged to the allowance for loan losses. Costs of improvements are capitalized, whereas costs relating to holding other real estate owned and subsequent adjustments to the value are expensed. Operating and holding expenses of such properties, net of related income, are included in loan operations and other real estate owned expense on the accompanying consolidated statements of income. Gains or losses on dispositions are reflected in income as incurred. Bank-Owned Life Insurance The Company has purchased life insurance policies on certain employees. These bank-owned life insurance (“BOLI”) policies are recorded in the accompanying consolidated balance sheets at their cash surrender values. Income from these policies and changes in the cash surrender values are reported in the accompanying consolidated statements of income. Non-Marketable Securities The Company has restricted non-marketable securities which represent investment in Federal Home Loan Bank (“FHLB”) stock, Federal Reserve Bank (“FRB”) stock and Texas Independent Bank (“TIB”) stock. These investments are not readily marketable and carried at cost, which approximates fair value. As a member of the FHLB, FRB and TIB systems, the Company is required to maintain minimum level of investments in stock, based on the level of borrowings and other factors. Both cash and stock dividends are reported as income. Goodwill and Core Deposit Intangibles Goodwill represents the excess of cost over fair value of net assets acquired in a business combination. Goodwill is not amortized and is evaluated for impairment at least annually as of December 31 and on an interim basis if an event triggering impairment may have occurred. Core deposit intangibles are acquired customer relationships arising from bank acquisitions and are amortized on a straight-line basis over their estimated useful life of ten years. Core deposit intangibles are tested for impairment whenever events or changes in circumstances indicate the carrying amount of assets may not be recoverable from future undiscounted cash flows. Derivative Financial Instruments Derivatives are recorded on our Consolidated Balance Sheets as assets and liabilities measured at their fair value. The accounting for increases and decreases in the value of derivatives depends upon the use of the derivatives and whether the derivatives qualify for hedge accounting. At inception of the derivative, we designate the derivative as one of two types based on our intention and belief as to the likely effectiveness as a hedge. These two types are (1) a hedge of the fair value of a recognized asset or liability (“Fair Value Hedge”), and (2) a hedge of a forecasted transaction or the variability of cash flows to be received or paid related to a recognized asset or liability (“Cash Flow Hedge”). For a Fair Value Hedge, the gain or loss on the derivative, as well as the offsetting loss or gain on the hedged item, are recognized in noninterest income in our Consolidated Statements of Income. Fair Value Hedge instruments offered by the Company include pass-through interest rate swap products to qualified commercial banking customers. Under this type of contract, the Company enters into an interest rate swap contract with a customer, while at the same time entering into an offsetting interest rate swap contract with a financial institution counterparty. Changes in the fair value of the underlying derivatives are designed to offset each other so they would not significantly impact the Company's operating results. The Company also enters into Risk Participation Agreements (“RPAs”) with other banks, primarily to share a portion of the risk of borrower default related to the interest rate swap on certain participated loans. The aforementioned instruments are not designated as accounting hedges and do not qualify for hedge accounting. For a Cash Flow Hedge, the gain or loss on the derivative is reported in other comprehensive income (loss) and is reclassified into earnings in the same periods during which the hedged transaction affects earnings. Cash Flow Hedge instruments include pay-fixed interest rate swap agreements with a financial institution counterparty. Net cash settlements on derivatives that qualify for hedge accounting are recorded in interest expense in the Consolidated Statements of Income. Net cash settlements on derivatives that do not qualify for hedge accounting (pass-through interest rate swaps and RPAs) are reported in noninterest income in the Consolidated Statements of Income. Cash flows on hedges are classified in the cash flow statement the same as the items being hedged. We formally document the relationship between derivatives and hedged items, as well as the risk-management objective and the strategy for undertaking hedge transactions, at the inception of the hedging relationship. This documentation includes linking Cash Flow Hedges to specific assets and liabilities on the Consolidated Statements of Financial Condition or to forecasted transactions. See Note 17 – Derivative Financial Instruments. Business Combinations The Company applies the acquisition method of accounting for business combinations. Under the acquisition method, the acquiring entity in a business combination recognizes 100% of the assets acquired and liabilities assumed at their acquisition date fair values. Management utilizes valuation techniques appropriate for the asset or liability being measured in determining these fair values. Any excess of the purchase price over amounts allocated to assets acquired, including identifiable intangible assets, and liabilities assumed is recorded as goodwill. Adjustments identified during the measurement period are recognized in the reporting period in which the adjustment amounts are determined. Acquisition related costs are expensed as incurred. Comprehensive Income Comprehensive income includes all changes in shareholders’ equity during a period, except those resulting from transactions with shareholders. Other than net income, comprehensive income includes the net effect of changes in the fair value of securities available-for-sale and certain derivative instruments designated as cash flow hedges. Revenues from Contracts with Customers The Company’s revenues from services such as deposit related fees, wire transfer fees, interchange fees on debit cards, ATM fees, and merchant fee income are presented within the service charges and fees category in the accompanying consolidated statements of income and are recognized as revenue as the Company satisfies its obligation to the customer. Advertising and Marketing Expenses Advertising and marketing expenses consist of the Company’s advertising in its local market area and are expensed as incurred. For the years ended December 31, 2022, 2021 and 2020, advertising and marketing expenses were $ 1.9 million, $ 1.9 million and $ 1.3 million, respectively, and are included within noninterest expense in the accompanying consolidated statements of income. Income Taxes The Company files a consolidated income tax return with its subsidiary. Federal income tax expense or benefit is allocated on a separate return basis. Deferred tax assets and liabilities are reflected at currently enacted income tax rates applicable to the period in which the deferred tax assets and liabilities are expected to be realized or settled. As changes in tax laws or rates are enacted, deferred tax assets and liabilities are adjusted through the provision for income taxes. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Share-Based Compensation Compensation expense for stock options is based on the fair value of the award on the measurement date, which, for the Company, is the date of the grant and is recognized ratably over the service period of the award. The fair value of stock options is estimated using the Black-Scholes option-pricing model. Basic and Diluted Earnings Per Common Share Earnings per common share is computed in accordance with ASC Topic 260, “Earnings Per Share.” Basic earnings per common share is computed by dividing net earnings allocated to common stock by the weighted-average number of common shares outstanding during the applicable period. Diluted earnings per common share is computed using the weighted-average number of shares determined for the basic earnings per common share computation plus the dilutive effect of stock compensation using the treasury stock method, plus the dilutive effect of convertible preferred stock using the if-converted method. A reconciliation of the weighted-average shares used in calculating basic earnings per common share and the weighted average common shares used in calculating diluted earnings per common share for the reported periods is provided in Note 16 – Earnings Per Common Share. Reclassification Certain amounts in prior period consolidated financial statements may have been reclassified to conform to current period presentation. These reclassifications are immaterial and have no effect on net income, total assets or shareholders’ equity. Recently Adopted Accounting Standards The Company adopted ASU 2016-02 - “Leases” (Topic 842) on January 1, 2022 using the effective date as the date of initial adoption. The Company elected to apply certain practical expedients for transition, and under those expedients the Company did not reassess prior accounting decisions regarding the identification, classification and initial direct costs leases existing at the effective date. The Company also elected to use hindsight in determining the lease term when considering options to extend the lease and excluded short-term leases (defined as lease terms of 12 months or less). The Company elected to separate non-lease components from lease components in its application of ASU 2016-02. At adoption, the Company recorded right-of-use assets totaling $ 11.0 million, which represented the Company's right to use, or control the use of, specified assets for their lease terms, and the Company recorded lease liabilities totaling $ 10.9 million, which represented the Company's liability to make lease payments under these leases. The ASU 2016-02 standard applied to all leases existing at the date of initial adoption. The Company's financial statements and related footnotes were not updated for ASU 2016-02 for dates and periods before the date of adoption. See Note 9 – Leases. Recently Issued Accounting Standards - Not Yet Adopted In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 is effective for fiscal years beginning after December 15, 2022. ASU 2016-13 is intended to replace the incurred loss model for loans and other financial assets with an expected loss model, which is known as the current expected credit loss (“CECL”) model. The change is intended to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit. The Company adopted ASU 2016-13 on January 1, 2023 and recorded an increase in the allowance for credit losses of approximately $ 4.0 million.

Investment Securities Available

Investment Securities Available for Sale	12 Months Ended
Investment Securities Available for Sale	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Investment Securities Available for Sale	2. Investment Securities Available for Sale Investment securities have been classified in the consolidated balance sheets according to management’s intent. The carrying amount of securities and their approximate fair values as of December 31, 2022 and 2021 are as follows: December 31, 2022 (Dollars in thousands) Amortized Gross Gross Estimated Securities available-for-sale: State and municipal securities $ 422 $ — $ 5 $ 417 Mortgage-backed securities and other agency obligations 23,522 238 879 22,881 U.S. Treasury bonds 100,567 — 2,049 98,518 Corporate bonds 57,607 59 3,415 54,251 $ 182,118 $ 297 $ 6,348 $ 176,067 December 31, 2021 (Dollars in thousands) Amortized Gross Gross Estimated Securities Available-for-sale: State and municipal securities $ 1,087 $ 7 $ — $ 1,094 Mortgage-backed securities and other agency obligations 791 20 — 811 U.S. Treasury bonds — — — — Corporate bonds 23,556 972 1 24,527 $ 25,434 $ 999 $ 1 $ 26,432 Mortgage-backed securities are typically issued with stated principal amounts and are backed by pools of mortgages that have loans with varying maturities. The characteristics of the underlying pool of mortgages, such as prepayment risk, are passed on to the certificate holder. Accordingly, the term of mortgage-backed securities approximates the term of the underlying mortgages and can vary significantly due to prepayments. Therefore, schedules of maturities for mortgage-backed securities have been excluded from the below disclosure. The amortized cost and estimated fair value of securities available for sale at December 31, 2022, by contractual maturity, are shown below. December 31, 2022 Securities (Dollars in thousands) Amortized Estimated Due in one year or less $ 100,990 $ 98,935 Due from one year to five years 3,778 3,838 Due from five to ten years 53,828 50,413 158,596 153,186 Mortgage-backed securities and other agency obligations 23,522 22,881 $ 182,118 $ 176,067 The following table summarizes securities with unrealized losses at December 31, 2022 and 2021, aggregated by major security type and length of time in a continuous unrealized loss position: December 31, 2022 (Dollars in thousands) Less Than 12 Greater Than 12 Total Estimated Securities available-for-sale: State and municipal securities $ 5 $ — $ 5 $ 417 Mortgage-backed securities and other agency obligations 879 — 879 18,376 U.S. Treasury bonds 2,049 — 2,049 98,518 Corporate bonds 3,415 — 3,415 50,413 $ 6,348 $ — $ 6,348 $ 167,724 December 31, 2021 (Dollars in thousands) Less Than 12 Greater Than 12 Total Estimated Securities available-for-sale: State and municipal securities $ — $ — $ — $ — Mortgage-backed securities and other agency obligations — — — — U.S. Treasury bonds — — — — Corporate bonds — 1 1 3,999 $ — $ 1 $ 1 $ 3,999 There were 35 investments in an unrealized loss position at December 31, 2022, and two investments in an unrealized loss position at December 31, 2021. The Company does not consider any securities to be other-than-temporarily impaired. In estimating other-than-temporary impairment losses, the Company considers, among other things, (i) the length of time and the extent to which the fair value has been less than cost, (ii) the financial condition and near term prospects of the issuer, (iii) that the Company does not intend to sell these securities, and (iv) it is more likely than not that the Company will not be required to sell before a period of time sufficient to allow for any anticipated recovery in fair value. The Company has reviewed the ratings of the issuers and has not identified any issues related to the ultimate repayment of principal because of credit concerns on these securities. There were no securities pledged as collateral as of December 31, 2022 and 2021.

Loans and Allowance for Loan Lo

Loans and Allowance for Loan Losses	12 Months Ended
Loans and Allowance for Loan Losses	Dec. 31, 2022
Receivables [Abstract]
Loans and Allowance for Loan Losses	3. Lo ans and Allowance for Loan Losses Loans in the accompanying consolidated balance sheets consisted of the following: December 31, (Dollars in thousands) 2022 2021 Real estate loans: Non-farm non-residential owner occupied $ 493,791 $ 383,941 Non-farm non-residential non-owner occupied 506,012 445,308 Residential 308,775 213,264 Construction, development & other 567,851 320,335 Farmland 22,820 9,934 Commercial & industrial 1,058,910 611,348 Consumer 3,872 4,001 Municipal and other 145,520 80,593 3,107,551 2,068,724 Allowance for loan losses ( 30,351 ) ( 19,295 ) Loans, net $ 3,077,200 $ 2,049,429 Total loans are presented net of unaccreted discounts and deferred fees net of deferred costs tota ling $ 7.8 million and $ 6.5 million at December 31, 2022 and 2021, respectively. The Company h ad $ 537,000 and $ 81.6 million in outstanding loan balances related to the guaranteed SBA Paycheck Protection Program (“PPP”) as of December 31, 2022 and 2021, respectively. These loans are included within the commercial and industrial loan balances throughout the footnotes. Non-accrual and Past Due Loans Loans are considered past due if the required principal and interest payments have not been received as of the date such payments were due. As mentioned in Note 1, the accrual of interest on loans is discontinued when there is a clear indication that the borrower’s cash flow may not be sufficient to meet payments as they become due, which is generally when a loan is 90 days past due. Non-accrual loans and accruing loans past due more than 90 days segregated by class of loans were as follows: December 31, 2022 2021 (Dollars in thousands) Non-accrual Accruing loans Non-accrual Accruing loans Real estate loans: Non-farm non-residential owner occupied $ 1,699 $ 157 $ 1,008 $ — Non-farm non-residential non-owner occupied 296 — 346 — Residential 513 — 127 — Construction, development & other 40 — 244 — Farmland — — — — Commercial & industrial 8,390 361 8,297 278 Consumer 20 — — — Municipal and other — — — — Purchased credit impaired 5 — 8 — $ 10,963 $ 518 $ 10,030 $ 278 As of December 31, 2022, 2021, and 2020, the amount of income that would have been accrued for loans on non-accrual was approximately $ 581,000 , $ 453,000 , and $ 298,000 , respectively. An age analysis of past due loans, segregated by class of loans, were as follows: December 31, 2022 (Dollars in thousands) 30-59 60-89 Over 90 Total Total Total Real estate loans: Non-farm non-residential $ 2,996 $ — $ 1,856 $ 4,852 $ 488,939 $ 493,791 Non-farm non-residential 132 — 296 428 505,584 506,012 Residential 2,356 — 513 2,869 305,906 308,775 Construction, 130 — 40 170 567,676 567,846 Farmland — — — — 22,820 22,820 Commercial & industrial 791 613 8,751 10,155 1,048,704 1,058,859 Consumer — — 20 20 3,852 3,872 Municipal and other 162 — — 162 145,358 145,520 Purchased credit impaired — — 5 5 51 56 $ 6,567 $ 613 $ 11,481 $ 18,661 $ 3,088,890 $ 3,107,551 December 31, 2021 (Dollars in thousands) 30-59 60-89 Over 90 Total Total Total Real estate loans: Non-farm non-residential $ 291 $ — $ 1,008 $ 1,299 $ 382,642 $ 383,941 Non-farm non-residential 161 — 346 507 444,079 444,586 Residential 230 — 127 357 212,822 213,179 Construction, — 395 244 639 315,584 316,223 Farmland — — — — 9,934 9,934 Commercial & industrial 960 457 8,575 9,992 601,291 611,283 Consumer 9 — — 9 3,992 4,001 Municipal and other 18 1 — 19 80,574 80,593 Purchased credit impaired — — 8 8 4,976 4,984 $ 1,669 $ 853 $ 10,308 $ 12,830 $ 2,055,894 $ 2,068,724 Impaired Loans The following tables present impaired loans by class of loans: December 31, 2022 (Dollars in thousands) Unpaid Recorded Recorded Total Related Average Real estate loans: Non-farm non-residential $ 1,694 $ 1,699 $ — $ 1,699 $ — $ 1,751 Non-farm non-residential 5,497 5,496 — 5,496 — 5,563 Residential 516 513 — 513 — 524 Construction, 40 40 — 40 — 51 Farmland — — — — — — Commercial & industrial 11,891 7,734 4,162 11,896 1,587 10,691 Consumer 19 20 — 20 — 21 Municipal and other — — — — — — Purchased credit impaired 51 — 51 51 13 58 $ 19,708 $ 15,502 $ 4,213 $ 19,715 $ 1,600 $ 18,659 December 31, 2021 (Dollars in thousands) Unpaid Recorded Recorded Total Related Average Real estate loans: Non-farm non-residential $ 1,008 $ 1,008 $ — $ 1,008 $ — $ 1,051 Non-farm non-residential 5,641 5,630 — 5,630 — 5,680 Residential 130 127 — 127 — 138 Construction, 241 244 — 244 — 255 Farmland — — — — — — Commercial & industrial 8,297 7,331 967 8,298 290 9,117 Consumer — — — — — — Municipal and other — — — — — — Purchased credit impaired 65 — 65 65 17 71 $ 15,382 $ 14,340 $ 1,032 $ 15,372 $ 307 $ 16,312 Interest payments received on impaired loans are recorded as interest income unless collections of the remaining recorded investment are doubtful, at which time payments received are recorded as reductions of principal. Interest income collected on impaired loans was approximately $ 368,000 , $ 248,000 and $ 26,000 for the years ended December 31, 2022, 2021 and 2020, respectively. Troubled Debt Restructuring During the year ended December 31, 2022 and 2021, the terms of one loan were modified as a troubled debt restructuring (“TDR”). The following table presents modifications of loans the Company considers to be TDR loans: December 31, 2022 Loan modifications (Dollars in thousands) Number Pre- Post- Adjusted Payment Combined Real estate loans: Non-farm non-residential 3 $ 822 $ 822 $ — $ 822 $ — Non-farm non-residential — — — — — — Residential — — — — — — Construction, — — — — — — Farmland — — — — — — Commercial & industrial 1 780 780 — 780 — Consumer — — — — — — Municipal and other — — — — — — 4 $ 1,602 $ 1,602 $ — $ 1,602 $ — December 31, 2021 Loan modifications (Dollars in thousands) Number Pre- Post- Adjusted Payment Combined Real estate loans: Non-farm non-residential 3 $ 878 $ 878 $ — $ 878 $ — Non-farm non-residential 1 5,294 5,294 — 5,294 — Residential — — — — — — Construction, — — — — — — Farmland — — — — — — Commercial & industrial — — — — — — Consumer — — — — — — Municipal and other — — — — — — 4 $ 6,172 $ 6,172 $ — $ 6,172 $ — No loans modified under a TDR during the previous twelve-month period were in default as of December 31, 2022 and 2021. A default for purposes of this disclosure is a troubled debt restructured loan in which the borrower is 90 days past due or results in the foreclosure and repossession of the applicable collateral. At December 31, 2022 and 2021, the Company had no commitments to lend additional funds to borrowers with loans whose terms had been modified under TDRs. COVID-19 Loan Deferments Certain borrowers were unable to meet their contractual payment obligations because of the adverse effects of COVID-19. During March of 2020 and to help mitigate these effects, the Company began offering deferral modifications of principal and/or interest payments for varying periods, but typically no more than 90 days. After 90 days, customers could apply for an additional deferral, and a small portion of our customers requested such an additional deferral. At December 31, 2022 and 2021, the Company had approximately 261 and 500 loans totaling $ 150.7 mill ion and $ 223.6 million, respectively, in outstanding loan balances that were subject to deferral and modification agreements due to COVID-19 whereby the principal and/or interest payments were deferred to the end of each loan term. Subsequent to the approved deferral period, customers resumed their regular payments. The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) provides banks an option to elect to not account for certain loan modifications related to COVID-19 as TDRs if the borrowers were not more than 30 days past due at December 31, 2019. In the absence of other intervening factors, such short-term modifications made on a good faith basis are not categorized as TDRs, nor are loans granted payment deferrals related to COVID-19 reported as past due or placed on non-accrual status. At December 31, 2022 and 2021, $ 3.3 million and $ 4.4 million, respectively, in accrued interest receivables related to these loans remained outstanding and will be collected at the end of eac h loan term. Credit Quality Indicators Credit Quality Indicators. From a credit risk standpoint, the Company classifies its loans in one of six categories: (i) pass, (ii) special mention, (iii) substandard, (iv) purchased credit impaired, (v) doubtful, or (vi) loss. The classifications of loans reflect a judgment about the risks of default and loss associated with the loan. The Company reviews the ratings on credits monthly. Ratings are adjusted to reflect the degree of risk and loss that is felt to be inherent in each credit as of each monthly reporting period. The Company’s methodology is structured so that specific allocations are increased in accordance with deterioration in credit quality (and a corresponding increase in risk and loss) or decreased in accordance with improvement in credit quality (and a corresponding decrease in risk and loss). (i) The Company has several pass credit grades that are assigned to loans based on varying levels of credits, ranging from credits that are secured by cash or marketable securities, to watch credits that have all the characteristics of an acceptable credit risk but warrant more than the normal level of supervision. (ii) Special mention loans are loans that still show sufficient cash flow to service their debt but show a declining financial trend with potential cash flow shortages if trends continue. This category should be treated as a temporary grade. If cash flow deteriorates further to become negative, then a substandard grade should be given. If cash flow trends begin to improve then an upgrade back to pass would be justified. Nonfinancial reasons for rating a credit special mention include management problems, pending litigation, an ineffective loan agreement or other material structure weakness. (iii) A substandard loan has material weakness in the primary repayment source such as insufficient cash flow from operations to service the debt. However, other weaknesses such as limited paying capacity of the obligor or the collateral pledged could justify a substandard grade. Substandard loans must have a well-defined weakness, or weaknesses that jeopardize the liquidation of the debt. (iv) Credits purchased from third parties are recorded at their estimated fair value at the acquisition date and are classified as PCI loans if the loans reflect credit deterioration since origination and it is probable at acquisition that the Company will be unable to collect all contractually required payments. See Note 1 – Nature of Operations and Summary of Significant Accounting Policies - Certain Acquired Loans. (v) A loan classified as doubtful has all the weaknesses of a substandard loan with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable. A doubtful loan has a high probability of total or substantial loss, but because of specific pending events that may strengthen the asset, its classification as loss is deferred. Doubtful borrowers are usually in default, lack adequate liquidity or capital, and lack the resources necessary to remain an operating entity. Because of high probability of loss, non-accrual status is required on doubtful loans. (vi) Loans classified as loss are considered uncollectible and of such little value that their continuance as banking assets are not warranted. This classification does not mean that the asset has absolutely no recovery or salvage value, but rather that it is not practical or desirable to defer writing off this basically worthless asset even though partial recovery may be affected in the future. With loans classified as loss, the underlying borrowers are often in bankruptcy, have formally suspended debt repayments, or have otherwise ceased normal business operations. Once an asset is classified as loss, there is little prospect of collecting either its principal or interest. When access to collateral, rather than the value of the collateral, is a problem, a less severe classification may be appropriate. However, the Company does not maintain an asset on the balance sheet if realizing its value would require long-term litigation or other lengthy recovery efforts. Losses are to be recorded in the period an obligation becomes uncollectible. The following tables summarize the Company’s internal ratings of its loans: December 31, 2022 (Dollars in thousands) Pass Special Substandard Purchased Doubtful Total Real estate loans: Non-farm non-residential $ 487,633 $ 1,885 $ 4,273 $ — $ — $ 493,791 Non-farm non-residential 498,987 228 6,797 — — 506,012 Residential 307,881 — 894 — — 308,775 Construction, 559,186 8,620 40 5 — 567,851 Farmland 22,820 — — — — 22,820 Commercial & industrial 1,051,314 2,252 5,293 51 — 1,058,910 Consumer 3,852 — 20 — — 3,872 Municipal and other 145,520 — — — — 145,520 $ 3,077,193 $ 12,985 $ 17,317 $ 56 $ — $ 3,107,551 December 31, 2021 (Dollars in thousands) Pass Special Substandard Purchased Doubtful Total Real estate loans: Non-farm non-residential $ 370,062 $ 6,953 $ 6,926 $ — $ — $ 383,941 Non-farm non-residential 428,972 8,338 7,276 722 — 445,308 Residential 212,109 — 1,069 86 — 213,264 Construction, 315,979 — 244 4,112 — 320,335 Farmland 9,934 — — — — 9,934 Commercial & industrial 605,322 1,146 4,816 64 — 611,348 Consumer 3,979 22 — — — 4,001 Municipal and other 80,593 — — — — 80,593 $ 2,026,950 $ 16,459 $ 20,331 $ 4,984 $ — $ 2,068,724 Allowance for Loan Losses The majority of the loan portfolio is comprised of loans to businesses and individuals in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets. This geographic concentration subjects the loan portfolio to the general economic conditions within this area. The risks created by this concentration has been considered by management in the determination of the adequacy of the allowance for loan losses. Management believes the allowance for loan losses is adequate to cover estimated losses on loans at December 31, 2022, 2021 and 2020. The following tables detail the activity in the allowance for loan losses by portfolio segment: For the Year Ended December 31, 2022 (Dollars in thousands) Beginning Provision for Charge-offs Recoveries Ending Real estate loans: Non-farm non-residential $ 3,456 $ 317 $ — $ — $ 3,773 Non-farm non-residential 5,935 ( 194 ) — — 5,741 Residential 957 107 — — 1,064 Construction, development & other 2,064 989 — — 3,053 Farmland 45 37 — — 82 Commercial & industrial 6,500 10,911 ( 1,214 ) 72 16,269 Consumer 6 5 ( 18 ) 13 6 Municipal and other 332 28 — 3 363 $ 19,295 $ 12,200 $ ( 1,232 ) $ 88 $ 30,351 For the Year Ended December 31, 2021 (Dollars in thousands) Beginning Provision for Charge-offs Recoveries Ending Real estate loans: Non-farm non-residential $ 2,608 $ 848 $ — $ — $ 3,456 Non-farm non-residential 3,107 2,828 — — 5,935 Residential 1,218 ( 261 ) — — 957 Construction, development & other 932 1,132 — — 2,064 Farmland 32 13 — — 45 Commercial & industrial 3,858 5,233 ( 2,914 ) 323 6,500 Consumer 35 ( 30 ) — 1 6 Municipal and other 189 160 ( 20 ) 3 332 $ 11,979 $ 9,923 $ ( 2,934 ) $ 327 $ 19,295 For the Year Ended December 31, 2020 (Dollars in thousands) Beginning Provision for Charge-offs Recoveries Ending Real estate loans: Non-farm non-residential $ 2,158 $ 450 $ — $ — $ 2,608 Non-farm non-residential 1,627 3,816 ( 2,336 ) — 3,107 Residential 373 845 — — 1,218 Construction, development & other 330 602 — — 932 Farmland 29 3 — — 32 Commercial & industrial 3,504 1,710 ( 1,389 ) 33 3,858 Consumer 16 21 ( 7 ) 5 35 Municipal and other 86 103 — — 189 $ 8,123 $ 7,550 $ ( 3,732 ) $ 38 $ 11,979 The following tables summarize the allocation of the allowance for loan losses, by portfolio segment, for loans evaluated for impairment individually and collectively: December 31, 2022 Period end amounts of ALLL (Dollars in thousands) Individually Collectively PCI Total Real estate loans: Non-farm non-residential owner occupied $ — $ 3,773 $ — $ 3,773 Non-farm non-residential non-owner occupied — 5,741 — 5,741 Residential — 1,064 — 1,064 Construction, development & other — 3,053 — 3,053 Farmland — 82 — 82 Commercial & industrial 1,587 14,669 13 16,269 Consumer — 6 — 6 Municipal and other — 363 — 363 $ 1,587 $ 28,751 $ 13 $ 30,351 December 31, 2021 Period end amounts of ALLL (Dollars in thousands) Individually Collectively PCI Total Real estate loans: Non-farm non-residential owner occupied $ — $ 3,456 $ — $ 3,456 Non-farm non-residential non-owner occupied — 5,935 — 5,935 Residential — 957 — 957 Construction, development & other — 2,064 — 2,064 Farmland — 45 — 45 Commercial & industrial 290 6,193 17 6,500 Consumer — 6 — 6 Municipal and other — 332 — 332 $ 290 $ 18,988 $ 17 $ 19,295 The company’s recorded investment in loans related to the balance in the allowance for loan losses on the basis of the Company’s impairment methodology is as follows: December 31, 2022 Loans evaluated for (Dollars in thousands) Individually Collectively PCI Total Real estate loans: Non-farm non-residential owner occupied $ 1,699 $ 492,092 $ — $ 493,791 Non-farm non-residential non-owner occupied 5,496 500,516 — 506,012 Residential 513 308,262 — 308,775 Construction, development & other 40 567,811 — 567,851 Farmland — 22,820 — 22,820 Commercial & industrial 11,896 1,046,963 51 1,058,910 Consumer 20 3,852 — 3,872 Municipal and other — 145,520 — 145,520 $ 19,664 $ 3,087,836 $ 51 $ 3,107,551 December 31, 2021 Loans evaluated for (Dollars in thousands) Individually Collectively PCI Total Real estate loans: Non-farm non-residential owner occupied $ 1,008 $ 382,933 — $ 383,941 Non-farm non-residential non-owner occupied 5,630 439,678 — 445,308 Residential 127 213,137 — 213,264 Construction, development & other 244 320,091 — 320,335 Farmland — 9,934 — 9,934 Commercial & industrial 8,363 602,920 65 611,348 Consumer — 4,001 — 4,001 Municipal and other — 80,593 — 80,593 $ 15,372 $ 2,053,287 $ 65 $ 2,068,724 Certain Acquired Loans During 2013, the Company purchased certain loans from a third party with gross contractual balances of $ 8.2 million for a purchase price of $ 6.3 million, resulting in a discount of $ 1.9 million. Upon acquisition, the acquired loans were initially segregated and classified in one of two categories: 1) PCI loans and 2) acquired performing loans. At acquisition date, estimated fair values of PCI loans and acquired performing loans were $ 3.2 million and $ 3.1 million, respectively. The gross contractual amounts receivable for PCI loans and acquired performing loans were $ 4.5 million and $ 3.7 million, respectively, as of the acquisition date. In connection with the January 1, 2020 acquisition of Heritage Bancorp, Inc. and its subsidiary, Heritage Bank, the Company acquired loans with gross contractual balances of $ 263.3 million for a fair value of $ 259.6 million, resulting in a discount of $ 3.7 million. At acquisition date, the estimated fair values of PCI loans and acquired performing loans were $ 9.8 million and $ 249.8 million, respectively. The gross contractual amounts receivable for PCI loans and acquired performing loans were $ 12.6 million and $ 250.7 million, respectively, as of the acquisition date. The following table presents the gross contractual amounts receivable balances, by portfolio segment, and the carrying amount of PCI loans: December 31, (Dollars in thousands) 2022 2021 Real estate loans: Non-farm non-residential owner occupied $ — $ — Non-farm non-residential non-owner occupied — 820 Residential 77 181 Construction, development & other 5 5,169 Farmland — — Commercial & industrial 52 66 Consumer — — Other — — Total outstanding balances $ 134 $ 6,236 Carrying amount $ 56 $ 4,984 The accretable discount is accreted into income using the interest method over the life of the loans. At December 31, 2022 and 2021, unaccreted discounts on PCI loans tot aled $ 164,000 and $ 926,000 , respectively, and were included in net loans in the accompanying consolidated balance sheets. At December 31, 2022 and 2021, the allowance for loan losses related to the PCI loans disclosed above was $ 13,000 and $ 17,000 , respectively. Accretable yield, or income expected to be collected on PCI loans was as follows: December 31, (Dollars in thousands) 2022 2021 2020 Balance at beginning of year $ 926 $ 2,261 $ 83 New loans acquired from Heritage acquisition — — 2,726 Accretion of income ( 762 ) ( 1,335 ) ( 808 ) Reclassifications from non-accretable difference — — 260 Balance at end of year $ 164 $ 926 $ 2,261

Premises and Equipment

Premises and Equipment	12 Months Ended
Premises and Equipment	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Premises and Equipment	4. Premises and Equipment Premises and equipment in the accompanying consolidated balance sheets consisted of the following: Estimated December 31, (Dollars in thousands) Useful Life 2022 2021 Building 30 years $ 8,662 $ 8,404 Building improvements 3 - 10 years 4,943 3,752 Land 3,894 3,894 Equipment 3 - 5 years 5,757 4,308 Leasehold improvements 3 - 10 years 9,761 2,888 Furniture and fixtures 3 - 5 years 4,170 2,541 Construction in process 1,964 1,174 39,151 26,961 Accumulated depreciation ( 10,489 ) ( 7,916 ) $ 28,662 $ 19,045 Depreciation expense for the years ended December 31, 2022, 2021 and 2020 amounted to $ 2.6 million, $ 1.7 million and $ 1.5 million, respectively. Depreciation expense is included in occupancy and equipment expense in the accompanying consolidated statements of income.

Deposits

Deposits	12 Months Ended
Deposits	Dec. 31, 2022
Deposits Liabilities, Balance Sheet, Reported Amounts [Abstract]
Deposit	5. Deposits Deposits in the accompanying consolidated balance sheets consisted of the following: December 31, (Dollars in thousands) 2022 2021 Transaction accounts: Noninterest bearing demand accounts $ 486,114 $ 531,401 Interest bearing demand accounts 2,498,325 1,298,546 Savings 35,677 33,539 Total transaction accounts 3,020,116 1,863,486 Time deposits 216,030 277,713 Total deposits $ 3,236,146 $ 2,141,199 The aggregate amount of time deposits in denominations of $250,000 or more totaled $ 135.5 million and $ 113.2 million as of December 31, 2022 and 2021, respectively. Scheduled maturities of time deposits at December 31, 2022 are as follows: 2023 $ 181,926 2024 28,578 2025 2,971 2026 1,567 2027 and thereafter 988 $ 216,030 At December 31, 2022 and 2021, the aggregate amount of demand deposit overdrafts that were reclassified as loans was approximately $ 31,000 and $ 40,000 , respectively. Deposits received from related parties at December 31, 2022 and 2021, totaled approximately $ 16.0 million and $ 19.0 million, respectively.

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	6. Income Taxes During the years ended December 31, 2022 and 2021, the Company recorded income tax provision expense of $ 4.5 million and $ 3.1 million, reflecting an effective tax rate of 19.5 % and 21.1 %, respectively. The provision for income taxes consisted of the following: December 31, (Dollars in thousands) 2022 2021 Current income tax expense $ 5,759 $ 3,439 Deferred income tax benefit ( 1,250 ) ( 380 ) Income tax expense as reported $ 4,509 $ 3,059 A reconciliation of reported income tax expense to the amount computed by the Company's statutory income tax rate of 21 % to income before income taxes is presented below: December 31, (Dollars in thousands) 2022 2021 Income tax expense computed at statutory rate $ 4,865 $ 3,042 Stock-based compensation 117 93 Bank-owned life insurance ( 276 ) ( 119 ) Non-deductible meals, entertainment, and dues 91 57 Tax-exempt income ( 283 ) ( 2 ) Non-deductible merger costs — 2 Other, net ( 5 ) ( 14 ) Income tax expense as reported $ 4,509 $ 3,059 A summary of deferred taxes is presented below: December 31, (Dollars in thousands) 2022 2021 Deferred tax assets: Allowance for loan losses $ 6,352 $ 4,046 Organizational and start-up costs 6 18 Accrued expenses 264 1,189 Stock options and restricted stock 114 131 Loan purchase mark-to-mark 62 216 Deposit purchase premium — 38 Deferred loan origination fees 1,564 433 Net unrealized loss on securities available for sale 1,271 — Non-accrual interest 241 150 Other 118 2 Total deferred tax assets 9,992 6,223 Deferred tax liabilities: Premises and equipment 2,468 1,161 Goodwill and core deposit intangibles 237 271 Investments 68 66 Net unrealized gain on securities available for sale — 210 Unrealized gain on derivatives 712 161 Prepaid expenses and other 204 231 Total deferred tax liabilities 3,689 2,100 Net deferred tax asset $ 6,303 $ 4,123 GAAP prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Benefits from tax positions should be recognized in the consolidated financial statements only when it is more likely than not that the tax position will be sustained upon examination by the appropriate taxing authority that would have full knowledge of all relevant information. A tax position that meets the more-likely-than-not recognition threshold is measured at the largest amount of cumulative benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not recognition threshold should be derecognized in the first subsequent financial reporting period in which that threshold is no longer met. GAAP also provides guidance on the accounting for and disclosure of unrecognized tax benefits, interest and penalties.

FHLB Advances and Other Borrowi

FHLB Advances and Other Borrowings	12 Months Ended
FHLB Advances and Other Borrowings	Dec. 31, 2022
Federal Home Loan Banks [Abstract]
FHLB Advances and Other Borrowings	7. FHLB Advances and Other Borrowings FHLB Borrowings The FHLB allows the Company to borrow on a blanket floating lien status collateralized by FHLB stock and real estate loans. As of December 31, 2022 and 2021, total borrowing capacity available under this arrangement was $ 719.1 million and $ 450.4 million, respectively. The Company had no FHLB advances outstanding at December 31, 2022 and $ 50.0 million were outstanding at December 31, 2021. Letters of credit with the FHLB in the amount of $ 290.3 million were issued at December 31, 2022. The letters of credit are used to collateralize public fund deposit accounts in excess of FDIC insurance limits and have expirations ranging f rom January 2023 through December 2023 . Line of Credit - Senior Debt On March 10, 2021, the Company combined a $ 10.0 million promissory note scheduled to mature on August 31, 2021 , with the remaining balance of a $ 10.9 million note scheduled to mature on March 10, 2021 . The remaining balance of the two aforementioned notes totaling $ 20.9 million was consolidated into a new revolving line of credit loan with new funds of $ 10.0 million for a total facility of $ 30.9 million. The note bore interest at The Wall Street Journal US Prime Rate, as such changes from time to time, with a floor rate of 4.00 % per annum. Interest was payable quarterly on the 10 th day of March, June, September and December through maturity date of September 10, 2022 . All principal and unpaid interest was due at maturity. Upon maturity, the outstanding balance of the note was renewed for $ 30.9 million, and the total revolving line of credit facility was increased to $ 50.0 million with payment terms similar to the payment terms of the previous agreement. The note bears interest at The Wall Street Journal US Prime Rate, as such changes from time to time, plus 0.50 %, with a floor rate of 5.00 % per annum. Interest is payable quarterly on the 10 th day of March, June, September and December through maturity date of September 10, 2024 . All principal and unpaid interest is due at maturity. The note is secured by 100 % of the outstanding stock of the Bank and is senior in rights to the subordinated debt and subordinated notes described below. At December 31, 2022, the outstanding balance on the line of credit was $ 30.9 million. Note Payable - Subordinated Debt During August 2021, the Company paid off a $ 2.0 million promissory note scheduled to mature on September 27, 2022 and an $ 11.0 million promissory note scheduled to mature on July 29, 2022 . Each note bore interest at a fixed rate of 6.00 %. Quarterly interest payments for the $ 2.0 million note were due on the 27 th day of March, June, September and December. Quarterly interest payments for the $ 11.0 million note were due on the 29 th day of March, June, September and December. The notes were subordinate and junior in rights to the senior indebtedness described above. On March 31, 2022, the Company entered into Subordinated Note Purchase Agreements (the “Note Purchase Agreements”) with certain qualified institutional buyers and institutional accredited investors (the “Purchasers”) pursuant to which the Company issued and sold $ 82.3 million in aggregate principal amount of its 5.500 % Fixed-to-Floating Rate Subordinated Notes due 2032 (the “Notes”) in a private placement transaction in reliance on exemptions from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) of the Securities Act and Regulation D thereunder. The Notes were issued by the Company to the Purchasers at a price equal to 100 % of their face amount. The Note Purchase Agreements contain certain customary representations, warranties and covenants made by the Company, on the one hand, and the Purchasers, severally and not jointly, on the other hand. The Notes are intended to qualify as Tier 2 capital for regulatory capital purposes. The Notes were issued under an Indenture, dated as of March 31, 2022 (the “Indenture”), by and between the Company and UMB Bank, N.A., as trustee. The Notes will mature on April 1, 2032 . From and including March 31, 2022, to, but excluding, April 1, 2027 or the date of early redemption, the Company will pay interest on the Notes semi-annually in arrears on April 1 and October 1 of each year, commencing on October 1, 2022 , at a fixed interest rate of 5.500 % per annum. From and including April 1, 2027, to, but excluding, the maturity date or the date of early redemption (the “Floating Rate Period”), the Company will pay interest on the Notes at a floating interest rate. The floating interest rate will be reset quarterly, and the interest rate for any Floating Rate Period shall be equal to the then-current Three-Month Term Secured Overnight Financing Rate (“SOFR”) plus 315 basis points for each quarterly interest period during the Floating Rate Period. Interest payable on the Notes during the Floating Rate Period will be paid quarterly in arrears on January 1, April 1, July 1 and October 1, of each year, commencing on July 1, 2027. Notwithstanding the foregoing, in the event that Three-Month Term SOFR is less than zero, then Three-Month Term SOFR rate shall be deemed to be zero. On March 31, 2022, in connection with the issuance and sale of the Notes, the Company entered into Registration Rights Agreements with the Purchasers. Under the terms of the Registration Rights Agreements, the Company agreed to take certain actions to provide for the exchange of the Notes for subordinated notes that are registered under the Securities Act and have substantially the same terms as the Notes. The exchange offer under the Registration Rights Agreement was completed on July 19, 2022. The Company may, at its option, redeem the Notes (i) in whole or in part beginning with the interest payment date on April 1, 2027 , and on any interest payment date thereafter, or (ii) in whole, but not in part, upon the occurrence of a “Tier 2 Capital Event,” a “Tax Event,” or “Investment Company Event”. The redemption price for any redemption is 100 % of the principal amount of the Notes, plus accrued and unpaid interest thereon to, but excluding, the date of redemption. Any redemption of the Notes will be subject to the receipt of the approval of the Board of Governors of the Federal Reserve System (the “Federal Reserve”) to the extent then required under applicable laws or regulations, including capital adequacy rules or regulations. There is no right of acceleration of maturity of the Notes in the case of default in the payment of principal of, or interest on, the Notes or in the performance of any other obligation of the Company under the Notes or the Indenture. The Indenture provides that holders of the Notes may accelerate payment of indebtedness only upon the Company’s bankruptcy, insolvency, reorganization, receivership or other similar proceedings. The Notes are general unsecured, subordinated obligations of the Company and rank junior to all of its existing and future Senior Indebtedness (as defined in the Indenture), including all of its general creditors. The Notes will be equal in right of payment with any of the Company’s existing and future subordinated indebtedness, and will be senior to the Company’s obligations relating to any junior subordinated debt securities. In addition, the Notes are effectively subordinated to all secured indebtedness of the Company, including without limitation, the Bank’s liabilities to depositors in connection with deposits in the Bank, to the extent of the value of the collateral securing such indebtedness. In connection with the above offering, the Company incurred approximatel y $ 2.1 million in debt issuance costs which will be amortized to interest expense on a straight-line basis over the ten-year life of the note. As of December 31, 2022, the Company had $ 82.3 million in out standing principal and $ 1.9 million in unamortized debt issuance costs. Contractual maturities of FHLB advances and other borrowings at December 31, 2022 were as follows: (Dollars in thousands) FHLB Senior Debt Subordinated 2023 $ — $ — $ — 2024 — 30,875 — 2025 — — — 2026 — — — 2027 and thereafter — — 80,348 $ — $ 30,875 $ 80,348 At December 31, 2022 and 2021, the Company had federal funds lines of credit with commercial banks that provide for availability to borrow up to an aggregate of $ 36.5 million and $ 50.5 million, respectively. The Company had no advances outstanding under these lines at December 31, 2022 and 2021.

Stock Options and Warrants

Stock Options and Warrants	12 Months Ended
Stock Options and Warrants	Dec. 31, 2022
Stock Options And Warrants [Abstract]
Stock Options and Warrants	8. Stock Options and Warrants 2013 Stock Option Plan In 2008 upon shareholder approval, the Bank adopted the 2008 Stock Option Plan. In 2013 upon formation of Third Coast Bancshares, Inc., the Company adopted the 2013 Stock Option Plan (the “2013 Plan”). All outstanding options from the 2008 Stock Option Plan were grandfathered into the 2013 Plan. The 2013 Plan permits the grant of stock options for up to 500,000 shares of common stock from time to time during the term of the plan, subject to adjustment upon changes in capitalization. Under the 2013 Plan, the Bank may grant either incentive stock options or nonqualified stock options to eligible directors, executive officers, key employees and non-employee shareholders of the Bank. At December 31, 2022, there were no shares remaining available for grant for future awards as all outstanding options under the 2013 Plan were grandfathered into the 2019 Omnibus Incentive Plan (see 2019 Omnibus Incentive Plan). Awards outstanding under the 2013 Plan remain in full force and effect, according to their respective terms. 2019 Omnibus Incentive Plan On May 29, 2019, the Company’s shareholders approved the Third Coast Bancshares, Inc. 2019 Omnibus Incentive Plan (the “2019 Plan”), which was previously approved by the Company’s board of directors. Under the 2019 Plan, the Company may issue stock options, stock appreciation rights, restricted stock, restricted stock units, stock bonuses, other stock-based awards, cash awards, and dividend equivalents. On May 20, 2021, the Company’s shareholders approved an amendment to the plan such that the maximum number of shares reserved for issuance under the Plan was increased by an additional 500,000 shares. The maximum aggregate number of shares of common stock that may be issued under the 2019 Plan is equal to the sum of (i) 800,000 shares of common stock, (ii) the total number of shares remaining available for new awards under the 2013 Plan as of May 29, 2019, which was 152,750 shares of common stock, and (iii) any shares subject to outstanding stock options issued under the 2013 Plan to the extent that (A) any such award is forfeited or otherwise terminates or is canceled without the delivery of shares of common stock, or (B) shares of common stock are withheld from any such award to satisfy any tax or withholding obligation, in which case the shares of common stock covered by such forfeited, terminated or canceled award or which are equal to the number of shares of common stock withheld, will become available for issuance under the 2019 Plan. At December 31, 2022, there were 125,266 shares r emaining available for grant for future awards under the 2019 Plan. 2017 Non-Employee Director Stock Option Plan In December 2017, the Bank adopted the 2017 Non-Employee Director Stock Option Plan (the “Director Plan”). The Director Plan originally authorized the grant of stock options for up to 100,000 shares of common stock to non-employee directors of the Company pursuant to the terms of the Director Plan. During July 2018, the Company's board of directors approved the grant of stock options for 50,000 additional shares of common stock under the Director Plan, such that the Director Plan permitted the grant of stock options for up to 150,000 shares of common stock. On January 1, 2021, the Director Plan was amended and subsequently approved by the Company’s board of directors such that the aggregate number of shares of common stock to be issued pursuant to options shall not exceed 187,000 shares. Options are generally granted with an exercise price equal to the market price of the Company’s stock at the date of the grant. Option awards generally vest based on 5 years of continuous service and have 10-year contractual terms for non-controlling participants as defined by the Director Plan. Other grant terms can vary for controlling participants as defined by the Director Plan. At December 31, 2022, there were 8,000 shares re maining available for grant for future awards under the Director Plan. 2020 Heritage Stock Option Plan On January 1, 2020, the Company acquired a stock option plan which originated under Heritage Bancorp, Inc. as part of a merger of the two companies. The options granted to employees must be exercised within 10 years from the date of grant and vesting schedules are determined on an individual basis. At merger date, 109,908 outstanding options became fully vested and were converted to options to purchase 97,821 shares of the Company’s common stock at an exchange ratio of 0.89 , which was equal to the acquisition exchange rate for common shares. At December 31, 2022, there were no shares remaining available f or grant for future awards. Stock Options During the year ended December 31, 2022, the Company granted stock options under the 2019 Plan to certain directors, executive officers and other key employees of the Company. These options vest ratably over 5 years and have a 10 year contractual term. Options granted during the year ended December 31, 2022 were granted with an exercise price ranging fro m $ 17.11 to $ 25.76 . Options granted during the year ended December 31, 2021 were granted with an exercise price ranging from $ 16.30 to $ 24.00 prior to the Company's initial public offering (“IPO”) of stock, and $ 26.68 following the IPO. The fair value of each option award is estimated on the grant date using the Black-Scholes option-pricing model with the foll owing assumptions used for the options granted during the year ended December 31, 2022: risk-free interest rate ranging from 1.45 % to 4.168 %; dividend yield of 0.00 %; estimated volatility ranging from 10.00 % to 38.00 %; and expected lives of options of 7.5 y ears. The following assumptions were used for options granted during the year ended December 31, 2021: risk-free interest rate ranging from 0.70 % to 1.48 %; dividend yield of 0.00 %; estimated volatility of 10.00 %; and expected lives of options of 7.5 years. The following assumptions were used for options granted during the year ended December 31, 2020: risk-free interest rate ranging from 0.47 % to 1.85 %; dividend yield of 0.00 %; estimated volatility of 10.00 %; and expected lives of options of 7.5 years. Expected volatilities are based on historical volatilities of the Company’s common stock and similar peer group averages. For the years ended December 31, 2022, 2021 and 2020, the Company recognized stock-based compensation expense of approximately $ 646,000 , $ 552,000 and $ 275,000 , respectively, associated with stock options. As of December 31, 2022, there was approximately $ 2.2 million of unrecognized compensation costs related to non-vested stock options that are expected to be recognized over the remaining vesting periods. Forfeitures are recognized as they occur. A summary of stock option activity for years ended December 31, 2022 and 2021 is presented below: December 31, 2022 2021 (Dollars in thousands, except share and per share data) Shares Weighted Shares Weighted Outstanding at beginning of period 1,220,428 $ 17.83 660,251 $ 14.37 Granted during the period 136,000 21.15 788,250 20.22 Forfeited during the period ( 105,167 ) 21.18 ( 144,903 ) 17.55 Exercised during the period ( 47,333 ) 14.38 ( 83,170 ) 13.48 Outstanding at the end of period 1,203,928 $ 18.05 1,220,428 $ 17.83 Options exercisable at end of period 527,658 $ 15.51 361,758 $ 13.59 Weighted-average grant date fair value of options granted $ 6.80 $ 3.15 A summary of weighted average remaining life is presented below: December 31, (Dollars in thousands, except 2022 2021 Exercise Price Options Outstanding Weighted Options Exercisable Options Outstanding Weighted Options $ 10.00 - $ 12.99 146,553 1.96 146,553 162,223 5.15 162,223 $ 13.00 - $ 16.99 435,175 6.45 280,905 496,955 7.48 199,535 $ 17.00 - $ 26.99 622,200 8.69 100,200 561,250 9.52 — 1,203,928 7.06 527,658 1,220,428 8.11 361,758 Shares issued in connection with stock compensation awards are issued from available authorized shares. The total intrinsic value of outstanding in-the-money stock options and outstanding in-the-money exercisable stock options was $ 2.1 million and $ 1.8 million, respectively, at December 31, 2022. The total intrinsic value of outstanding in-the-money stock options and outstanding in-the-money exercisable stock options was $ 5.8 million and $ 3.0 million, respectively, at December 31, 2021. The intrinsic value of stock options exercised during the years ended December 31, 2022, 2021 and 2020 was approximately $ 236,000 , $ 506,000 an d $ 139,000 , re spectively. A summary of the activity in the Company’s nonvested shares is as follows: December 31, 2022 2021 (Dollars in thousands, except share and per share data) Shares Weighted Shares Weighted Nonvested at January 1, 858,670 $ 3.15 262,670 $ 3.04 Granted during the period 136,000 6.80 788,250 3.15 Vested during the period ( 219,900 ) 3.07 ( 72,500 ) 3.17 Forfeited during the period ( 98,500 ) 3.70 ( 119,750 ) 2.88 Nonvested at end of period 676,270 $ 3.82 858,670 $ 3.15 For the year ended December 31, 2020, the weighted-average grant date fair value of options granted and vested during the period was $ 2.65 and $ 3.58 , respectively. Warrants The Company has fully vested stock warrants issued in connection with the organization of the Company which are exercisable over a ten-year period that expire on July 1, 2023 . The warrants are exercisable to purchase one share of common stock for each warrant held. The weighted average remaining contractual life of these outstanding stock warrants was six months as of December 31, 2022. In connection with the preferred stock private placement on September 30, 2022, the Company issued warrants to purchase an aggregate of 175,000 shares of the Company's common stock (or, at the election of the warrant holder in accordance with the terms of the warrant agreement, Series B Convertible Perpetual Preferred Stock, par value $ 1.00 per share, or non-voting common stock, par value $ 1.00 per share, of the Company) (the “Preferred Warrants”) to certain investors. The Preferred Warrants have an exercise price of $ 22.50 per share, are fully vested, and are exercisable over a seven-year period that expires on September 30, 2029 . The fair value of the warrants was approximately $ 380,000 on grant date and is included in additional paid in capital. The weighted average remaining contractual life of these outstanding Preferred Warrants was 6.75 years as of December 31, 2022. A summary of the Company’s stock warrant activity is presented below: December 31, 2022 2021 (Dollars in thousands, except share and per share data) Shares Weighted Shares Weighted Outstanding at beginning of period 4,285 $ 11.00 6,000 $ 11.00 Granted 175,000 22.50 — — Exercised — — ( 1,715 ) 11.00 Outstanding at end of period 179,285 $ 22.23 4,285 $ 11.00 Exercisable at end of period 179,285 $ 22.23 4,285 $ 11.00 Restricted Stock Awards During the years ended December 31, 2022 and 2021, the Company granted restricted stock awards (“RSAs”) to certain directors, executive officers, and employees of the Company. Restricted stock is common stock with certain restrictions that relate to trading and the possibility of forfeiture. Holders of restricted stock have full voting rights. Generally, the awards vest ratably over a two -to- four year period but vesting periods may vary. The RSAs have a 10 year contractual term. A summary of the activity for non-vested RSAs for the years ended December 31, 2022, 2021 and 2020 is presented below: December 31, 2022 2021 (Dollars in thousands, except share and per share data) Shares Weighted Shares Weighted Nonvested at beginning of period 49,750 $ 24.00 — $ — Granted during the period 54,424 21.81 49,750 24.00 Vested during the period ( 18,580 ) 24.00 — — Forfeited during the period ( 9,500 ) 24.67 — — Nonvested at the end of period 76,094 $ 22.35 49,750 $ 24.00 Compensation expense for restricted stock awards is determined based on the number of restricted shares granted and the market price of our common stock at issue date. The fair value of shares vested during the year ended December 31, 2022 was $ 342,000 . The fair value of shares vested during each of the years ended December 31, 2021 and 2020 was zero . The Company recognized stock-based compensation expense associated with RSAs of appro ximately $ 629,000 and $ 106,000 during the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, there was $ 1.4 mil lion of tot al unrecognized compensation cost related to non-vested RSAs that is expected to be recognized over the remaining vesting period.

Leases

Leases	12 Months Ended
Leases	Dec. 31, 2022
Leases [Abstract]
Leases	9. Leases Operating Leases The Company leases certain office space and stand-alone buildings which are recognized as operating lease right-of-use (“ROU”) assets and operating lease liabilities and are included in other assets and other liabilities in the consolidated balance sheets. Lease liabilities represent the Company's liability to make lease payments under these leases, on a discounted basis. For leases with renewal options available, the Company evaluates each lease to determine if exercise of the renewal option is reasonably certain. As of December 31, 2022, the Company's operating lease ROU asset and operating lease liability totaled $ 17.9 million and $ 18.2 million, respectively. In order to calculate its ROU assets and lease liabilities, ASC Topic 842 requires the Company to use the rate of interest implicit in the lease when readily determinable. If the rate implicit in the lease is not readily determinable, the Company is required to use its incremental borrowing rate, which is the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar term in a similar economic environment. The Company was unable to determine the implicit interest rate in any of the leases and therefore used its incremental borrowing rate. As of December 31, 2022, the weighted-average discount rate for the Company's operating lease s was 4.05 %. The Company's lease terms range f rom five months to one hundred forty-four months . T he weighted-average remaining term of the leases w as 9.7 ye ars. Lease costs for the period shown below were as follows: December 31, (Dollars in thousands) 2022 2021 2020 Operating lease cost $ 2,804 $ 1,605 $ 1,154 Short-term lease cost 607 — — Total lease cost $ 3,411 $ 1,605 $ 1,154 Total operating lease expense for the years ended December 31, 2022, 2021 and 2020 was $ 3.4 million, $ 1.6 million and $ 1.2 million, respectively. A schedule of the Company's lease liabilities by contractual maturity for operating leases with initial or remaining terms in excess of one year for each year through 2027 and thereafter is presented below: (Dollars in thousands) 2023 $ 2,516 2024 2,944 2025 2,957 2026 3,027 2027 and thereafter 16,917 Total undiscounted lease liability 28,361 Less: Discount on cash flows ( 3,920 ) Lease signed, but not yet commenced ( 6,232 ) Total operating lease liability $ 18,209

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Contingencies	19. Contingencies Litigation In the normal course of business, the Company is involved in various legal proceedings. In the opinion of management, any liability resulting from such proceedings would not have a material adverse effect on the consolidated financial statements.

Financial Instruments With Off

Financial Instruments With Off Balance Sheet Risk	12 Months Ended
Financial Instruments With Off Balance Sheet Risk	Dec. 31, 2022
Financial Instruments With Off Balance Sheet Risk [Abstract]
Financial Instruments With Off Balance Sheet Risk	10. Financial Instruments With Off-Balance Sheet Risk The Company is a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit and standby letters of credit. Those instruments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the balance sheet. The Company’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for unfunded lines of credit, commitments to extend credit and standby letters of credit is represented by the contractual notional amount of these instruments. The Company generally uses the same credit policies in making commitments and conditional obligations as it does for on-balance sheet instruments. The following financial instruments were outstanding whose contract amounts represent credit risk: December 31, (Dollars in thousands) 2022 2021 Commitments to extend credit $ 1,148,012 $ 606,160 Standby letters of credit 21,728 14,144 Total $ 1,169,740 $ 620,304 Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since many of the commitments may expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements. Management evaluates each customer’s credit-worthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary upon extension of credit, is based on management’s credit evaluation of the borrower. Standby letters of credit are conditional commitments issued by the Bank to guarantee the performance of a customer to a third party. Standby letters of credit generally have fixed expiration dates or other termination clauses and may require payment of a fee. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending loan facilities to customers. The Bank's policy for obtaining collateral and the nature of such collateral is essentially the same as that involved in making commitments to extend credit. Although the maximum exposure to loss is the amount of such commitments, management currently anticipates no material losses from such activities.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
Fair Value Measurements	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	11. Fair Value Measurements GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability. The price in the principal (or most advantageous) market used to measure the fair value of the asset or liability shall not be adjusted for transaction costs. An orderly transaction is a transaction that assumes exposure to the market for a period prior to the measurement date to allow for marketing activities that are usual and customary for transactions involving such assets and liabilities; it is not a forced transaction. Market participants are buyers and sellers in the principal market that are (i) independent, (ii) knowledgeable, (iii) able to transact and (iv) willing to transact. GAAP requires the use of valuation techniques that are consistent with the market approach, the income approach and/or the cost approach. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets and liabilities. The income approach uses valuation techniques to convert future amounts, such as cash flows or earnings, to a single present amount on a discounted basis. The cost approach is based on the amount that currently would be required to replace the service capacity of an asset (replacement costs). Valuation techniques should be consistently applied. Inputs to valuation techniques refer to the assumptions that market participants would use in pricing the asset or liability. Inputs may be observable, meaning those that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from independent sources, or unobservable, meaning those that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. In that regard, the authoritative guidance establishes a fair value hierarchy for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows: • Level 1 Inputs – Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. • Level 2 Inputs – Inputs other than quoted prices included in level 1 that are observable for the asset and liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (for example, interest rates, volatilities, prepayment speeds, loss severities, credit risks and default rates) or inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 2 investments consist primarily of obligations of U.S. government sponsored enterprises and agencies, obligations of state and municipal subdivisions, corporate bonds and mortgage backed securities. • Level 3 Inputs – Significant unobservable inputs that reflect an entity’s own assumptions that market participants would use in pricing the assets or liabilities. A description of the valuation methodologies used for instruments measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy, is set forth below. In general, fair value is based upon quoted market prices, where available. If such quoted market prices are not available, fair value is based upon internally developed models that primarily use, as inputs, observable market-based parameters. Valuation adjustments may be made to ensure that financial instruments are recorded at fair value. While management believes the Company’s valuation methodologies are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. Financial assets and financial liabilities measured at fair value on a recurring and nonrecurring basis include the following: Investment Securities Available-for-sale . Investment securities classified as available-for-sale are reported at fair value utilizing Level 2 inputs. For these securities, the Company obtains fair value measurements from an independent pricing service. The fair value measurements consider observable data that may include dealer quotes, market spreads, cash flows, the U.S. Treasury yield curve, live trading levels, trade execution data, market consensus prepayments speeds, credit information, and the bond’s terms and conditions, among other things. Loans Held for Sale . Loans held for sale are reported at aggregate cost which has been deemed to be the equivalent of fair value using Level 3 inputs. Impaired Loans . Impaired loans are reported at the estimated fair value of the underlying collateral. Collateral values are estimated using Level 2 inputs based on observable market data or independent appraisals using Level 3 inputs. Derivative Instruments . The estimated fair value of interest rate derivative positions are obtained from a pricing service that provides the swaps’ unwind value using Level 2 inputs. There were no transfers between levels during the year ended December 31, 2022 or 2021. The following table summarizes financial assets and financial liabilities measured at fair value on a recurring basis, segregated by the level of the valuation inputs within the fair value hierarchy utilized to measure fair value as of December 31, 2022 and 2021: Fair Value Measurements Using (Dollars in thousands) Level 1 Inputs Level 2 Inputs Level 3 Inputs Total Fair Value At December 31, 2022: Securities available for sale: State and municipal securities $ — $ 417 $ — $ 417 Mortgage-backed securities and other agency obligations — 22,881 — 22,881 U.S. Treasury bonds — 98,518 — 98,518 Corporate bonds — 54,251 — 54,251 Total investment securities available for sale $ — $ 176,067 $ — $ 176,067 Asset derivatives: Interest rate swaps $ — $ 9,213 $ — $ 9,213 Total asset derivatives $ — $ 9,213 $ — $ 9,213 Liability derivatives: Interest rate swaps $ — $ 9,213 $ — $ 9,213 Risk participation agreements — 8 — 8 Total liability derivatives $ — $ 9,221 $ — $ 9,221 Fair Value Measurements Using (Dollars in thousands) Level 1 Inputs Level 2 Inputs Level 3 Inputs Total Fair Value At December 31, 2021: Securities available for sale: State and municipal securities $ — $ 1,094 $ — $ 1,094 Mortgage-backed securities and other agency obligations — 811 — 811 Corporate bonds — 24,527 — 24,527 Total investment securities available for sale $ — $ 26,432 $ — $ 26,432 Asset derivatives: Interest rate swaps $ — $ 389 $ — $ 389 Total asset derivatives $ — $ 389 $ — $ 389 Liability derivatives: Interest rate swaps $ — $ 389 $ — $ 389 Total liability derivatives $ — $ 389 $ — $ 389 Certain financial assets and financial liabilities are measured at fair value on a nonrecurring basis, that is, the instruments are not measured at fair value on an ongoing basis but are subject to fair value adjustments in certain circumstances (for example, when there is evidence of impairment). Financial assets and financial liabilities measured at fair value on a non-recurring basis include the following at December 31, 2022 and 2021: Impaired loans. At December 31, 2022, impaired loans with carrying values of $ 19.7 million were reduced by specific valuation allowances totaling $ 1.6 million resulting in a net fair value of $ 18.1 million, based on Level 3 inputs. At December 31, 2021, impaired loans with carrying values of $ 15.4 million were reduced by specific valuation allowances totaling $ 307,000 resulting in a net fair value of $ 15.1 million, based on Level 3 inputs. Non-financial assets measured at fair value on a non-recurring basis include certain foreclosed assets which, upon initial recognition, were remeasured and reported at fair value through a charge-off to the allowance for loan losses and certain foreclosed assets which, subsequent to their initial recognition, were remeasured at fair value through a write-down included in current earnings. The fair value of a foreclosed asset is estimated using Level 2 inputs based on observable market data or Level 3 inputs based on customized discounting criteria. The Company had no foreclosed assets as of December 31, 2022. The following table presents the foreclosed assets that were remeasured and recorded at fair value during the year ended December 31, 2021: December 31, (Dollars in thousands) 2022 2021 Foreclosed assets remeasured subsequent to initial recognition: Carrying value of foreclosed assets prior to remeasurement $ — $ 1,676 Fair value of foreclosed assets remeasured subsequent to initial recognition $ — $ 1,676 For the Company, as for most financial institutions, substantially all its assets and liabilities are considered financial instruments as defined. Many of the Company’s financial instruments, however, lack an available trading market as characterized by a willing buyer and willing seller engaging in an exchange transaction. The estimated fair value amounts of financial instruments have been determined by the Company using available market information and appropriate valuation methodologies. However, considerable judgment is required to interpret data to develop the estimates of fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts. In addition, reasonable comparability between financial institutions may not be likely due to the wide range of permitted valuation techniques and numerous estimates that must be made given the absence of active secondary markets for many of the financial instruments. This lack of uniform valuation methodologies also introduces a greater degree of subjectivity to these estimated fair values. Financial instruments with stated maturities have been valued using a present value discounted cash flow with a discount rate approximating current market rates for similar assets and liabilities. Financial instrument assets with variable rates and financial instrument liabilities with no stated maturities have an estimated fair value equal to both the amount payable on demand and the carrying value. The carrying value and the estimated fair value of the Company’s contractual off-balance sheet unfunded lines of credit, loan commitments and letters of credit, which are generally priced at market at the time of funding, are not material. The estimated fair values and carrying values of all financial instruments under current authoritative guidance, segregated by the level of the valuation inputs within the fair value hierarchy utilized to measure fair value are as follows: December 31, 2022 December 31, 2021 (Dollars in thousands) Carrying Estimated Carrying Estimated Financial assets Level 2 inputs Cash and cash equivalents $ 332,014 $ 332,014 $ 327,025 $ 327,025 Interest bearing time deposits in other banks — — 131 131 Investment securities available for sale 176,067 176,067 26,432 26,432 Non-marketable securities 15,405 15,405 7,527 7,527 Accrued interest receivable 18,340 18,340 10,228 10,228 Bank-owned life insurance 60,761 60,761 26,528 26,528 Derivative instruments assets 9,213 9,213 389 389 $ 611,800 $ 611,800 $ 398,260 $ 398,260 Level 3 inputs Loans, including held for sale, net $ 3,077,200 $ 2,920,213 $ 2,049,429 $ 2,023,761 Financial liabilities Level 2 inputs Deposits $ 3,236,146 $ 3,238,857 $ 2,141,199 $ 2,141,999 Accrued interest payable 2,545 2,545 437 437 FHLB advances — — 50,000 50,000 Notes payable 111,223 111,223 1,000 1,000 Derivative instrument liabilities 9,221 9,221 389 389 $ 3,359,135 $ 3,361,846 $ 2,193,025 $ 2,193,825

Significant Group Concentration

Significant Group Concentrations of Credit Risk	12 Months Ended
Significant Group Concentrations of Credit Risk	Dec. 31, 2022
Risks and Uncertainties [Abstract]
Significant Group Concentrations of Credit Risk	12. Significant Group Concentrations of Credit Risk All of the Company’s business activity is with customers primarily located within Texas. Such customers are normally also depositors of the Company. The distribution of commitments to extend credit approximates the distribution of loans outstanding. The contractual amounts of credit related financial instruments such as commitments to extend credit and credit card arrangements represent the amounts of potential accounting loss should the contract be fully drawn upon, the customer default, and the value of any existing collateral become worthless. At December 31, 2022, the Company had federal funds sold aggregating approximately $ 2.1 million which represents a concentration of credit risk. At December 31, 2021, the Company had federal funds sold aggregating approximately $ 292,000 . The Company had uninsured deposits o f $ 179.3 millio n and $ 189.7 million as of December 31, 2022 and 2021, respectively.

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
Employee Benefit Plans	Dec. 31, 2022
Postemployment Benefits [Abstract]
Employee Benefit Plans	13. Employee Benefit Plans Defined Contribution Plan In 2009, the Company adopted the Third Coast Bank, SSB 401(k) Plan (the “Plan”) covering substantially all employees. Employees may elect to defer a percentage of their compensation subject to certain limits based on federal tax laws. The Company may make a discretionary match of employees’ contributions based on a percentage of salary contributed by participants. Effective January 1, 2018, the discretionary contributions made by the Company were invested in the common stock of the Company in accordance with the Third Coast Bank, SSB Employee Stock Ownership Plan (“ESOP”). The ESOP became effective on January 1, 2018 for the exclusive benefit of the participants and their beneficiaries. Benefits under the ESOP generally are distributed in the form of cash. In addition, until the Company’s common stock was actively traded on an established securities market, the participant could demand (in accordance with the terms of the ESOP and applicable laws) that the Company repurchase shares of common stock distributed to the participant at the estimated fair value. This put option terminated upon the consummation of the Company's IPO and listing of its common stock on the Nasdaq Global Select Market in November 2021. Prior to the IPO, the fair value of shares of common stock held by the ESOP was deducted from permanent shareholders’ equity in the consolidated balance sheets, and was reflected in a line item below liabilities and above shareholders’ equity. This presentation was necessary in order to recognize the put option within the ESOP, consistent with SEC guidelines, because the Company was not publicly traded. The Company used an external third party to determine the maximum possible cash obligation related to those securities. The valuation was the same that was used for the stock option plan. Increases or decreases in the value of the cash obligation were included in a separate line item in the statements of changes in shareholders’ equity. An increase of approximately $ 317,000 in the fair value of the cash obligation was recorded for the year ended December 31, 2021. At December 31, 2021, the $ 2.3 million estimated fair value of the cash obligation for stock allocated under the ESOP plan was eliminated upon completion of the IPO. As of December 31, 2021, the number of shares held by the ESO P was 113,306 and there were no shares unallocated to plan participants. At December 31, 2021, shares committed to be released to the plan we re 10,826 s hares for a fair value o f $ 284,000 . During the year ended December 31, 2021, the Company repurchase d 8,211 shares for $ 167,000 fro m ESOP participants that received distributions and exercised the put option described above. All shares held by the ESOP were treated as outstanding at December 31, 2021. For the years ended December 31, 2021 and 2020, Company contributions to the ESOP were approximately $ 936,000 , and $ 645,000 , respectiv ely. Administrative expenses related to the ESOP and the Plan for the same twelve month periods totaled approximatel y $ 41,000 and $ 16,000 , r espectively. The costs are included in salaries and employee benefits in the accompanying consolidated statements of income. ESOP Plan Merged Into 401-K Plan Effective July 1, 2022, the Company amended the Plan and merged it into the ESOP (the “Merged Plan”). In connection with this amendment and plan merger, on July 1, 2022, the Company registered an aggregate of 400,000 shares of the Company's common stock, par value $ 1.00 per share, for issuance to the Merged Plan in connection with elections by participants to allocate a portion of their plan account balances (up to the limits prescribed under the Merged Plan) to the Company stock fund investment option. The number of shares held by the ESOP immediately prior to the plan merger was 149,461 shares. Under the Merged Plan, discretionary contributions made by the Company will be invested at the direction of the plan participant, in accordance with participant plan elections. For the year ended December 31, 2022, Company contributions to the Merged Plan were approximately $ 1.4 million. Administrative expenses related to the Merged Plan for the same twelve month period totaled approximately $ 59,000 . The costs are included in salaries and employee benefits in the accompanying consolidated statements of income.

Related Party Transactions

Related Party Transactions	12 Months Ended
Related Party Transactions	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	14. Related Party Transactions During the normal course of business, the Company may enter into transactions with significant stockholders, directors and principal officers and their affiliates (collectively referred to herein as “related parties”). It is the Company’s policy that all such transactions are on substantially the same terms as those prevailing at the time for comparable transactions with third parties. At December 31, 2022 and 2021, the aggregate amount of loans to related parties was approximately $ 1,491,000 and $ 569,000 , respectively. During the year ended December 31, 2022, loan originations to related parties totaled $ 1,344,000 and repayments from related party loans totaled $ 422,000 . Related party unfunded commitments at December 31, 2022, were $ 587,000 . There were no related party unfunded commitments at December 31, 2021. Deposits received from related parties at December 31, 2022 and 2021, totaled approximately $ 16.0 million and $ 19.0 million, respectively.

Shareholders_ Equity and Regula

Shareholders’ Equity and Regulatory Matters	12 Months Ended
Shareholders’ Equity and Regulatory Matters	Dec. 31, 2022
Stockholders' Equity Note [Abstract]
Shareholders’ Equity and Regulatory Matters	15. Shareholders’ Equity and Regulatory Matters Preferred Stock Under the Company's Certification of Formation, the Company is authorized to issue 1,000,000 shares of preferred stock, par value $ 1.00 per share. On September 30, 2022, the Company adopted resolutions creating Series A Convertible Non-Cumulative Preferred Stock and Series B Convertible Perpetual Preferred Stock, with 69,400 shares authorized for each series. Preferred Stock - Private Placement On September 30, 2022, the Company completed a private placement of (i) 69,400 shares of a new series of preferred stock designated Series A Convertible Non-Cumulative Preferred Stock, par value $ 1.00 per share, with a liquidation preference of $ 1,000 per share (the “Series A Preferred Stock”), and (ii) the Preferred Warrants at an exercise price equal to $ 22.50 per share, for aggregate gross proceeds of $ 69.4 million before deducting plac ement fees and offering expenses. Aggregate net proceeds were $ 66.2 million after deducting placement fees and offering expenses of $ 3.2 mill ion. The Company used the net proceeds of the private placement for general corporate purposes. The securities sold in the private placement were sold only to accredited investors and were issued without registration under the Securities Act, in reliance upon the exemption provided under Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder as securities offered and sold only to accredited investors (as defined in Rule 501(a) of Regulation D under the Securities Act) in a transaction not involving any public offering. Officers and directors of the Company purchased $ 2.7 million of the Series A Preferred Stock. Initial Public Offering On November 9, 2021, the Company's common stock began trading on the Nasdaq Global Select Market under the symbol “TCBX”. The Company issued and sold an aggregate of 4,025,000 shares of its common stock, including 525,000 shares of common stock sold pursuant to the underwriters’ full exercise of their option to purchase additional shares, in its IPO at a public offering price of $ 25.00 per share for aggregate gross proceeds of $ 100.6 million before deducting underwriting discounts and offering expenses. Aggregate net proceeds from our IPO were $ 92.0 million after deducting underwriting discounts and offering expenses of $ 8.6 million. The initial closing of the IPO occurred on November 12, 2021, and the closing for the shares issued pursuant to the underwriters’ option occurred on November 17, 2021. In connection with the closing of the IPO, the Company issued an aggregate of 49,750 shares of restricted stock to its directors, advisory directors, and executive officers. Common Stock - Private Placement On August 27, 2021, the Company completed the issuance and sale of 2,937,876 shares of its common stock for aggregate proceeds of approximately $ 70.5 million, consisting of 227,307 shares issued and sold during the six months ended June 30, 2021 for aggregate proceeds of approximately $ 5.4 million and 2,710,569 shares issued and sold between July 1, 2021 and August 27, 2021 for aggregate proceeds of approximately $ 65.1 million, in a private placement in reliance upon the exemption from the registration requirements of the Securities Act under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. The Company used a portion of the net proceeds from the private placement to repay $ 32.5 million of outstanding indebtedness, consisting of (i) $ 19.5 million under the Company's senior debt due September 10, 2022 ; (ii) $ 11.0 million under a subordinated debt due July 29, 2022 ; and (iii) $ 2.0 million under a subordinated debt due September 27, 2022 . Regulatory Matters The Bank is subject to various regulatory capital requirements administered by the federal banking agencies. Failure to meet minimum capital requirements can initiate certain mandatory (and possibly additional discretionary) actions by regulators that, if undertaken, could have a direct material effect on the Company’s consolidated financial statements. Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Bank must meet specific capital guidelines that involve quantitative measures of the Bank’s assets, liabilities, and certain off-balance sheet items as calculated under regulatory accounting practices. The Bank’s capital amounts and classification are also subject to qualitative judgments by the regulators about components, risk weightings and other factors. Quantitative measures established by regulation to ensure capital adequacy require the Bank to maintain minimum amounts and ratios (set forth in the table below) of total, Tier I capital, and Common Equity Tier I capital (as defined in the regulations) to risk-weighted assets (as defined), and of Tier I capital (as defined) to average assets (as defined). Management believes, as of December 31, 2022 and 2021 the Bank meets all capital adequacy requirements to which it is subject. Financial institutions are categorized as well capitalized or adequately capitalized, based on minimum total risk-based, Tier 1 risk-based and Tier 1 leverage ratios as set forth in the tables below. As shown below, the Bank’s capital ratios exceed the regulatory definition of well capitalized as of December 31, 2022 and 2021. Based upon the information in its most recently filed call report, the Bank continues to meet the capital ratios necessary to be well capitalized under the regulatory framework for prompt corrective action. There are no conditions or events since December 31, 2022, that management believes have changed the Bank’s category. A comparison of the Bank’s actual capital amounts and ratios to required capital amounts and ratios are presented in the following table: Actual For Capital Adequacy (2) To Be Well Capitalized (Dollars in thousands) Amount Ratio Amount Ratio Amount Ratio As of December 31, 2022: Total capital (to risk Bank 496,222 13.8 % ≥ 377,782 ≥ 10.5 % ≥ 359,793 ≥ 10.0 % Tier I capital (to risk Bank 465,871 12.9 % ≥ 305,824 ≥ 8.5 % ≥ 287,834 ≥ 8.0 % Tier I capital (to average (1) Bank 465,871 13.1 % ≥ 142,188 ≥ 4.0 % ≥ 177,734 ≥ 5.0 % Common equity tier 1 (to Bank 465,871 12.9 % ≥ 251,855 ≥ 7.0 % ≥ 233,865 ≥ 6.5 % As of December 31, 2021: Total capital (to risk Bank 288,022 13.5 % ≥ 223,444 ≥ 10.5 % ≥ 212,804 ≥ 10.0 % Tier I capital (to risk Bank 268,727 12.6 % ≥ 180,883 ≥ 8.5 % ≥ 170,243 ≥ 8.0 % Tier I capital (to average (1) Bank 268,727 12.3 % ≥ 87,602 ≥ 4.0 % ≥ 109,503 ≥ 5.0 % Common equity tier 1 (to Bank 268,727 12.6 % ≥ 148,962 ≥ 7.0 % ≥ 138,322 ≥ 6.5 % (1) The Tier 1 capital ratio (to average assets) is not impacted by the Basel III Capital Rules; however, the Federal Reserve and the FDIC may require the Bank to maintain a Tier 1 capital ratio (to average assets) above the minimum required. (2) Percentages represent the minimum capital ratios plus, as applicable, the fully phased-in 2.5 % CIT1 capital buffer under the Basel III Capital Rules.

Earnings Per Common Share

Earnings Per Common Share	12 Months Ended
Earnings Per Common Share	Dec. 31, 2022
Earnings Per Share [Abstract]
Earnings Per Common Share	16. Earnings Per Common Share Basic earnings per common share is computed by dividing net earnings allocated to common stock by the weighted-average number of common shares outstanding during the applicable period. Diluted earnings per common share is computed using the weighted-average number of shares determined for the basic earnings per common share computation plus the dilutive effect of stock compensation using the treasury stock method, plus the dilutive effect of convertible preferred stock using the if-converted method. At December 31, 2022, the dilutive effects of convertible preferred stock were excluded from diluted earnings per share due to their anti-dilutive effects on the computation. The following table presents a reconciliation of net income available to common shareholders and the number of shares used in the calculation of basic and diluted earnings per common share shown on the consolidated statements of income. For the Years Ended December 31, (Dollars in thousands, except share and per share data) 2022 2021 2020 Net income $ 18,659 $ 11,424 $ 12,115 Less dividends declared, Preferred Series A stock 1,418 — — Net income available to common shareholders $ 17,241 $ 11,424 $ 12,115 Weighted-average shares outstanding for basic earnings per common share 13,465,196 7,874,110 6,232,115 Dilutive effect of stock compensation 289,414 264,714 97,645 Weighted-average shares outstanding for diluted earnings per common share 13,754,610 8,138,824 6,329,760

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
Derivative Financial Instruments	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	17. Derivative Financial Instruments Cash Flow Hedges During July 2022 and as part of its hedging strategy, the Company entered into a five-year pay-fixed interest rate swap agreement with a notional amount of $ 200 million on its floating rate deposits. The facility, which was designated as a cash flow hedge, was discontinued on August 24, 2022, and a gain on the terminated hedge of $ 3.0 million was recognized by the Company. The gain is being accreted from other comprehensive income (loss), net of deferred taxes, into interest expense through the maturity date of the contract, or July 9, 2027 . On February 18, 2021, a $ 100.0 million pay-fixed interest rate swap facility designated as a cash flow hedge was discontinued and a gain on the terminated hedge of $ 945,000 was recognized by the Company. The gain is being accreted from other comprehensive income (loss), net of deferred taxes, into interest expense through the maturity date of the contract, or September 4, 2025 . For the year ended December 31, 2022, approximately $ 401,000 was reclassified out of accumulated other comprehensive income and recognized as a reduction of interest expense on discontinued hedges. Fair Value Hedges The Company offers certain interest rate swap products directly to its qualified commercial banking customers. These financial instruments are not designated as hedging instruments. The interest rate swap derivative positions relate to transactions in which the Company enters into an interest rate swap with a customer, while at the same time entering into an offsetting interest rate swap with another financial institution. An interest rate swap transaction allows customers to effectively convert a variable rate loan to a fixed rate. In connection with each swap, the Company agrees to pay interest on a notional amount at a variable interest rate and receive interest from the customer on a similar notional amount at a fixed interest rate. At the same time, the Company agrees to pay another financial institution the same fixed interest rate on the same notional amount and receive the same variable interest rate on the same notional amount. Because the Bank acts as an intermediary for its customer, changes in the fair value of the underlying derivative contracts are designed to offset each other and would not significantly impact the Company’s operating results except in certain situations where there is a significant deterioration in the customer’s credit worthiness or that of the counterparties. At December 31, 2022, no such deterioration was determined by management. For some of its loan participation facilities, the Company enters into Risk Participation Agreements (“RPAs”) with other banks in order to hedge or share a portion of the risk of borrower default related to the interest rate swap on a participated loan. All derivatives are carried at fair value as either assets or liabilities in the accompanying consolidated balance sheets. At December 31, 2022, the Company's derivative assets and liabilities each totaled $ 9.2 million. As of December 31, 2022 and 2021, c ash of $ 730,000 w as pledged as collateral for derivative financial instruments. The following tables provide the outstanding notional balances and fair values of outstanding derivative positions at December 31, 2022 and 2021. (Dollars in thousands) Outstanding Asset Liability Pay (1) Receive (1) Remaining (2) December 31, 2022 Risk participation agreements purchased $ 10,621 $ — $ — — 4.87 % 2.2 Risk participation agreements sold 29,360 — 8 — 5.54 % 4.2 Commercial loan interest rate swaps: Loan customer counterparty 147,560 — 9,213 — 4.77 % 4.5 Financial institution counterparty 147,560 9,213 — 4.77 % — 4.5 Total derivatives $ 335,101 $ 9,213 $ 9,221 (Dollars in thousands) Outstanding Asset Liability Pay (1) Receive (1) Remaining (2) December 31, 2021 Commercial loan interest rate swaps: Loan customer counterparty $ 77,587 $ — $ 389 4.21 % 7.6 Financial institution counterparty 77,587 389 — 4.21 % 7.6 Total derivatives $ 155,174 $ 389 $ 389 (1) Weighted average rate. (2) Weighted average life (in years).

Core Deposit Intangibles, Net

Core Deposit Intangibles, Net	12 Months Ended
Core Deposit Intangibles, Net	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Core Deposit Intangibles, Net	18. Core Deposit Intangibles, Net Amortization expense of the core deposit intangible (“CDI”) was approximately $ 162,000 for each of the years ended December 31, 2022, 2021 and 2020. The remaining weighted average life is 7 years at December 31, 2022. Scheduled amortization of CDI at December 31, 2022 are as follows: (Dollars in thousands) CDI 2023 162 2024 162 2025 162 2026 162 2027 and thereafter 483 $ 1,131

Parent Company Financial Statem

Parent Company Financial Statements	12 Months Ended
Parent Company Financial Statements	Dec. 31, 2022
Condensed Financial Information Disclosure [Abstract]
Parent Company Financial Statements	20. Parent Company Financial Statements The following balance sheets, statements of income and statements of cash flows for Third Coast Bancshares, Inc. should be read in conjunction with the consolidated financial statements and the notes thereto. Condensed Balance Sheets of the Company (Parent company only) for the periods presented are as follows: (Dollars in thousands) December 31, ASSETS 2022 2021 Cash and cash equivalents $ 8,752 $ 8,707 Investment in subsidiary 482,933 289,446 Other assets 3,795 1,856 Total assets $ 495,480 $ 300,009 LIABILITIES AND SHAREHOLDERS' EQUITY Other borrowings $ 111,223 $ 1,000 Other liabilities 2,477 2 Total liabilities 113,700 1,002 Shareholders' equity: Series A Convertible Non-Cumulative Preferred Stock 69 — Series B Convertible Perpetual Preferred Stock — — Common stock 13,610 13,482 Additional paid-in capital 318,033 249,202 Retained earnings 53,270 36,029 Accumulated other comprehensive (loss) income ( 2,103 ) 1,393 Treasury stock: at cost ( 1,099 ) ( 1,099 ) Total shareholders' equity 381,780 299,007 Total liabilities & shareholders' equity $ 495,480 $ 300,009 Condensed Statements of Income and Comprehensive Income of the Company (Parent company only) for the periods are as follows: For the Years Ended December 31, (Dollars in thousands) 2022 2021 2020 Interest expense: Interest on notes payable $ 4,605 $ 1,091 $ 1,615 Total interest expense 4,605 1,091 1,615 Noninterest expense: Legal and professional 302 680 1,233 Other 230 23 37 Total noninterest expense 532 703 1,270 Loss before income tax expense and equity in undistributed earnings of subsidiaries ( 5,137 ) ( 1,794 ) ( 2,885 ) Income tax benefit 1,087 359 384 Loss before equity in undistributed earnings of subsidiaries ( 4,050 ) ( 1,435 ) ( 2,501 ) Equity in undistributed earnings of subsidiaries 22,709 12,859 14,616 Net income $ 18,659 $ 11,424 $ 12,115 Comprehensive income $ 15,163 $ 12,538 $ 12,394 Condensed Statements of Cash Flows of the Company (Parent company only) for the periods presented are as follows: For the Years Ended December 31, (Dollars in thousands) 2022 2021 2020 Cash flows from operating activities: Net income $ 18,659 $ 11,424 $ 12,115 Adjustments to reconcile net income to net cash used in operating activities: Equity in undistributed net income of subsidiaries ( 22,709 ) ( 12,859 ) ( 14,616 ) Amortization of subordinated debt issuance costs 154 — — Net change in other assets ( 1,938 ) ( 359 ) 501 Net change in other liabilities 1,278 ( 150 ) ( 320 ) Net cash used in operating activities ( 4,556 ) ( 1,944 ) ( 2,320 ) Cash flows from investing activities: Capital investment in subsidiaries ( 173,000 ) ( 125,800 ) — Net cash used in investing activities ( 173,000 ) ( 125,800 ) — Cash flows from financing activities: Net (repayment of) proceeds from subordinated notes payable - related party — ( 13,000 ) 5,000 Net proceeds from (repayment of) line of credit - senior debt 29,875 ( 19,875 ) ( 1,500 ) Net proceeds from subordinated debt issuance 80,194 — — Net proceeds from issuance of preferred stock 66,225 — — Proceeds from issuance of common stock 856 163,199 536 Dividends paid on Series A preferred stock ( 221 ) — — Proceeds from stock warrants exercised — 19 — Proceeds from stock options exercised 672 995 385 Net redemption of treasury stock — ( 121 ) ( 38 ) Net cash provided by financing activities 177,601 131,217 4,383 Increase in cash and cash equivalents 45 3,473 2,063 Cash and cash equivalents at beginning of period 8,707 5,234 3,171 Cash and cash equivalents at end of period $ 8,752 $ 8,707 $ 5,234

Quarterly Financial Data (UNAUD

Quarterly Financial Data (UNAUDITED)	12 Months Ended
Quarterly Financial Data (UNAUDITED)	Dec. 31, 2022
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Data (UNAUDITED)	21. Quarterly Financial Data (UNAUDITED) The summary quarterly financial information set forth below for each of the last eight quarters has been derived from the Company's unaudited interim consolidated financial statements and other financial information. The summary historical quarterly financial information includes all adjustments consisting of normal recurring accruals that the Company considers necessary for a fair presentation of the financial position and the results of operations for the periods. The information below is only a summary and should be read in conjunction with “Management's Discussion and Analysis of Financial Condition and Results of Operations” and the consolidated historical financial statements and the related notes thereto included in this Annual Report on Form 10-K. For the Quarters Ended December 31, 2022 (Dollars in thousands) Q4 Q3 Q2 Q1 Selected income statement data: Interest income $ 51,151 $ 43,102 $ 32,509 $ 27,184 Interest expense 19,000 11,747 4,771 1,974 Net interest income 32,151 31,355 27,738 25,210 Provision for loan losses 1,950 2,900 3,350 4,000 Net interest income after provision for loan losses 30,201 28,455 24,388 21,210 Noninterest income 1,753 2,538 1,266 1,666 Noninterest expense 22,627 22,728 22,773 20,181 Income before income tax expense 9,327 8,265 2,881 2,695 Income tax expense 1,802 1,495 604 608 Net income $ 7,525 $ 6,770 $ 2,277 $ 2,087 For the Quarters Ended December 31, 2021 (Dollars in thousands) Q4 Q3 Q2 Q1 Selected income statement data: Interest income $ 26,660 $ 24,399 $ 23,931 $ 25,625 Interest expense 2,041 2,397 2,717 2,907 Net interest income 24,619 22,002 21,214 22,718 Provision for loan losses 6,100 2,323 - 1,500 Net interest income after provision for loan losses 18,519 19,679 21,214 21,218 Noninterest income 2,055 964 1,109 750 Noninterest expense 20,087 17,641 17,779 15,518 Income before income tax expense 487 3,002 4,544 6,450 Income tax expense 133 617 955 1,354 Net income $ 354 $ 2,385 $ 3,589 $ 5,096

Contingencies

Contingencies	12 Months Ended
Contingencies	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Contingencies	19. Contingencies Litigation In the normal course of business, the Company is involved in various legal proceedings. In the opinion of management, any liability resulting from such proceedings would not have a material adverse effect on the consolidated financial statements.

Nature of Operations and Summ_2

Nature of Operations and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Nature of Operations	Nature of Operations Third Coast Bancshares, Inc. (“Bancshares”), through its subsidiary, Third Coast Bank, SSB, a Texas state savings bank (the “Bank”), and the Bank’s subsidiary, Third Coast Commercial Capital, Inc. (“TCCC”), (collectively known as the “Company”), provide general consumer and commercial banking services through fifteen branch offices in the Greater Houston, Dallas-Fort Worth and Austin-San Antonio markets, and one branch in Detroit, Texas. Branch locations include: Humble, Kingwood, Houston-Galleria, Conroe, Pearland, Lake Jackson, Beaumont, Port Arthur, Dallas, Fort Worth, Plano, La Vernia, Nixon, San Antonio, Georgetown, and Detroit. The Bank is engaged in traditional community banking activities, which include commercial and retail lending, deposit gathering, and investment and liquidity management activities. The Bank’s primary deposit products are demand deposits, money market accounts and certificates of deposit; its primary lending products are commercial business and real estate, residential-construction, real estate mortgage and consumer loans. TCCC engages in accounts receivable factoring activities. The Company is subject to the regulations of certain government agencies and undergoes periodic examinations by those regulatory authorities.
Basis of Presentation	Basis of Presentation The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and with reporting practices prescribed by the financial services industry. The accompanying consolidated financial statements include the accounts of Bancshares, the Bank, and TCCC. All significant intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all adjustments that were recurring in nature and considered necessary have been included for fair presentation of the Company’s financial position and results of operations. The Company has evaluated subsequent events for potential recognition and/or disclosure through the date the consolidated financial statements were issued.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates. Estimates subject to significant changes include the allowance for loan and lease losses, the expected cash flows and collateral values associated with impaired loans, the carrying value of other real estate owned (“OREO”), the fair value of financial instruments, business combination fair value computations, the valuation of goodwill and other intangible assets, stock-based compensation and deferred income tax assets.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents include cash, deposits with other financial institutions that have initial maturities of less than 90 days when acquired by the Company and federal funds sold.
Interest Bearing Time Deposits in Other Banks	Interest Bearing Time Deposits in Other Banks Interest bearing time deposits in other banks are carried at cost and generally mature between 90 days to one year from purchase date.
Investment Securities Available For Sale	Investment Securities Available-For-Sale Investment securities available-for-sale consist of bonds, notes, and debentures that are not classified as trading securities or held-to-maturity securities. Investment securities available-for-sale are held for indefinite periods of time and carried at fair value, with the unrealized holding gains and losses reported as a component of other comprehensive income (loss), net of tax. Management determines the appropriate classification of investment securities at the time of purchase.
Loans and Allowance for Loan Losses	Loans and Allowance for Loan Losses Loans are stated at the amount of unpaid principal, reduced by unearned income and an allowance for loan losses (“ALLL”). Interest on loans is recognized using the effective interest method and includes amortization of deferred loan origination fees and costs over the life of the loans. A loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due (both principal and interest) according to the terms of the loan agreement. Reserves on impaired loans are primarily measured based on the fair value of the underlying collateral. Impaired loans, or portions thereof, are charged off when deemed uncollectible. The accrual of interest on loans is discontinued when there is a clear indication that the borrower’s cash flow may not be sufficient to meet payments as they become due, which is generally when a loan is 90 days past due. When a loan is placed on non-accrual status, all previously accrued and unpaid interest is reversed. Interest income is subsequently recognized on a cash basis as long as the remaining book balance of the asset is deemed to be collectible. If collectability is questionable, then cash payments are applied to principal. A loan is placed back on accrual status when both principal and interest are current and it is probable that the Company will be able to collect all amounts due (both principal and interest) according to the terms of the loan agreement. The allowance for loan losses is established through a provision for loan losses charged against income. The allowance for loan losses includes specific reserves for impaired loans and an estimate of losses inherent in the loan portfolio at the balance sheet date, but not yet identified with specific loans. Loans deemed to be uncollectible are charged against the allowance when management believes that the collectability of the principal is unlikely and subsequent recoveries, if any, are credited to the allowance. Management’s periodic evaluation of the adequacy of the allowance is based on an assessment of the current loan portfolio, including known inherent risks, adverse situations that may affect the borrowers’ ability to repay, the estimated value of any underlying collateral and current economic conditions. From time to time, the Company modifies its loan agreement with a borrower. A modified loan is considered a troubled debt restructuring when two conditions are met: (i) the borrower is experiencing financial difficulty and (ii) concessions are made by the Company that would not otherwise be considered for a borrower with similar credit risk characteristics. Modifications to loan terms may include a lower interest rate, a reduction of principal, or a longer term to maturity. At the time of restructuring, the Company evaluates the economic and business conditions and collection efforts, and should the collection of interest be doubtful, the loan is placed on non-accrual. Each of these loans is evaluated for impairment and a specific reserve is recorded, as necessary, based on probable losses, taking into consideration the related collateral and modified loan terms and cash flow. The Company has certain lending policies and procedures in place that are designed to maximize loan income with an acceptable level of risk. Management reviews and approves these policies and procedures on a regular basis and makes changes as appropriate. Management receives frequent reports related to loan originations, quality, concentrations, delinquencies, non-performing, and potential problem loans. Diversification in the loan portfolio is a means of managing risk associated with fluctuations in economic conditions, both by type of loan and geography. Commercial loans are underwritten after evaluating and understanding the borrower’s ability to operate profitably and effectively. Underwriting standards are designed to determine whether the borrower possesses sound business ethics and practices and to evaluate current and projected cash flows to determine the ability of the borrower to repay their obligations as agreed. Commercial loans are primarily made based on the identified cash flows of the borrower and, secondarily, on the underlying collateral provided by the borrower. Most commercial loans are secured by the assets being financed or other business assets, such as accounts receivable or inventory, and include personal guarantees. Real estate loans are also subject to underwriting standards and processes similar to commercial and agricultural loans. These loans are underwritten primarily based on projected cash flows and, secondarily, as loans secured by real estate. The repayment of real estate loans is generally largely dependent on the successful operation of the property securing the loans or the business conducted on the property securing the loan. Real estate loans may be more adversely affected by conditions in the real estate markets or in the general economy. The properties securing the Company’s real estate portfolio are generally diverse in terms of type and geographic location primarily throughout the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio metropolitan areas. This diversity helps reduce the exposure to adverse economic events that affect any single market or industry. Generally, real estate loans are owner occupied which further reduces the Company’s risk. Agricultural loans are subject to underwriting standards and processes similar to commercial loans. Agricultural loans are primarily made based on the identified cash flows of the borrower and, secondarily, on the underlying collateral provided by the borrower. Most agricultural loans are secured by the agriculture related assets being financed, such as farmland, cattle, or equipment, and include personal guarantees. The Company utilizes methodical credit standards and analysis to supplement its policies and procedures in underwriting consumer loans. The Company’s loan policy addresses types of consumer loans that may be originated and the collateral, if secured, which must be perfected. The relatively smaller individual dollar amounts of consumer loans that are spread over numerous individual borrowers also minimizes the Company’s risk.
Certain Acquired Loans	Certain Acquired Loans Acquired loans purchased from third parties are recorded at their estimated fair value at the acquisition date and are initially classified as either purchased credit impaired (“PCI”) loans (i.e., loans that reflect credit deterioration since origination and it is probable at acquisition that the Company will be unable to collect all contractually required payments) or purchased non-impaired loans (“acquired performing loans”). Acquired performing loans are accounted for under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 310-20. Performance of certain loans may be monitored and based on management’s assessment of the cash flows and other facts available, portions of the accretable difference may be delayed or suspended if management deems appropriate. The Company’s policy for determining when to discontinue accruing interest on acquired performing loans and the subsequent accounting for such loans is essentially the same as the policy for originated loans described above. An ALLL is calculated using a methodology similar to that described for originated loans. Acquired performing loans are subsequently evaluated for any required allowance at each reporting date. Such required allowance for each loan is compared to the remaining fair value discount for that loan. If greater, the excess is recognized as an addition to the allowance through a provision for loan losses. If less than the discount, no additional allowance is recorded. Charge-offs and losses first reduce any remaining fair value discount for the loan and once the discount is depleted, losses are applied against the allowance established for that loan. PCI loans are accounted for under the accounting guidance for loans and debt securities acquired with deteriorated credit quality, found in FASB ASC Topic 310-30, Receivables—Loans and Debt Securities Acquired with Deteriorated Credit Quality . The Company estimates the amount and timing of expected principal, interest and other cash flows for each loan meeting the criteria above and determines the excess of the loan’s scheduled contractual principal and contractual interest payments over all cash flows expected to be collected at acquisition as an amount that should not be accreted. These credit discounts (“nonaccretable marks”) are included in the determination of the initial fair value for acquired loans; therefore, an allowance for loan losses is not recorded at the acquisition date. Differences between the estimated fair values and expected cash flows of acquired loans at the acquisition date that are not credit-based (“accretable marks”) are subsequently accreted to interest income over the estimated life of the loans using a method that approximates a level yield method if the timing and amount of the future cash flows is reasonably estimable. Subsequent to the acquisition date for PCI loans, increases in cash flows over those expected at the acquisition date result in a move of the discount from nonaccretable to accretable. Decreases in expected cash flows after the acquisition date are recognized through the provision for loan losses. For PCI loans after acquisition, cash flows expected to be collected are recast for each loan periodically as determined appropriate by management. If the present value of expected cash flows for a loan is less than its carrying value, impairment is reflected by an increase in the ALLL and a charge to the provision for loan losses. If the present value of the expected cash flows for a loan is greater than its carrying value, any previously established ALLL is reversed and any remaining difference increases the accretable yield, which will be taken into income over the remaining life of the loan. Loan dispositions may include sales of loans, receipt of payments in full from the borrower, or foreclosure. Write-downs are not recorded on the PCI loan until actual losses exceed the remaining non-accretable difference. To date, no write-downs have been recorded for the PCI loans held by the Company. Loans that were considered troubled debt restructurings by the third party prior to the acquisition date are not required to be classified as troubled debt restructurings in the Company’s consolidated financial statements unless or until such loans would subsequently meet criteria to be classified as such, since acquired loans were recorded at their estimated fair values at the time of the acquisition.
Servicing Assets	Servicing Assets Certain Small Business Administration (“SBA”) loans are originated and intended for sale in the secondary market. They are carried at the lower of cost or estimated fair value in the aggregate. Net unrealized losses, if any, are recognized through a valuation allowance by charges to income. Gains or losses recognized upon the sale of loans are determined on a specific identification basis and are included in non-interest income. SBA loan transfers are accounted for as sales when control over the loan has been surrendered. Control over such loans is deemed to be surrendered when (i) the assets have been isolated from the Company, (ii) the transferee obtains the right (free of conditions that constrain it from taking advantage of that right) to pledge or exchange the transferred assets, and (iii) the Company does not maintain effective control over the transferred assets through an agreement to repurchase them before their maturity. The Company has adopted guidance issued by the FASB that clarifies the accounting and reporting standards for transfers and servicing of financial assets and extinguishments of liabilities, in which, after a transfer of financial assets, an entity recognizes the financial and servicing assets it controls and liabilities it has incurred, derecognizes financial assets when control has been surrendered, and derecognizes liabilities when extinguished. To calculate the gain or loss on sale of loans, the Company’s investment in the loan is allocated among the retained portion of the loan, the servicing retained, the interest-only strip and the sold portion of the loan, based on the relative fair value of each portion. The gain or loss on the sold portion of the loan is recognized based on the difference between the sale proceeds and the allocated investment. As a result of the relative fair value allocation, the carrying value of the retained portion is discounted, with the discount accreted to interest income over the life of the loan. Servicing assets are amortized over an estimated life using a method that is in proportion to the estimated future servicing income. In the event future prepayments exceed management’s estimates and future cash flows are inadequate to cover the servicing asset, additional amortization would be recognized. The portion of servicing fees in excess of the contracted servicing fees is reflected as interest-only strips receivable, which are classified as available for sale and are carried at fair value. At December 31, 2022 and 2021, the Company was servicing loans previously sold of approxima tely $ 8.3 million and $ 3.8 million, respectively. The related servicing assets receivable were not material to the consolidated financial statements at December 31, 2022 and 2021.
Premises and Equipment	Premises and Equipment Buildings, leasehold improvements, furniture and fixtures, and equipment are carried at cost, less accumulated depreciation, computed principally by the straight-line method based on the estimated useful lives of the related asset. Land is not depreciated. Major replacements and betterments are capitalized while maintenance and repairs are charged to expense when incurred. Gains or losses on dispositions are reflected in income as incurred. A small portion of building floor space is currently leased out to tenants and recognized in income when earned.
Operating Leases	Operating Leases The Company leases certain office space and stand-alone buildings which are recognized as operating lease right-of-use assets and operating lease liabilities in the consolidated balance sheets. Lease liabilities represent the Company's liability to make lease payments under these leases on a discounted basis and are amortized on a straight-line basis over the lease term for each related lease agreement. Right-of-use assets represent the Company's right to use, or control the use of, leased assets for their lease term and are amortized over the lease term of the related lease agreement. See further discussion of Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842) below. The Company does not recognize short-term operating leases on the consolidated balance sheets. A short-term lease has a term of 12 months or less and does not have a purchase option that is likely to be exercised.
Other Real Estate Owned	Other Real Estate Owned Other real estate owned represents properties acquired through or in lieu of loan foreclosure and are initially recorded at fair value less estimated costs to sell. Any write-down to fair value at the time of transfer to other real estate owned is charged to the allowance for loan losses. Costs of improvements are capitalized, whereas costs relating to holding other real estate owned and subsequent adjustments to the value are expensed. Operating and holding expenses of such properties, net of related income, are included in loan operations and other real estate owned expense on the accompanying consolidated statements of income. Gains or losses on dispositions are reflected in income as incurred.
Bank Owned Life Insurance	Bank-Owned Life Insurance The Company has purchased life insurance policies on certain employees. These bank-owned life insurance (“BOLI”) policies are recorded in the accompanying consolidated balance sheets at their cash surrender values. Income from these policies and changes in the cash surrender values are reported in the accompanying consolidated statements of income.
Non-Marketable Securities	Non-Marketable Securities The Company has restricted non-marketable securities which represent investment in Federal Home Loan Bank (“FHLB”) stock, Federal Reserve Bank (“FRB”) stock and Texas Independent Bank (“TIB”) stock. These investments are not readily marketable and carried at cost, which approximates fair value. As a member of the FHLB, FRB and TIB systems, the Company is required to maintain minimum level of investments in stock, based on the level of borrowings and other factors. Both cash and stock dividends are reported as income.
Goodwill and Core Deposit Intangibles	Goodwill and Core Deposit Intangibles Goodwill represents the excess of cost over fair value of net assets acquired in a business combination. Goodwill is not amortized and is evaluated for impairment at least annually as of December 31 and on an interim basis if an event triggering impairment may have occurred. Core deposit intangibles are acquired customer relationships arising from bank acquisitions and are amortized on a straight-line basis over their estimated useful life of ten years. Core deposit intangibles are tested for impairment whenever events or changes in circumstances indicate the carrying amount of assets may not be recoverable from future undiscounted cash flows.
Derivative Financial Instruments	Derivative Financial Instruments Derivatives are recorded on our Consolidated Balance Sheets as assets and liabilities measured at their fair value. The accounting for increases and decreases in the value of derivatives depends upon the use of the derivatives and whether the derivatives qualify for hedge accounting. At inception of the derivative, we designate the derivative as one of two types based on our intention and belief as to the likely effectiveness as a hedge. These two types are (1) a hedge of the fair value of a recognized asset or liability (“Fair Value Hedge”), and (2) a hedge of a forecasted transaction or the variability of cash flows to be received or paid related to a recognized asset or liability (“Cash Flow Hedge”). For a Fair Value Hedge, the gain or loss on the derivative, as well as the offsetting loss or gain on the hedged item, are recognized in noninterest income in our Consolidated Statements of Income. Fair Value Hedge instruments offered by the Company include pass-through interest rate swap products to qualified commercial banking customers. Under this type of contract, the Company enters into an interest rate swap contract with a customer, while at the same time entering into an offsetting interest rate swap contract with a financial institution counterparty. Changes in the fair value of the underlying derivatives are designed to offset each other so they would not significantly impact the Company's operating results. The Company also enters into Risk Participation Agreements (“RPAs”) with other banks, primarily to share a portion of the risk of borrower default related to the interest rate swap on certain participated loans. The aforementioned instruments are not designated as accounting hedges and do not qualify for hedge accounting. For a Cash Flow Hedge, the gain or loss on the derivative is reported in other comprehensive income (loss) and is reclassified into earnings in the same periods during which the hedged transaction affects earnings. Cash Flow Hedge instruments include pay-fixed interest rate swap agreements with a financial institution counterparty. Net cash settlements on derivatives that qualify for hedge accounting are recorded in interest expense in the Consolidated Statements of Income. Net cash settlements on derivatives that do not qualify for hedge accounting (pass-through interest rate swaps and RPAs) are reported in noninterest income in the Consolidated Statements of Income. Cash flows on hedges are classified in the cash flow statement the same as the items being hedged. We formally document the relationship between derivatives and hedged items, as well as the risk-management objective and the strategy for undertaking hedge transactions, at the inception of the hedging relationship. This documentation includes linking Cash Flow Hedges to specific assets and liabilities on the Consolidated Statements of Financial Condition or to forecasted transactions. See Note 17 – Derivative Financial Instruments.
Business Combinations	Business Combinations The Company applies the acquisition method of accounting for business combinations. Under the acquisition method, the acquiring entity in a business combination recognizes 100% of the assets acquired and liabilities assumed at their acquisition date fair values. Management utilizes valuation techniques appropriate for the asset or liability being measured in determining these fair values. Any excess of the purchase price over amounts allocated to assets acquired, including identifiable intangible assets, and liabilities assumed is recorded as goodwill. Adjustments identified during the measurement period are recognized in the reporting period in which the adjustment amounts are determined. Acquisition related costs are expensed as incurred.
Comprehensive Income	Comprehensive Income Comprehensive income includes all changes in shareholders’ equity during a period, except those resulting from transactions with shareholders. Other than net income, comprehensive income includes the net effect of changes in the fair value of securities available-for-sale and certain derivative instruments designated as cash flow hedges.
Revenue from Contract with Customers	Revenues from Contracts with Customers The Company’s revenues from services such as deposit related fees, wire transfer fees, interchange fees on debit cards, ATM fees, and merchant fee income are presented within the service charges and fees category in the accompanying consolidated statements of income and are recognized as revenue as the Company satisfies its obligation to the customer.
Advertising and Marketing Expenses	Advertising and Marketing Expenses Advertising and marketing expenses consist of the Company’s advertising in its local market area and are expensed as incurred. For the years ended December 31, 2022, 2021 and 2020, advertising and marketing expenses were $ 1.9 million, $ 1.9 million and $ 1.3 million, respectively, and are included within noninterest expense in the accompanying consolidated statements of income.
Income Taxes	Income Taxes The Company files a consolidated income tax return with its subsidiary. Federal income tax expense or benefit is allocated on a separate return basis. Deferred tax assets and liabilities are reflected at currently enacted income tax rates applicable to the period in which the deferred tax assets and liabilities are expected to be realized or settled. As changes in tax laws or rates are enacted, deferred tax assets and liabilities are adjusted through the provision for income taxes. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
Share-Based Compensation	Share-Based Compensation Compensation expense for stock options is based on the fair value of the award on the measurement date, which, for the Company, is the date of the grant and is recognized ratably over the service period of the award. The fair value of stock options is estimated using the Black-Scholes option-pricing model.
Basic and Diluted Earnings Per Common Share	Basic and Diluted Earnings Per Common Share Earnings per common share is computed in accordance with ASC Topic 260, “Earnings Per Share.” Basic earnings per common share is computed by dividing net earnings allocated to common stock by the weighted-average number of common shares outstanding during the applicable period. Diluted earnings per common share is computed using the weighted-average number of shares determined for the basic earnings per common share computation plus the dilutive effect of stock compensation using the treasury stock method, plus the dilutive effect of convertible preferred stock using the if-converted method. A reconciliation of the weighted-average shares used in calculating basic earnings per common share and the weighted average common shares used in calculating diluted earnings per common share for the reported periods is provided in Note 16 – Earnings Per Common Share.
Reclassification	Reclassification Certain amounts in prior period consolidated financial statements may have been reclassified to conform to current period presentation. These reclassifications are immaterial and have no effect on net income, total assets or shareholders’ equity.
Recently Adopted and Issued Accounting Standards	Recently Adopted Accounting Standards The Company adopted ASU 2016-02 - “Leases” (Topic 842) on January 1, 2022 using the effective date as the date of initial adoption. The Company elected to apply certain practical expedients for transition, and under those expedients the Company did not reassess prior accounting decisions regarding the identification, classification and initial direct costs leases existing at the effective date. The Company also elected to use hindsight in determining the lease term when considering options to extend the lease and excluded short-term leases (defined as lease terms of 12 months or less). The Company elected to separate non-lease components from lease components in its application of ASU 2016-02. At adoption, the Company recorded right-of-use assets totaling $ 11.0 million, which represented the Company's right to use, or control the use of, specified assets for their lease terms, and the Company recorded lease liabilities totaling $ 10.9 million, which represented the Company's liability to make lease payments under these leases. The ASU 2016-02 standard applied to all leases existing at the date of initial adoption. The Company's financial statements and related footnotes were not updated for ASU 2016-02 for dates and periods before the date of adoption. See Note 9 – Leases. Recently Issued Accounting Standards - Not Yet Adopted In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 is effective for fiscal years beginning after December 15, 2022. ASU 2016-13 is intended to replace the incurred loss model for loans and other financial assets with an expected loss model, which is known as the current expected credit loss (“CECL”) model. The change is intended to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit. The Company adopted ASU 2016-13 on January 1, 2023 and recorded an increase in the allowance for credit losses of approximately $ 4.0 million.

Investment Securities Availab_2

Investment Securities Available for Sale (Tables)	12 Months Ended
Investment Securities Available for Sale (Tables)	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Carrying Amount and Fair Values of Investment Securities Available For Sale	The carrying amount of securities and their approximate fair values as of December 31, 2022 and 2021 are as follows: December 31, 2022 (Dollars in thousands) Amortized Gross Gross Estimated Securities available-for-sale: State and municipal securities $ 422 $ — $ 5 $ 417 Mortgage-backed securities and other agency obligations 23,522 238 879 22,881 U.S. Treasury bonds 100,567 — 2,049 98,518 Corporate bonds 57,607 59 3,415 54,251 $ 182,118 $ 297 $ 6,348 $ 176,067 December 31, 2021 (Dollars in thousands) Amortized Gross Gross Estimated Securities Available-for-sale: State and municipal securities $ 1,087 $ 7 $ — $ 1,094 Mortgage-backed securities and other agency obligations 791 20 — 811 U.S. Treasury bonds — — — — Corporate bonds 23,556 972 1 24,527 $ 25,434 $ 999 $ 1 $ 26,432
Schedule of Amortized Cost and Fair Value of Securities by Contractual Maturity	The amortized cost and estimated fair value of securities available for sale at December 31, 2022, by contractual maturity, are shown below. December 31, 2022 Securities (Dollars in thousands) Amortized Estimated Due in one year or less $ 100,990 $ 98,935 Due from one year to five years 3,778 3,838 Due from five to ten years 53,828 50,413 158,596 153,186 Mortgage-backed securities and other agency obligations 23,522 22,881 $ 182,118 $ 176,067
Summary of Securities with Unrealized Losses	The following table summarizes securities with unrealized losses at December 31, 2022 and 2021, aggregated by major security type and length of time in a continuous unrealized loss position: December 31, 2022 (Dollars in thousands) Less Than 12 Greater Than 12 Total Estimated Securities available-for-sale: State and municipal securities $ 5 $ — $ 5 $ 417 Mortgage-backed securities and other agency obligations 879 — 879 18,376 U.S. Treasury bonds 2,049 — 2,049 98,518 Corporate bonds 3,415 — 3,415 50,413 $ 6,348 $ — $ 6,348 $ 167,724 December 31, 2021 (Dollars in thousands) Less Than 12 Greater Than 12 Total Estimated Securities available-for-sale: State and municipal securities $ — $ — $ — $ — Mortgage-backed securities and other agency obligations — — — — U.S. Treasury bonds — — — — Corporate bonds — 1 1 3,999 $ — $ 1 $ 1 $ 3,999

Loans and Allowance for Loan _2

Loans and Allowance for Loan Losses (Tables)	12 Months Ended
Loans and Allowance for Loan Losses (Tables)	Dec. 31, 2022
Receivables [Abstract]
Schedule of Amounts Recognized in Balance Sheet	Loans in the accompanying consolidated balance sheets consisted of the following: December 31, (Dollars in thousands) 2022 2021 Real estate loans: Non-farm non-residential owner occupied $ 493,791 $ 383,941 Non-farm non-residential non-owner occupied 506,012 445,308 Residential 308,775 213,264 Construction, development & other 567,851 320,335 Farmland 22,820 9,934 Commercial & industrial 1,058,910 611,348 Consumer 3,872 4,001 Municipal and other 145,520 80,593 3,107,551 2,068,724 Allowance for loan losses ( 30,351 ) ( 19,295 ) Loans, net $ 3,077,200 $ 2,049,429
Schedule of Non-accrual and Accruing Past Due Loans, Segregated by Class of Loans	Non-accrual loans and accruing loans past due more than 90 days segregated by class of loans were as follows: December 31, 2022 2021 (Dollars in thousands) Non-accrual Accruing loans Non-accrual Accruing loans Real estate loans: Non-farm non-residential owner occupied $ 1,699 $ 157 $ 1,008 $ — Non-farm non-residential non-owner occupied 296 — 346 — Residential 513 — 127 — Construction, development & other 40 — 244 — Farmland — — — — Commercial & industrial 8,390 361 8,297 278 Consumer 20 — — — Municipal and other — — — — Purchased credit impaired 5 — 8 — $ 10,963 $ 518 $ 10,030 $ 278
Schedule of Aging Past Due Loans, Segregated by Class of Loans	An age analysis of past due loans, segregated by class of loans, were as follows: December 31, 2022 (Dollars in thousands) 30-59 60-89 Over 90 Total Total Total Real estate loans: Non-farm non-residential $ 2,996 $ — $ 1,856 $ 4,852 $ 488,939 $ 493,791 Non-farm non-residential 132 — 296 428 505,584 506,012 Residential 2,356 — 513 2,869 305,906 308,775 Construction, 130 — 40 170 567,676 567,846 Farmland — — — — 22,820 22,820 Commercial & industrial 791 613 8,751 10,155 1,048,704 1,058,859 Consumer — — 20 20 3,852 3,872 Municipal and other 162 — — 162 145,358 145,520 Purchased credit impaired — — 5 5 51 56 $ 6,567 $ 613 $ 11,481 $ 18,661 $ 3,088,890 $ 3,107,551 December 31, 2021 (Dollars in thousands) 30-59 60-89 Over 90 Total Total Total Real estate loans: Non-farm non-residential $ 291 $ — $ 1,008 $ 1,299 $ 382,642 $ 383,941 Non-farm non-residential 161 — 346 507 444,079 444,586 Residential 230 — 127 357 212,822 213,179 Construction, — 395 244 639 315,584 316,223 Farmland — — — — 9,934 9,934 Commercial & industrial 960 457 8,575 9,992 601,291 611,283 Consumer 9 — — 9 3,992 4,001 Municipal and other 18 1 — 19 80,574 80,593 Purchased credit impaired — — 8 8 4,976 4,984 $ 1,669 $ 853 $ 10,308 $ 12,830 $ 2,055,894 $ 2,068,724
Schedule of Impaired Loans by Class of Loans	The following tables present impaired loans by class of loans: December 31, 2022 (Dollars in thousands) Unpaid Recorded Recorded Total Related Average Real estate loans: Non-farm non-residential $ 1,694 $ 1,699 $ — $ 1,699 $ — $ 1,751 Non-farm non-residential 5,497 5,496 — 5,496 — 5,563 Residential 516 513 — 513 — 524 Construction, 40 40 — 40 — 51 Farmland — — — — — — Commercial & industrial 11,891 7,734 4,162 11,896 1,587 10,691 Consumer 19 20 — 20 — 21 Municipal and other — — — — — — Purchased credit impaired 51 — 51 51 13 58 $ 19,708 $ 15,502 $ 4,213 $ 19,715 $ 1,600 $ 18,659 December 31, 2021 (Dollars in thousands) Unpaid Recorded Recorded Total Related Average Real estate loans: Non-farm non-residential $ 1,008 $ 1,008 $ — $ 1,008 $ — $ 1,051 Non-farm non-residential 5,641 5,630 — 5,630 — 5,680 Residential 130 127 — 127 — 138 Construction, 241 244 — 244 — 255 Farmland — — — — — — Commercial & industrial 8,297 7,331 967 8,298 290 9,117 Consumer — — — — — — Municipal and other — — — — — — Purchased credit impaired 65 — 65 65 17 71 $ 15,382 $ 14,340 $ 1,032 $ 15,372 $ 307 $ 16,312
Summary of Troubled Debt Restructuring	During the year ended December 31, 2022 and 2021, the terms of one loan were modified as a troubled debt restructuring (“TDR”). The following table presents modifications of loans the Company considers to be TDR loans: December 31, 2022 Loan modifications (Dollars in thousands) Number Pre- Post- Adjusted Payment Combined Real estate loans: Non-farm non-residential 3 $ 822 $ 822 $ — $ 822 $ — Non-farm non-residential — — — — — — Residential — — — — — — Construction, — — — — — — Farmland — — — — — — Commercial & industrial 1 780 780 — 780 — Consumer — — — — — — Municipal and other — — — — — — 4 $ 1,602 $ 1,602 $ — $ 1,602 $ — December 31, 2021 Loan modifications (Dollars in thousands) Number Pre- Post- Adjusted Payment Combined Real estate loans: Non-farm non-residential 3 $ 878 $ 878 $ — $ 878 $ — Non-farm non-residential 1 5,294 5,294 — 5,294 — Residential — — — — — — Construction, — — — — — — Farmland — — — — — — Commercial & industrial — — — — — — Consumer — — — — — — Municipal and other — — — — — — 4 $ 6,172 $ 6,172 $ — $ 6,172 $ —
Summary of Internal Ratings of Loans	The following tables summarize the Company’s internal ratings of its loans: December 31, 2022 (Dollars in thousands) Pass Special Substandard Purchased Doubtful Total Real estate loans: Non-farm non-residential $ 487,633 $ 1,885 $ 4,273 $ — $ — $ 493,791 Non-farm non-residential 498,987 228 6,797 — — 506,012 Residential 307,881 — 894 — — 308,775 Construction, 559,186 8,620 40 5 — 567,851 Farmland 22,820 — — — — 22,820 Commercial & industrial 1,051,314 2,252 5,293 51 — 1,058,910 Consumer 3,852 — 20 — — 3,872 Municipal and other 145,520 — — — — 145,520 $ 3,077,193 $ 12,985 $ 17,317 $ 56 $ — $ 3,107,551 December 31, 2021 (Dollars in thousands) Pass Special Substandard Purchased Doubtful Total Real estate loans: Non-farm non-residential $ 370,062 $ 6,953 $ 6,926 $ — $ — $ 383,941 Non-farm non-residential 428,972 8,338 7,276 722 — 445,308 Residential 212,109 — 1,069 86 — 213,264 Construction, 315,979 — 244 4,112 — 320,335 Farmland 9,934 — — — — 9,934 Commercial & industrial 605,322 1,146 4,816 64 — 611,348 Consumer 3,979 22 — — — 4,001 Municipal and other 80,593 — — — — 80,593 $ 2,026,950 $ 16,459 $ 20,331 $ 4,984 $ — $ 2,068,724
Schedule of Allowance for Loan Losses	The following tables detail the activity in the allowance for loan losses by portfolio segment: For the Year Ended December 31, 2022 (Dollars in thousands) Beginning Provision for Charge-offs Recoveries Ending Real estate loans: Non-farm non-residential $ 3,456 $ 317 $ — $ — $ 3,773 Non-farm non-residential 5,935 ( 194 ) — — 5,741 Residential 957 107 — — 1,064 Construction, development & other 2,064 989 — — 3,053 Farmland 45 37 — — 82 Commercial & industrial 6,500 10,911 ( 1,214 ) 72 16,269 Consumer 6 5 ( 18 ) 13 6 Municipal and other 332 28 — 3 363 $ 19,295 $ 12,200 $ ( 1,232 ) $ 88 $ 30,351 For the Year Ended December 31, 2021 (Dollars in thousands) Beginning Provision for Charge-offs Recoveries Ending Real estate loans: Non-farm non-residential $ 2,608 $ 848 $ — $ — $ 3,456 Non-farm non-residential 3,107 2,828 — — 5,935 Residential 1,218 ( 261 ) — — 957 Construction, development & other 932 1,132 — — 2,064 Farmland 32 13 — — 45 Commercial & industrial 3,858 5,233 ( 2,914 ) 323 6,500 Consumer 35 ( 30 ) — 1 6 Municipal and other 189 160 ( 20 ) 3 332 $ 11,979 $ 9,923 $ ( 2,934 ) $ 327 $ 19,295 For the Year Ended December 31, 2020 (Dollars in thousands) Beginning Provision for Charge-offs Recoveries Ending Real estate loans: Non-farm non-residential $ 2,158 $ 450 $ — $ — $ 2,608 Non-farm non-residential 1,627 3,816 ( 2,336 ) — 3,107 Residential 373 845 — — 1,218 Construction, development & other 330 602 — — 932 Farmland 29 3 — — 32 Commercial & industrial 3,504 1,710 ( 1,389 ) 33 3,858 Consumer 16 21 ( 7 ) 5 35 Municipal and other 86 103 — — 189 $ 8,123 $ 7,550 $ ( 3,732 ) $ 38 $ 11,979
Schedule of Allowance for Loan Losses for Loans Evaluated for Impairment Individually and Collectively	The following tables summarize the allocation of the allowance for loan losses, by portfolio segment, for loans evaluated for impairment individually and collectively: December 31, 2022 Period end amounts of ALLL (Dollars in thousands) Individually Collectively PCI Total Real estate loans: Non-farm non-residential owner occupied $ — $ 3,773 $ — $ 3,773 Non-farm non-residential non-owner occupied — 5,741 — 5,741 Residential — 1,064 — 1,064 Construction, development & other — 3,053 — 3,053 Farmland — 82 — 82 Commercial & industrial 1,587 14,669 13 16,269 Consumer — 6 — 6 Municipal and other — 363 — 363 $ 1,587 $ 28,751 $ 13 $ 30,351 December 31, 2021 Period end amounts of ALLL (Dollars in thousands) Individually Collectively PCI Total Real estate loans: Non-farm non-residential owner occupied $ — $ 3,456 $ — $ 3,456 Non-farm non-residential non-owner occupied — 5,935 — 5,935 Residential — 957 — 957 Construction, development & other — 2,064 — 2,064 Farmland — 45 — 45 Commercial & industrial 290 6,193 17 6,500 Consumer — 6 — 6 Municipal and other — 332 — 332 $ 290 $ 18,988 $ 17 $ 19,295
Schedule Of Allowance for Loan losses For loans evaluated for Impairment Methodology	The company’s recorded investment in loans related to the balance in the allowance for loan losses on the basis of the Company’s impairment methodology is as follows: December 31, 2022 Loans evaluated for (Dollars in thousands) Individually Collectively PCI Total Real estate loans: Non-farm non-residential owner occupied $ 1,699 $ 492,092 $ — $ 493,791 Non-farm non-residential non-owner occupied 5,496 500,516 — 506,012 Residential 513 308,262 — 308,775 Construction, development & other 40 567,811 — 567,851 Farmland — 22,820 — 22,820 Commercial & industrial 11,896 1,046,963 51 1,058,910 Consumer 20 3,852 — 3,872 Municipal and other — 145,520 — 145,520 $ 19,664 $ 3,087,836 $ 51 $ 3,107,551 December 31, 2021 Loans evaluated for (Dollars in thousands) Individually Collectively PCI Total Real estate loans: Non-farm non-residential owner occupied $ 1,008 $ 382,933 — $ 383,941 Non-farm non-residential non-owner occupied 5,630 439,678 — 445,308 Residential 127 213,137 — 213,264 Construction, development & other 244 320,091 — 320,335 Farmland — 9,934 — 9,934 Commercial & industrial 8,363 602,920 65 611,348 Consumer — 4,001 — 4,001 Municipal and other — 80,593 — 80,593 $ 15,372 $ 2,053,287 $ 65 $ 2,068,724
Schedule of Gross Contractual Amounts Receivable Balances By Portfolio Segment PCI Loans	The following table presents the gross contractual amounts receivable balances, by portfolio segment, and the carrying amount of PCI loans: December 31, (Dollars in thousands) 2022 2021 Real estate loans: Non-farm non-residential owner occupied $ — $ — Non-farm non-residential non-owner occupied — 820 Residential 77 181 Construction, development & other 5 5,169 Farmland — — Commercial & industrial 52 66 Consumer — — Other — — Total outstanding balances $ 134 $ 6,236 Carrying amount $ 56 $ 4,984
Schedule of Accretable Yield Collected on PCI Loans	Accretable yield, or income expected to be collected on PCI loans was as follows: December 31, (Dollars in thousands) 2022 2021 2020 Balance at beginning of year $ 926 $ 2,261 $ 83 New loans acquired from Heritage acquisition — — 2,726 Accretion of income ( 762 ) ( 1,335 ) ( 808 ) Reclassifications from non-accretable difference — — 260 Balance at end of year $ 164 $ 926 $ 2,261

Premises and Equipment (Tables)

Premises and Equipment (Tables)	12 Months Ended
Premises and Equipment (Tables)	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Premises and Equipment	Premises and equipment in the accompanying consolidated balance sheets consisted of the following: Estimated December 31, (Dollars in thousands) Useful Life 2022 2021 Building 30 years $ 8,662 $ 8,404 Building improvements 3 - 10 years 4,943 3,752 Land 3,894 3,894 Equipment 3 - 5 years 5,757 4,308 Leasehold improvements 3 - 10 years 9,761 2,888 Furniture and fixtures 3 - 5 years 4,170 2,541 Construction in process 1,964 1,174 39,151 26,961 Accumulated depreciation ( 10,489 ) ( 7,916 ) $ 28,662 $ 19,045

Deposits (Tables)

Deposits (Tables)	12 Months Ended
Deposits (Tables)	Dec. 31, 2022
Deposits Liabilities, Balance Sheet, Reported Amounts [Abstract]
Schedule of Deposit Liabilities	Deposits in the accompanying consolidated balance sheets consisted of the following: December 31, (Dollars in thousands) 2022 2021 Transaction accounts: Noninterest bearing demand accounts $ 486,114 $ 531,401 Interest bearing demand accounts 2,498,325 1,298,546 Savings 35,677 33,539 Total transaction accounts 3,020,116 1,863,486 Time deposits 216,030 277,713 Total deposits $ 3,236,146 $ 2,141,199
Schedule Maturities of time deposit	Scheduled maturities of time deposits at December 31, 2022 are as follows: 2023 $ 181,926 2024 28,578 2025 2,971 2026 1,567 2027 and thereafter 988 $ 216,030

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Summary of Provision for Income Taxes	The provision for income taxes consisted of the following: December 31, (Dollars in thousands) 2022 2021 Current income tax expense $ 5,759 $ 3,439 Deferred income tax benefit ( 1,250 ) ( 380 ) Income tax expense as reported $ 4,509 $ 3,059
Reconciliation of Reported Income Tax Expense	A reconciliation of reported income tax expense to the amount computed by the Company's statutory income tax rate of 21 % to income before income taxes is presented below: December 31, (Dollars in thousands) 2022 2021 Income tax expense computed at statutory rate $ 4,865 $ 3,042 Stock-based compensation 117 93 Bank-owned life insurance ( 276 ) ( 119 ) Non-deductible meals, entertainment, and dues 91 57 Tax-exempt income ( 283 ) ( 2 ) Non-deductible merger costs — 2 Other, net ( 5 ) ( 14 ) Income tax expense as reported $ 4,509 $ 3,059
Summary of Deferred Taxes	A summary of deferred taxes is presented below: December 31, (Dollars in thousands) 2022 2021 Deferred tax assets: Allowance for loan losses $ 6,352 $ 4,046 Organizational and start-up costs 6 18 Accrued expenses 264 1,189 Stock options and restricted stock 114 131 Loan purchase mark-to-mark 62 216 Deposit purchase premium — 38 Deferred loan origination fees 1,564 433 Net unrealized loss on securities available for sale 1,271 — Non-accrual interest 241 150 Other 118 2 Total deferred tax assets 9,992 6,223 Deferred tax liabilities: Premises and equipment 2,468 1,161 Goodwill and core deposit intangibles 237 271 Investments 68 66 Net unrealized gain on securities available for sale — 210 Unrealized gain on derivatives 712 161 Prepaid expenses and other 204 231 Total deferred tax liabilities 3,689 2,100 Net deferred tax asset $ 6,303 $ 4,123

FHLB Advances and Other Borro_2

FHLB Advances and Other Borrowings (Tables)	12 Months Ended
FHLB Advances and Other Borrowings (Tables)	Dec. 31, 2022
Federal Home Loan Banks [Abstract]
Summary of Contractual Maturities of FHLB Advances and Other Borrowings	Contractual maturities of FHLB advances and other borrowings at December 31, 2022 were as follows: (Dollars in thousands) FHLB Senior Debt Subordinated 2023 $ — $ — $ — 2024 — 30,875 — 2025 — — — 2026 — — — 2027 and thereafter — — 80,348 $ — $ 30,875 $ 80,348

Stock Options and Warrants (Tab

Stock Options and Warrants (Table)	12 Months Ended
Stock Options and Warrants (Table)	Dec. 31, 2022
Stock Options And Warrants [Abstract]
Summary of Stock Option Activity	A summary of stock option activity for years ended December 31, 2022 and 2021 is presented below: December 31, 2022 2021 (Dollars in thousands, except share and per share data) Shares Weighted Shares Weighted Outstanding at beginning of period 1,220,428 $ 17.83 660,251 $ 14.37 Granted during the period 136,000 21.15 788,250 20.22 Forfeited during the period ( 105,167 ) 21.18 ( 144,903 ) 17.55 Exercised during the period ( 47,333 ) 14.38 ( 83,170 ) 13.48 Outstanding at the end of period 1,203,928 $ 18.05 1,220,428 $ 17.83 Options exercisable at end of period 527,658 $ 15.51 361,758 $ 13.59 Weighted-average grant date fair value of options granted $ 6.80 $ 3.15
Schedule of Weighted Average Remaining life	A summary of weighted average remaining life is presented below: December 31, (Dollars in thousands, except 2022 2021 Exercise Price Options Outstanding Weighted Options Exercisable Options Outstanding Weighted Options $ 10.00 - $ 12.99 146,553 1.96 146,553 162,223 5.15 162,223 $ 13.00 - $ 16.99 435,175 6.45 280,905 496,955 7.48 199,535 $ 17.00 - $ 26.99 622,200 8.69 100,200 561,250 9.52 — 1,203,928 7.06 527,658 1,220,428 8.11 361,758
Schedule of Nonvested Share Activity	A summary of the activity in the Company’s nonvested shares is as follows: December 31, 2022 2021 (Dollars in thousands, except share and per share data) Shares Weighted Shares Weighted Nonvested at January 1, 858,670 $ 3.15 262,670 $ 3.04 Granted during the period 136,000 6.80 788,250 3.15 Vested during the period ( 219,900 ) 3.07 ( 72,500 ) 3.17 Forfeited during the period ( 98,500 ) 3.70 ( 119,750 ) 2.88 Nonvested at end of period 676,270 $ 3.82 858,670 $ 3.15
Schedule Of Stock Warrant Activity	A summary of the Company’s stock warrant activity is presented below: December 31, 2022 2021 (Dollars in thousands, except share and per share data) Shares Weighted Shares Weighted Outstanding at beginning of period 4,285 $ 11.00 6,000 $ 11.00 Granted 175,000 22.50 — — Exercised — — ( 1,715 ) 11.00 Outstanding at end of period 179,285 $ 22.23 4,285 $ 11.00 Exercisable at end of period 179,285 $ 22.23 4,285 $ 11.00
Summary of Activity for Nonvested RSAs	A summary of the activity for non-vested RSAs for the years ended December 31, 2022, 2021 and 2020 is presented below: December 31, 2022 2021 (Dollars in thousands, except share and per share data) Shares Weighted Shares Weighted Nonvested at beginning of period 49,750 $ 24.00 — $ — Granted during the period 54,424 21.81 49,750 24.00 Vested during the period ( 18,580 ) 24.00 — — Forfeited during the period ( 9,500 ) 24.67 — — Nonvested at the end of period 76,094 $ 22.35 49,750 $ 24.00

Leases (Tables)

Leases (Tables)	12 Months Ended
Leases (Tables)	Dec. 31, 2022
Leases [Abstract]
Schedule of Lease cost	Lease costs for the period shown below were as follows: December 31, (Dollars in thousands) 2022 2021 2020 Operating lease cost $ 2,804 $ 1,605 $ 1,154 Short-term lease cost 607 — — Total lease cost $ 3,411 $ 1,605 $ 1,154
Schedule of maturities of operating leases	A schedule of the Company's lease liabilities by contractual maturity for operating leases with initial or remaining terms in excess of one year for each year through 2027 and thereafter is presented below: (Dollars in thousands) 2023 $ 2,516 2024 2,944 2025 2,957 2026 3,027 2027 and thereafter 16,917 Total undiscounted lease liability 28,361 Less: Discount on cash flows ( 3,920 ) Lease signed, but not yet commenced ( 6,232 ) Total operating lease liability $ 18,209

Financial Instruments With Of_2

Financial Instruments With Off Balance Sheet Risk (Table)	12 Months Ended
Financial Instruments With Off Balance Sheet Risk (Table)	Dec. 31, 2022
Financial Instruments With Off Balance Sheet Risk [Abstract]
Schedule of Financial Instruments Outstanding Whose Contract Amounts Represent Credit Risk	The following financial instruments were outstanding whose contract amounts represent credit risk: December 31, (Dollars in thousands) 2022 2021 Commitments to extend credit $ 1,148,012 $ 606,160 Standby letters of credit 21,728 14,144 Total $ 1,169,740 $ 620,304

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
Fair Value Measurements (Tables)	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Summary of Financial Assets and Financial Liabilities Measured at Fair Value	The following table summarizes financial assets and financial liabilities measured at fair value on a recurring basis, segregated by the level of the valuation inputs within the fair value hierarchy utilized to measure fair value as of December 31, 2022 and 2021: Fair Value Measurements Using (Dollars in thousands) Level 1 Inputs Level 2 Inputs Level 3 Inputs Total Fair Value At December 31, 2022: Securities available for sale: State and municipal securities $ — $ 417 $ — $ 417 Mortgage-backed securities and other agency obligations — 22,881 — 22,881 U.S. Treasury bonds — 98,518 — 98,518 Corporate bonds — 54,251 — 54,251 Total investment securities available for sale $ — $ 176,067 $ — $ 176,067 Asset derivatives: Interest rate swaps $ — $ 9,213 $ — $ 9,213 Total asset derivatives $ — $ 9,213 $ — $ 9,213 Liability derivatives: Interest rate swaps $ — $ 9,213 $ — $ 9,213 Risk participation agreements — 8 — 8 Total liability derivatives $ — $ 9,221 $ — $ 9,221 Fair Value Measurements Using (Dollars in thousands) Level 1 Inputs Level 2 Inputs Level 3 Inputs Total Fair Value At December 31, 2021: Securities available for sale: State and municipal securities $ — $ 1,094 $ — $ 1,094 Mortgage-backed securities and other agency obligations — 811 — 811 Corporate bonds — 24,527 — 24,527 Total investment securities available for sale $ — $ 26,432 $ — $ 26,432 Asset derivatives: Interest rate swaps $ — $ 389 $ — $ 389 Total asset derivatives $ — $ 389 $ — $ 389 Liability derivatives: Interest rate swaps $ — $ 389 $ — $ 389 Total liability derivatives $ — $ 389 $ — $ 389
Summary of Foreclosed Assets Remeasured and Recorded at Fair Value	December 31, (Dollars in thousands) 2022 2021 Foreclosed assets remeasured subsequent to initial recognition: Carrying value of foreclosed assets prior to remeasurement $ — $ 1,676 Fair value of foreclosed assets remeasured subsequent to initial recognition $ — $ 1,676
Summary of Estimated Fair Values and Carrying Values of Financial Instruments	The estimated fair values and carrying values of all financial instruments under current authoritative guidance, segregated by the level of the valuation inputs within the fair value hierarchy utilized to measure fair value are as follows: December 31, 2022 December 31, 2021 (Dollars in thousands) Carrying Estimated Carrying Estimated Financial assets Level 2 inputs Cash and cash equivalents $ 332,014 $ 332,014 $ 327,025 $ 327,025 Interest bearing time deposits in other banks — — 131 131 Investment securities available for sale 176,067 176,067 26,432 26,432 Non-marketable securities 15,405 15,405 7,527 7,527 Accrued interest receivable 18,340 18,340 10,228 10,228 Bank-owned life insurance 60,761 60,761 26,528 26,528 Derivative instruments assets 9,213 9,213 389 389 $ 611,800 $ 611,800 $ 398,260 $ 398,260 Level 3 inputs Loans, including held for sale, net $ 3,077,200 $ 2,920,213 $ 2,049,429 $ 2,023,761 Financial liabilities Level 2 inputs Deposits $ 3,236,146 $ 3,238,857 $ 2,141,199 $ 2,141,999 Accrued interest payable 2,545 2,545 437 437 FHLB advances — — 50,000 50,000 Notes payable 111,223 111,223 1,000 1,000 Derivative instrument liabilities 9,221 9,221 389 389 $ 3,359,135 $ 3,361,846 $ 2,193,025 $ 2,193,825

Shareholders_ Equity and Regu_2

Shareholders’ Equity and Regulatory Matters (Tables)	12 Months Ended
Shareholders’ Equity and Regulatory Matters (Tables)	Dec. 31, 2022
Stockholders' Equity Note [Abstract]
Schedule of Comparison of the Actual Capital Amounts and Ratios	A comparison of the Bank’s actual capital amounts and ratios to required capital amounts and ratios are presented in the following table: Actual For Capital Adequacy (2) To Be Well Capitalized (Dollars in thousands) Amount Ratio Amount Ratio Amount Ratio As of December 31, 2022: Total capital (to risk Bank 496,222 13.8 % ≥ 377,782 ≥ 10.5 % ≥ 359,793 ≥ 10.0 % Tier I capital (to risk Bank 465,871 12.9 % ≥ 305,824 ≥ 8.5 % ≥ 287,834 ≥ 8.0 % Tier I capital (to average (1) Bank 465,871 13.1 % ≥ 142,188 ≥ 4.0 % ≥ 177,734 ≥ 5.0 % Common equity tier 1 (to Bank 465,871 12.9 % ≥ 251,855 ≥ 7.0 % ≥ 233,865 ≥ 6.5 % As of December 31, 2021: Total capital (to risk Bank 288,022 13.5 % ≥ 223,444 ≥ 10.5 % ≥ 212,804 ≥ 10.0 % Tier I capital (to risk Bank 268,727 12.6 % ≥ 180,883 ≥ 8.5 % ≥ 170,243 ≥ 8.0 % Tier I capital (to average (1) Bank 268,727 12.3 % ≥ 87,602 ≥ 4.0 % ≥ 109,503 ≥ 5.0 % Common equity tier 1 (to Bank 268,727 12.6 % ≥ 148,962 ≥ 7.0 % ≥ 138,322 ≥ 6.5 % (1) The Tier 1 capital ratio (to average assets) is not impacted by the Basel III Capital Rules; however, the Federal Reserve and the FDIC may require the Bank to maintain a Tier 1 capital ratio (to average assets) above the minimum required. (2) Percentages represent the minimum capital ratios plus, as applicable, the fully phased-in 2.5 % CIT1 capital buffer under the Basel III Capital Rules.

Earnings Per Common Share (Tabl

Earnings Per Common Share (Tables)	12 Months Ended
Earnings Per Common Share (Tables)	Dec. 31, 2022
Earnings Per Share [Abstract]
Schedule Of Earnings Per Share Basic And Diluted	The following table presents a reconciliation of net income available to common shareholders and the number of shares used in the calculation of basic and diluted earnings per common share shown on the consolidated statements of income. For the Years Ended December 31, (Dollars in thousands, except share and per share data) 2022 2021 2020 Net income $ 18,659 $ 11,424 $ 12,115 Less dividends declared, Preferred Series A stock 1,418 — — Net income available to common shareholders $ 17,241 $ 11,424 $ 12,115 Weighted-average shares outstanding for basic earnings per common share 13,465,196 7,874,110 6,232,115 Dilutive effect of stock compensation 289,414 264,714 97,645 Weighted-average shares outstanding for diluted earnings per common share 13,754,610 8,138,824 6,329,760

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
Derivative Financial Instruments (Tables)	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Outstanding Notional Balances and Fair Values of Outstanding Derivative Positions	The following tables provide the outstanding notional balances and fair values of outstanding derivative positions at December 31, 2022 and 2021. (Dollars in thousands) Outstanding Asset Liability Pay (1) Receive (1) Remaining (2) December 31, 2022 Risk participation agreements purchased $ 10,621 $ — $ — — 4.87 % 2.2 Risk participation agreements sold 29,360 — 8 — 5.54 % 4.2 Commercial loan interest rate swaps: Loan customer counterparty 147,560 — 9,213 — 4.77 % 4.5 Financial institution counterparty 147,560 9,213 — 4.77 % — 4.5 Total derivatives $ 335,101 $ 9,213 $ 9,221 (Dollars in thousands) Outstanding Asset Liability Pay (1) Receive (1) Remaining (2) December 31, 2021 Commercial loan interest rate swaps: Loan customer counterparty $ 77,587 $ — $ 389 4.21 % 7.6 Financial institution counterparty 77,587 389 — 4.21 % 7.6 Total derivatives $ 155,174 $ 389 $ 389 (1) Weighted average rate. (2) Weighted average life (in years).

Core Deposit Intangibles, Net (

Core Deposit Intangibles, Net (Tables)	12 Months Ended
Core Deposit Intangibles, Net (Tables)	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Amortization of Core Deposit Intangibles	Scheduled amortization of CDI at December 31, 2022 are as follows: (Dollars in thousands) CDI 2023 162 2024 162 2025 162 2026 162 2027 and thereafter 483 $ 1,131

Parent Company Financial Stat_2

Parent Company Financial Statements (Tables)	12 Months Ended
Parent Company Financial Statements (Tables)	Dec. 31, 2022
Condensed Financial Information Disclosure [Abstract]
Schedule of Condensed Balance Sheets	Condensed Balance Sheets of the Company (Parent company only) for the periods presented are as follows: (Dollars in thousands) December 31, ASSETS 2022 2021 Cash and cash equivalents $ 8,752 $ 8,707 Investment in subsidiary 482,933 289,446 Other assets 3,795 1,856 Total assets $ 495,480 $ 300,009 LIABILITIES AND SHAREHOLDERS' EQUITY Other borrowings $ 111,223 $ 1,000 Other liabilities 2,477 2 Total liabilities 113,700 1,002 Shareholders' equity: Series A Convertible Non-Cumulative Preferred Stock 69 — Series B Convertible Perpetual Preferred Stock — — Common stock 13,610 13,482 Additional paid-in capital 318,033 249,202 Retained earnings 53,270 36,029 Accumulated other comprehensive (loss) income ( 2,103 ) 1,393 Treasury stock: at cost ( 1,099 ) ( 1,099 ) Total shareholders' equity 381,780 299,007 Total liabilities & shareholders' equity $ 495,480 $ 300,009
Schedule of Condensed Statements of Income and Comprehensive Income	Condensed Statements of Income and Comprehensive Income of the Company (Parent company only) for the periods are as follows: For the Years Ended December 31, (Dollars in thousands) 2022 2021 2020 Interest expense: Interest on notes payable $ 4,605 $ 1,091 $ 1,615 Total interest expense 4,605 1,091 1,615 Noninterest expense: Legal and professional 302 680 1,233 Other 230 23 37 Total noninterest expense 532 703 1,270 Loss before income tax expense and equity in undistributed earnings of subsidiaries ( 5,137 ) ( 1,794 ) ( 2,885 ) Income tax benefit 1,087 359 384 Loss before equity in undistributed earnings of subsidiaries ( 4,050 ) ( 1,435 ) ( 2,501 ) Equity in undistributed earnings of subsidiaries 22,709 12,859 14,616 Net income $ 18,659 $ 11,424 $ 12,115 Comprehensive income $ 15,163 $ 12,538 $ 12,394
Schedule of Condensed Statements of Cash Flows	Condensed Statements of Cash Flows of the Company (Parent company only) for the periods presented are as follows: For the Years Ended December 31, (Dollars in thousands) 2022 2021 2020 Cash flows from operating activities: Net income $ 18,659 $ 11,424 $ 12,115 Adjustments to reconcile net income to net cash used in operating activities: Equity in undistributed net income of subsidiaries ( 22,709 ) ( 12,859 ) ( 14,616 ) Amortization of subordinated debt issuance costs 154 — — Net change in other assets ( 1,938 ) ( 359 ) 501 Net change in other liabilities 1,278 ( 150 ) ( 320 ) Net cash used in operating activities ( 4,556 ) ( 1,944 ) ( 2,320 ) Cash flows from investing activities: Capital investment in subsidiaries ( 173,000 ) ( 125,800 ) — Net cash used in investing activities ( 173,000 ) ( 125,800 ) — Cash flows from financing activities: Net (repayment of) proceeds from subordinated notes payable - related party — ( 13,000 ) 5,000 Net proceeds from (repayment of) line of credit - senior debt 29,875 ( 19,875 ) ( 1,500 ) Net proceeds from subordinated debt issuance 80,194 — — Net proceeds from issuance of preferred stock 66,225 — — Proceeds from issuance of common stock 856 163,199 536 Dividends paid on Series A preferred stock ( 221 ) — — Proceeds from stock warrants exercised — 19 — Proceeds from stock options exercised 672 995 385 Net redemption of treasury stock — ( 121 ) ( 38 ) Net cash provided by financing activities 177,601 131,217 4,383 Increase in cash and cash equivalents 45 3,473 2,063 Cash and cash equivalents at beginning of period 8,707 5,234 3,171 Cash and cash equivalents at end of period $ 8,752 $ 8,707 $ 5,234

Quarterly Financial Data (UNA_2

Quarterly Financial Data (UNAUDITED) (Tables)	12 Months Ended
Quarterly Financial Data (UNAUDITED) (Tables)	Dec. 31, 2022
Quarterly Financial Information Disclosure [Abstract]
Summary of Quarterly Financial Information	The information below is only a summary and should be read in conjunction with “Management's Discussion and Analysis of Financial Condition and Results of Operations” and the consolidated historical financial statements and the related notes thereto included in this Annual Report on Form 10-K. For the Quarters Ended December 31, 2022 (Dollars in thousands) Q4 Q3 Q2 Q1 Selected income statement data: Interest income $ 51,151 $ 43,102 $ 32,509 $ 27,184 Interest expense 19,000 11,747 4,771 1,974 Net interest income 32,151 31,355 27,738 25,210 Provision for loan losses 1,950 2,900 3,350 4,000 Net interest income after provision for loan losses 30,201 28,455 24,388 21,210 Noninterest income 1,753 2,538 1,266 1,666 Noninterest expense 22,627 22,728 22,773 20,181 Income before income tax expense 9,327 8,265 2,881 2,695 Income tax expense 1,802 1,495 604 608 Net income $ 7,525 $ 6,770 $ 2,277 $ 2,087 For the Quarters Ended December 31, 2021 (Dollars in thousands) Q4 Q3 Q2 Q1 Selected income statement data: Interest income $ 26,660 $ 24,399 $ 23,931 $ 25,625 Interest expense 2,041 2,397 2,717 2,907 Net interest income 24,619 22,002 21,214 22,718 Provision for loan losses 6,100 2,323 - 1,500 Net interest income after provision for loan losses 18,519 19,679 21,214 21,218 Noninterest income 2,055 964 1,109 750 Noninterest expense 20,087 17,641 17,779 15,518 Income before income tax expense 487 3,002 4,544 6,450 Income tax expense 133 617 955 1,354 Net income $ 354 $ 2,385 $ 3,589 $ 5,096

Nature of Operations and Summ_3

Nature of Operations and Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jan. 01, 2022
Accounting Policies [Line Items]
Servicing loans previously sold	$ 8,300	$ 3,800
Right-of-use assets	17,872
Lease liabilities	18,209
Advertising and marketing expenses	$ 1,912	$ 1,889	$ 1,326
ASU 2016-02
Accounting Policies [Line Items]
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]	true
Change in Accounting Principle, Accounting Standards Update, Adoption Date	Jan. 01, 2022
Right-of-use assets				$ 11,000
Lease liabilities				$ 10,900
ASU 2016-13
Accounting Policies [Line Items]
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]	true
Allowance for credit losses	$ 4,000
Change in Accounting Principle, Accounting Standards Update, Adoption Date	Jan. 01, 2023

Investment Securities Availab_3

Investment Securities Available for Sale - Carrying Amount and Fair Values of Investment Securities Available For Sale (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	$ 182,118	$ 25,434
Gross Unrealized Gains	297	999
Gross Unrealized Losses	6,348	1
Estimated Fair Value	176,067	26,432
State and Muncipal Securities
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	422	1,087
Gross Unrealized Gains		7
Gross Unrealized Losses	5
Estimated Fair Value	417	1,094
Mortgage-Backed Securities and Other Agency Obligations
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	23,522	791
Gross Unrealized Gains	238	20
Gross Unrealized Losses	879
Estimated Fair Value	22,881	811
U.S. Treasury Bonds
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	100,567
Gross Unrealized Losses	2,049
Estimated Fair Value	98,518
Corporate Bonds
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	57,607	23,556
Gross Unrealized Gains	59	972
Gross Unrealized Losses	3,415	1
Estimated Fair Value	$ 54,251	$ 24,527

Investment Securities Availab_4

Investment Securities Available for Sale - Schedule of Amortized Cost and Fair Value of Securities by Contractual Maturity (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Securities Available-for-sale Amortized cost
Due in one year or less	$ 100,990
Due from one year to five years	3,778
Due from five to ten years	53,828
Debt securities, available-for-sale, maturity, amortized Cost	158,596
Mortgage-backed securities and other agency obligations	23,522
Amortized Cost	182,118	$ 25,434
Securities Available-for-sale, Estimated Fair Value
Due in one year or less	98,935
Due from one year to five years	3,838
Due from five to ten years	50,413
Debt securities, available-for-sale, maturity, estimated fair value	153,186
Mortgage-backed securities and other agency obligations	22,881
Estimated Fair Value	$ 176,067	$ 26,432

Investment Securities Availab_5

Investment Securities Available for Sale - Summary of Securities with Unrealized Losses (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Marketable Securities [Line Items]
Less Than 12 Months in a Loss Position	$ 6,348
Greater Than 12 Months in a Loss Position		$ 1
Total Unrealized Loss	6,348	1
Estimated Fair Value	167,724	3,999
State and Muncipal Securities
Marketable Securities [Line Items]
Less Than 12 Months in a Loss Position	5
Total Unrealized Loss	5
Estimated Fair Value	417
Mortgage-Backed Securities and Other Agency Obligations
Marketable Securities [Line Items]
Less Than 12 Months in a Loss Position	879
Total Unrealized Loss	879
Estimated Fair Value	18,376
U.S. Treasury Bonds
Marketable Securities [Line Items]
Less Than 12 Months in a Loss Position	2,049
Total Unrealized Loss	2,049
Estimated Fair Value	98,518
Corporate Bonds
Marketable Securities [Line Items]
Less Than 12 Months in a Loss Position	3,415
Greater Than 12 Months in a Loss Position		1
Total Unrealized Loss	3,415	1
Estimated Fair Value	$ 50,413	$ 3,999

Investment Securities Availab_6

Investment Securities Available for Sale - Additional Information (Details)	Dec. 31, 2022 Security Investment	Dec. 31, 2021 Investment Security
Investments, Debt and Equity Securities [Abstract]
Number of unrealized loss positions \| Investment	35	2
Number of securities pledged as collateral \| Security	0	0

Loans and Allowance for Loan _3

Loans and Allowance for Loan Losses - Schedule of Amounts Recognized in Balance Sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Accounts Notes And Loans Receivable [Line Items]
Total	$ 3,107,551	$ 2,068,724
Allowance for loan losses	(30,351)	(19,295)
Loans, net	3,077,200	2,049,429
Real Estate \| Non-Farm Non-Residential Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Total	493,791	383,941
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Total	506,012	445,308
Real Estate \| Residential
Accounts Notes And Loans Receivable [Line Items]
Total	308,775	213,264
Real Estate \| Construction, Development & Other
Accounts Notes And Loans Receivable [Line Items]
Total	567,851	320,335
Real Estate \| Farmland
Accounts Notes And Loans Receivable [Line Items]
Total	22,820	9,934
Commercial & Industrial
Accounts Notes And Loans Receivable [Line Items]
Total	1,058,910	611,348
Consumer
Accounts Notes And Loans Receivable [Line Items]
Total	3,872	4,001
Municipal and Other
Accounts Notes And Loans Receivable [Line Items]
Total	$ 145,520	$ 80,593

Loans and Allowance for Loan _4

Loans and Allowance for Loan Losses - Additional Information (Details)			12 Months Ended
	Jan. 01, 2020 USD ($)	Dec. 12, 2013 USD ($)	Dec. 31, 2022 USD ($) Loan	Dec. 31, 2021 USD ($) Loan	Dec. 31, 2020 USD ($)	Dec. 31, 2013 USD ($)
Accounts Notes And Loans Receivable [Line Items]
Loans unaccreted discounts and deferred fees net of deferred costs			$ 7,800,000	$ 6,500,000
Amount of interest income collected on impaired loans			$ 368,000	$ 248,000	$ 26,000
Number of loans modified under TDR during the previous twelve-month \| Loan			0	0
Commitments to lend under TDR			$ 0	$ 0
Gross contractual balance of loans from third party						$ 8,200,000
Purchase price of loans from third party						6,300,000
Discount of purchase price of loans from third party		$ 1,900,000
Estimated fair values of purchase credit impaired loans						3,200,000
Estimated fair values of acquired performing loans						3,100,000
Gross contractual amounts receivable purchase credit impaired loans						4,500,000
Gross contractual amounts receivable acquired performing loans						$ 3,700,000
Total amount of unaccreted discounts on PCI loans			164,000	926,000
Allowance for loan losses related to purchased credit impaired loans			13,000	17,000
Amount of income that would have been accrued for loans on non-accrual			581,000	453,000	$ 298,000
SBA Paycheck Protection Program (PPP) \| PPP Loans \| Commercial & Industrial
Accounts Notes And Loans Receivable [Line Items]
Outstanding loan balances			$ 537,000	$ 81,600,000
Heritage Bancorp Inc
Accounts Notes And Loans Receivable [Line Items]
Discount of purchase price of loans from third party	$ 3,700,000
Estimated fair values of purchase credit impaired loans	9,800,000
Estimated fair values of acquired performing loans	249,800,000
Fair value of loans acquired	259,600,000
Loans acquired carrying value	263,300,000
Heritage Bancorp Inc \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Loans acquired carrying value	250,700,000
Heritage Bancorp Inc \| Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
PCI loans acquired carrying value	$ 12,600,000
COVID-19
Accounts Notes And Loans Receivable [Line Items]
Number of outstanding loan balances subject to deferral and modification agreements \| Loan			261	500
Outstanding loan balance amount subject to deferral and modification agreements			$ 150,700,000	$ 223,600,000
Description of loan deferments			Certain borrowers were unable to meet their contractual payment obligations because of the adverse effects of COVID-19. During March of 2020 and to help mitigate these effects, the Company began offering deferral modifications of principal and/or interest payments for varying periods, but typically no more than 90 days. After 90 days, customers could apply for an additional deferral, and a small portion of our customers requested such an additional deferral. At December 31, 2022 and 2021, the Company had approximately 261 and 500 loans totaling $150.7 million and $223.6 million, respectively, in outstanding loan balances that were subject to deferral and modification agreements due to COVID-19 whereby the principal and/or interest payments were deferred to the end of each loan term. Subsequent to the approved deferral period, customers resumed their regular payments. The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) provides banks an option to elect to not account for certain loan modifications related to COVID-19 as TDRs if the borrowers were not more than 30 days past due at December 31, 2019. In the absence of other intervening factors, such short-term modifications made on a good faith basis are not categorized as TDRs, nor are loans granted payment deferrals related to COVID-19 reported as past due or placed on non-accrual status.
Accrued interest receivable related to loans			$ 3,300,000	$ 4,400,000

Loans and Allowance for Loan _5

Loans and Allowance for Loan Losses - Schedule of Non-accrual and Accruing Past Due Loans, Segregated by Class of Loans (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Accounts Notes And Loans Receivable [Line Items]
Non-accrual	$ 10,963	$ 10,030
Accruing loans past due more than 90 days	518	278
Real Estate \| Non-Farm Non-Residential Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Non-accrual	1,699	1,008
Accruing loans past due more than 90 days	157
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Non-accrual	296	346
Real Estate \| Residential
Accounts Notes And Loans Receivable [Line Items]
Non-accrual	513	127
Real Estate \| Construction, Development & Other
Accounts Notes And Loans Receivable [Line Items]
Non-accrual	40	244
Commercial & Industrial
Accounts Notes And Loans Receivable [Line Items]
Non-accrual	8,390	8,297
Accruing loans past due more than 90 days	361	278
Consumer
Accounts Notes And Loans Receivable [Line Items]
Non-accrual	20
Purchased Credit Impaired
Accounts Notes And Loans Receivable [Line Items]
Non-accrual	$ 5	$ 8

Loans and Allowance for Loan _6

Loans and Allowance for Loan Losses - Schedule of Aging Past Due Loans, Segregated by Class of Loans (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Accounts Notes And Loans Receivable [Line Items]
Total loans	$ 3,107,551	$ 2,068,724
30-59 Days
Accounts Notes And Loans Receivable [Line Items]
Total loans	6,567	1,669
60-89 Days
Accounts Notes And Loans Receivable [Line Items]
Total loans	613	853
Over 90 Days
Accounts Notes And Loans Receivable [Line Items]
Total loans	11,481	10,308
Total Past Due
Accounts Notes And Loans Receivable [Line Items]
Total loans	18,661	12,830
Current
Accounts Notes And Loans Receivable [Line Items]
Total loans	3,088,890	2,055,894
Real Estate \| Non-Farm Non-Residential Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Total loans	493,791	383,941
Real Estate \| Non-Farm Non-Residential Owner Occupied \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	493,791	383,941
Real Estate \| Non-Farm Non-Residential Owner Occupied \| 30-59 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	2,996	291
Real Estate \| Non-Farm Non-Residential Owner Occupied \| Over 90 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	1,856	1,008
Real Estate \| Non-Farm Non-Residential Owner Occupied \| Total Past Due \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	4,852	1,299
Real Estate \| Non-Farm Non-Residential Owner Occupied \| Current \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	488,939	382,642
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Total loans	506,012	445,308
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	506,012	444,586
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied \| 30-59 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	132	161
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied \| Over 90 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	296	346
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied \| Total Past Due \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	428	507
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied \| Current \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	505,584	444,079
Real Estate \| Residential
Accounts Notes And Loans Receivable [Line Items]
Total loans	308,775	213,264
Real Estate \| Residential \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	308,775	213,179
Real Estate \| Residential \| 30-59 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	2,356	230
Real Estate \| Residential \| Over 90 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	513	127
Real Estate \| Residential \| Total Past Due \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	2,869	357
Real Estate \| Residential \| Current \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	305,906	212,822
Real Estate \| Construction, Development & Other
Accounts Notes And Loans Receivable [Line Items]
Total loans	567,851	320,335
Real Estate \| Construction, Development & Other \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	567,846	316,223
Real Estate \| Construction, Development & Other \| 30-59 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	130
Real Estate \| Construction, Development & Other \| 60-89 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans		395
Real Estate \| Construction, Development & Other \| Over 90 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	40	244
Real Estate \| Construction, Development & Other \| Total Past Due \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	170	639
Real Estate \| Construction, Development & Other \| Current \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	567,676	315,584
Real Estate \| Farmland
Accounts Notes And Loans Receivable [Line Items]
Total loans	22,820	9,934
Real Estate \| Farmland \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	22,820	9,934
Real Estate \| Farmland \| Current \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	22,820	9,934
Commercial & Industrial
Accounts Notes And Loans Receivable [Line Items]
Total loans	1,058,910	611,348
Commercial & Industrial \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	1,058,859	611,283
Commercial & Industrial \| 30-59 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	791	960
Commercial & Industrial \| 60-89 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	613	457
Commercial & Industrial \| Over 90 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	8,751	8,575
Commercial & Industrial \| Total Past Due \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	10,155	9,992
Commercial & Industrial \| Current \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	1,048,704	601,291
Consumer
Accounts Notes And Loans Receivable [Line Items]
Total loans	3,872	4,001
Consumer \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	3,872	4,001
Consumer \| 30-59 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans		9
Consumer \| Over 90 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	20
Consumer \| Total Past Due \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	20	9
Consumer \| Current \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	3,852	3,992
Municipal and Other
Accounts Notes And Loans Receivable [Line Items]
Total loans	145,520	80,593
Municipal and Other \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	145,520	80,593
Municipal and Other \| 30-59 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	162	18
Municipal and Other \| 60-89 Days \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans		1
Municipal and Other \| Total Past Due \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	162	19
Municipal and Other \| Current \| Without Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	145,358	80,574
Purchased Credit Impaired \| Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	56	4,984
Purchased Credit Impaired \| Over 90 Days \| Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	5	8
Purchased Credit Impaired \| Total Past Due \| Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	5	8
Purchased Credit Impaired \| Current \| Deterioration Credit Quality
Accounts Notes And Loans Receivable [Line Items]
Total loans	$ 51	$ 4,976

Loans and Allowance for Loan _7

Loans and Allowance for Loan Losses - Schedule of Impaired Loans by Class of Loans (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Accounts Notes And Loans Receivable [Line Items]
Unpaid contractual principal balance	$ 19,708,000	$ 15,382,000
Recorded investment with no allowance	15,502,000	14,340,000
Recorded investment with allowance	4,213,000	1,032,000
Total recorded investment	19,715,000	15,372,000
Related allowance	1,600,000	307,000
Average recorded investment during year	18,659,000	16,312,000
Real Estate \| Non-Farm Non-Residential Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Unpaid contractual principal balance	1,694,000	1,008,000
Recorded investment with no allowance	1,699,000	1,008,000
Total recorded investment	1,699,000	1,008,000
Average recorded investment during year	1,751,000	1,051,000
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Unpaid contractual principal balance	5,497,000	5,641,000
Recorded investment with no allowance	5,496,000	5,630,000
Total recorded investment	5,496,000	5,630,000
Average recorded investment during year	5,563,000	5,680,000
Real Estate \| Residential
Accounts Notes And Loans Receivable [Line Items]
Unpaid contractual principal balance	516,000	130,000
Recorded investment with no allowance	513,000	127,000
Total recorded investment	513,000	127,000
Average recorded investment during year	524,000	138,000
Real Estate \| Construction, Development & Other
Accounts Notes And Loans Receivable [Line Items]
Unpaid contractual principal balance	40,000	241,000
Recorded investment with no allowance	40,000	244,000
Total recorded investment	40,000	244,000
Average recorded investment during year	51,000	255,000
Commercial & Industrial
Accounts Notes And Loans Receivable [Line Items]
Unpaid contractual principal balance	11,891,000	8,297,000
Recorded investment with no allowance	7,734,000	7,331,000
Recorded investment with allowance	4,162,000	967,000
Total recorded investment	11,896,000	8,298,000
Related allowance	1,587,000	290,000
Average recorded investment during year	10,691,000	9,117,000
Consumer
Accounts Notes And Loans Receivable [Line Items]
Unpaid contractual principal balance	19,000
Recorded investment with no allowance	20,000
Total recorded investment	20,000
Average recorded investment during year	21,000
Purchased Credit Impaired
Accounts Notes And Loans Receivable [Line Items]
Unpaid contractual principal balance	51,000	65,000
Recorded investment with allowance	51,000	65,000
Total recorded investment	51,000	65,000
Related allowance	13,000	17,000
Average recorded investment during year	$ 58,000	$ 71,000

Loans and Allowance for Loan _8

Loans and Allowance for Loan Losses - Summary of Troubled Debt Restructuring (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) Loan	Dec. 31, 2021 USD ($) Loan
Accounts Notes And Loans Receivable [Line Items]
Number of loans \| Loan	4	4
Pre- restructuring recorded investment	$ 1,602	$ 6,172
Post- restructuring recorded investment	1,602	6,172
Payment deferral	$ 1,602	$ 6,172
Real Estate \| Non-Farm Non-Residential Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Number of loans \| Loan	3	3
Pre- restructuring recorded investment	$ 822	$ 878
Post- restructuring recorded investment	822	878
Payment deferral	$ 822	$ 878
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Number of loans \| Loan		1
Pre- restructuring recorded investment		$ 5,294
Post- restructuring recorded investment		5,294
Payment deferral		$ 5,294
Commercial & Industrial
Accounts Notes And Loans Receivable [Line Items]
Number of loans \| Loan	1
Pre- restructuring recorded investment	$ 780
Post- restructuring recorded investment	780
Payment deferral	$ 780

Loans and Allowance for Loan _9

Loans and Allowance for Loan Losses - Summary of Internal Ratings of Loans (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Accounts Notes And Loans Receivable [Line Items]
Total loans	$ 3,107,551	$ 2,068,724
Pass
Accounts Notes And Loans Receivable [Line Items]
Total loans	3,077,193	2,026,950
Special Mention
Accounts Notes And Loans Receivable [Line Items]
Total loans	12,985	16,459
Substandard
Accounts Notes And Loans Receivable [Line Items]
Total loans	17,317	20,331
Purchased Credit Impaired
Accounts Notes And Loans Receivable [Line Items]
Total loans	56	4,984
Real Estate \| Non-Farm Non-Residential Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Total loans	493,791	383,941
Real Estate \| Non-Farm Non-Residential Owner Occupied \| Pass
Accounts Notes And Loans Receivable [Line Items]
Total loans	487,633	370,062
Real Estate \| Non-Farm Non-Residential Owner Occupied \| Special Mention
Accounts Notes And Loans Receivable [Line Items]
Total loans	1,885	6,953
Real Estate \| Non-Farm Non-Residential Owner Occupied \| Substandard
Accounts Notes And Loans Receivable [Line Items]
Total loans	4,273	6,926
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Total loans	506,012	445,308
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied \| Pass
Accounts Notes And Loans Receivable [Line Items]
Total loans	498,987	428,972
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied \| Special Mention
Accounts Notes And Loans Receivable [Line Items]
Total loans	228	8,338
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied \| Substandard
Accounts Notes And Loans Receivable [Line Items]
Total loans	6,797	7,276
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied \| Purchased Credit Impaired
Accounts Notes And Loans Receivable [Line Items]
Total loans		722
Real Estate \| Residential
Accounts Notes And Loans Receivable [Line Items]
Total loans	308,775	213,264
Real Estate \| Residential \| Pass
Accounts Notes And Loans Receivable [Line Items]
Total loans	307,881	212,109
Real Estate \| Residential \| Substandard
Accounts Notes And Loans Receivable [Line Items]
Total loans	894	1,069
Real Estate \| Residential \| Purchased Credit Impaired
Accounts Notes And Loans Receivable [Line Items]
Total loans		86
Real Estate \| Construction, Development & Other
Accounts Notes And Loans Receivable [Line Items]
Total loans	567,851	320,335
Real Estate \| Construction, Development & Other \| Pass
Accounts Notes And Loans Receivable [Line Items]
Total loans	559,186	315,979
Real Estate \| Construction, Development & Other \| Special Mention
Accounts Notes And Loans Receivable [Line Items]
Total loans	8,620
Real Estate \| Construction, Development & Other \| Substandard
Accounts Notes And Loans Receivable [Line Items]
Total loans	40	244
Real Estate \| Construction, Development & Other \| Purchased Credit Impaired
Accounts Notes And Loans Receivable [Line Items]
Total loans	5	4,112
Real Estate \| Farmland
Accounts Notes And Loans Receivable [Line Items]
Total loans	22,820	9,934
Real Estate \| Farmland \| Pass
Accounts Notes And Loans Receivable [Line Items]
Total loans	22,820	9,934
Commercial & Industrial
Accounts Notes And Loans Receivable [Line Items]
Total loans	1,058,910	611,348
Commercial & Industrial \| Pass
Accounts Notes And Loans Receivable [Line Items]
Total loans	1,051,314	605,322
Commercial & Industrial \| Special Mention
Accounts Notes And Loans Receivable [Line Items]
Total loans	2,252	1,146
Commercial & Industrial \| Substandard
Accounts Notes And Loans Receivable [Line Items]
Total loans	5,293	4,816
Commercial & Industrial \| Purchased Credit Impaired
Accounts Notes And Loans Receivable [Line Items]
Total loans	51	64
Consumer
Accounts Notes And Loans Receivable [Line Items]
Total loans	3,872	4,001
Consumer \| Pass
Accounts Notes And Loans Receivable [Line Items]
Total loans	3,852	3,979
Consumer \| Special Mention
Accounts Notes And Loans Receivable [Line Items]
Total loans		22
Consumer \| Substandard
Accounts Notes And Loans Receivable [Line Items]
Total loans	20
Municipal and Other
Accounts Notes And Loans Receivable [Line Items]
Total loans	145,520	80,593
Municipal and Other \| Pass
Accounts Notes And Loans Receivable [Line Items]
Total loans	$ 145,520	$ 80,593

Loans and Allowance for Loan_10

Loans and Allowance for Loan Losses - Schedule of Allowance for Loan Losses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Financing Receivable Allowance For Credit Losses [Line Items]
Beginning balance	$ 19,295	$ 11,979	$ 8,123
Provision for loan losses	12,200	9,923	7,550
Charge-offs	(1,232)	(2,934)	(3,732)
Recoveries	88	327	38
Ending balance	30,351	19,295	11,979
Real Estate \| Non-Farm Non-Residential Owner Occupied
Financing Receivable Allowance For Credit Losses [Line Items]
Beginning balance	3,456	2,608	2,158
Provision for loan losses	317	848	450
Ending balance	3,773	3,456	2,608
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied
Financing Receivable Allowance For Credit Losses [Line Items]
Beginning balance	5,935	3,107	1,627
Provision for loan losses	(194)	2,828	3,816
Charge-offs			(2,336)
Ending balance	5,741	5,935	3,107
Real Estate \| Residential
Financing Receivable Allowance For Credit Losses [Line Items]
Beginning balance	957	1,218	373
Provision for loan losses	107	(261)	845
Ending balance	1,064	957	1,218
Real Estate \| Construction, Development & Other
Financing Receivable Allowance For Credit Losses [Line Items]
Beginning balance	2,064	932	330
Provision for loan losses	989	1,132	602
Ending balance	3,053	2,064	932
Real Estate \| Farmland
Financing Receivable Allowance For Credit Losses [Line Items]
Beginning balance	45	32	29
Provision for loan losses	37	13	3
Ending balance	82	45	32
Commercial & Industrial
Financing Receivable Allowance For Credit Losses [Line Items]
Beginning balance	6,500	3,858	3,504
Provision for loan losses	10,911	5,233	1,710
Charge-offs	(1,214)	(2,914)	(1,389)
Recoveries	72	323	33
Ending balance	16,269	6,500	3,858
Consumer
Financing Receivable Allowance For Credit Losses [Line Items]
Beginning balance	6	35	16
Provision for loan losses	5	(30)	21
Charge-offs	(18)		(7)
Recoveries	13	1	5
Ending balance	6	6	35
Municipal and Other
Financing Receivable Allowance For Credit Losses [Line Items]
Beginning balance	332	189	86
Provision for loan losses	28	160	103
Charge-offs		(20)
Recoveries	3	3
Ending balance	$ 363	$ 332	$ 189

Loans and Allowance for Loan_11

Loans and Allowance for Loan Losses - Schedule of Allowance for Loan Losses for Loans Evaluated for Impairment Individually and Collectively (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accounts Notes And Loans Receivable [Line Items]
Allowance for loan losses, individually evaluated for impairment	$ 1,587	$ 290
Allowance for loan losses, collectively evaluated for impairment	28,751	18,988
Allowance for loan losses, PCI evaluated for impairment	13	17
Allowance for loan losses, total	30,351	19,295	$ 11,979	$ 8,123
Real Estate \| Non-Farm Non-Residential Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Allowance for loan losses, collectively evaluated for impairment	3,773	3,456
Allowance for loan losses, total	3,773	3,456	2,608	2,158
Real Estate \| Non-Farm Non-Residential Non-Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Allowance for loan losses, collectively evaluated for impairment	5,741	5,935
Allowance for loan losses, total	5,741	5,935	3,107	1,627
Real Estate \| Residential
Accounts Notes And Loans Receivable [Line Items]
Allowance for loan losses, collectively evaluated for impairment	1,064	957
Allowance for loan losses, total	1,064	957	1,218	373
Real Estate \| Construction, Development & Other
Accounts Notes And Loans Receivable [Line Items]
Allowance for loan losses, collectively evaluated for impairment	3,053	2,064
Allowance for loan losses, total	3,053	2,064	932	330
Real Estate \| Farmland
Accounts Notes And Loans Receivable [Line Items]
Allowance for loan losses, collectively evaluated for impairment	82	45
Allowance for loan losses, total	82	45	32	29
Commercial & Industrial
Accounts Notes And Loans Receivable [Line Items]
Allowance for loan losses, individually evaluated for impairment	1,587	290
Allowance for loan losses, collectively evaluated for impairment	14,669	6,193
Allowance for loan losses, PCI evaluated for impairment	13	17
Allowance for loan losses, total	16,269	6,500	3,858	3,504
Consumer
Accounts Notes And Loans Receivable [Line Items]
Allowance for loan losses, collectively evaluated for impairment	6	6
Allowance for loan losses, total	6	6	35	16
Municipal and Other
Accounts Notes And Loans Receivable [Line Items]
Allowance for loan losses, collectively evaluated for impairment	363	332
Allowance for loan losses, total	$ 363	$ 332	$ 189	$ 86

Loans and Allowance for Loan_12

Loans and Allowance for Loan Losses - Schedule Of Allowance for Loan losses For loans Evaluated for Impairment Methodology (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Accounts Notes And Loans Receivable [Line Items]
Total loans	$ 3,107,551	$ 2,068,724
Loan Impairment Methodology
Accounts Notes And Loans Receivable [Line Items]
Loans evaluated for impairment individually	19,664	15,372
Loans evaluated for impairment collectively	3,087,836	2,053,287
Loans evaluated for impairment PCI	51	65
Total loans	3,107,551	2,068,724
Loan Impairment Methodology \| Consumer
Accounts Notes And Loans Receivable [Line Items]
Loans evaluated for impairment individually	20
Loans evaluated for impairment collectively	3,852	4,001
Total loans	3,872	4,001
Loan Impairment Methodology \| Real Estate Loans \| Non-Farm Non-Residential Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Loans evaluated for impairment individually	1,699	1,008
Loans evaluated for impairment collectively	492,092	382,933
Total loans	493,791	383,941
Loan Impairment Methodology \| Real Estate Loans \| Non-Farm Non-Residential Non-Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Loans evaluated for impairment individually	5,496	5,630
Loans evaluated for impairment collectively	500,516	439,678
Total loans	506,012	445,308
Loan Impairment Methodology \| Real Estate Loans \| Residential
Accounts Notes And Loans Receivable [Line Items]
Loans evaluated for impairment individually	513	127
Loans evaluated for impairment collectively	308,262	213,137
Total loans	308,775	213,264
Loan Impairment Methodology \| Real Estate Loans \| Construction, Development & Other
Accounts Notes And Loans Receivable [Line Items]
Loans evaluated for impairment individually	40	244
Loans evaluated for impairment collectively	567,811	320,091
Total loans	567,851	320,335
Loan Impairment Methodology \| Real Estate Loans \| Farmland
Accounts Notes And Loans Receivable [Line Items]
Loans evaluated for impairment collectively	22,820	9,934
Total loans	22,820	9,934
Loan Impairment Methodology \| Commercial And Industrial Loans
Accounts Notes And Loans Receivable [Line Items]
Loans evaluated for impairment individually	11,896	8,363
Loans evaluated for impairment collectively	1,046,963	602,920
Loans evaluated for impairment PCI	51	65
Total loans	1,058,910	611,348
Loan Impairment Methodology \| Municipal and Other
Accounts Notes And Loans Receivable [Line Items]
Loans evaluated for impairment collectively	145,520	80,593
Total loans	$ 145,520	$ 80,593

Loans and Allowance for Loan_13

Loans and Allowance for Loan Losses - Schedule of Gross Contractual Amounts Receivable Balances By Portfolio Segment PCI Loans (Details) - PCI Loans - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Accounts Notes And Loans Receivable [Line Items]
Total outstanding balances	$ 134	$ 6,236
Carrying amount	56	4,984
Real Estate Loan Portfolio Segment \| Non-Farm Non-Residential Non-Owner Occupied
Accounts Notes And Loans Receivable [Line Items]
Total outstanding balances		820
Real Estate Loan Portfolio Segment \| Residential
Accounts Notes And Loans Receivable [Line Items]
Total outstanding balances	77	181
Real Estate Loan Portfolio Segment \| Construction, Development & Other
Accounts Notes And Loans Receivable [Line Items]
Total outstanding balances	5	5,169
Commercial & Industrial
Accounts Notes And Loans Receivable [Line Items]
Total outstanding balances	$ 52	$ 66

Loans and Allowance for Loan_14

Loans and Allowance for Loan Losses - Schedule of Accretable Yield Collected on PCI Loans (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Receivables [Abstract]
Balance at beginning of year	$ 926	$ 2,261	$ 83
New loans acquired from Heritage acquisition			2,726
Accretion of income	(762)	(1,335)	(808)
Reclassifications from non-accretable difference			260
Balance at end of year	$ 164	$ 926	$ 2,261

Premises and Equipment - Schedu

Premises and Equipment - Schedule of Premises and Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Property Plant And Equipment [Line Items]
Premises and equipment, gross	$ 39,151	$ 26,961
Accumulated depreciation	(10,489)	(7,916)
Premises and equipment, Net	$ 28,662	19,045
Building
Property Plant And Equipment [Line Items]
Premises and equipment, useful life	30 years
Premises and equipment, gross	$ 8,662	8,404
Building Improvements
Property Plant And Equipment [Line Items]
Premises and equipment, gross	$ 4,943	3,752
Building Improvements \| Minimum
Property Plant And Equipment [Line Items]
Premises and equipment, useful life	3 years
Building Improvements \| Maximum
Property Plant And Equipment [Line Items]
Premises and equipment, useful life	10 years
Land
Property Plant And Equipment [Line Items]
Premises and equipment, gross	$ 3,894	3,894
Equipment
Property Plant And Equipment [Line Items]
Premises and equipment, gross	$ 5,757	4,308
Equipment \| Minimum
Property Plant And Equipment [Line Items]
Premises and equipment, useful life	3 years
Equipment \| Maximum
Property Plant And Equipment [Line Items]
Premises and equipment, useful life	5 years
Leasehold Improvements
Property Plant And Equipment [Line Items]
Premises and equipment, gross	$ 9,761	2,888
Leasehold Improvements \| Minimum
Property Plant And Equipment [Line Items]
Premises and equipment, useful life	3 years
Leasehold Improvements \| Maximum
Property Plant And Equipment [Line Items]
Premises and equipment, useful life	10 years
Furniture and Fixtures
Property Plant And Equipment [Line Items]
Premises and equipment, gross	$ 4,170	2,541
Furniture and Fixtures \| Minimum
Property Plant And Equipment [Line Items]
Premises and equipment, useful life	3 years
Furniture and Fixtures \| Maximum
Property Plant And Equipment [Line Items]
Premises and equipment, useful life	5 years
Construction in Progress
Property Plant And Equipment [Line Items]
Premises and equipment, gross	$ 1,964	$ 1,174

Premises and Equipment - Additi

Premises and Equipment - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 2.6	$ 1.7	$ 1.5

Deposits - Schedule of Deposit

Deposits - Schedule of Deposit Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Transaction accounts:
Noninterest bearing demand accounts	$ 486,114	$ 531,401
Interest bearing demand accounts	2,498,325	1,298,546
Savings	35,677	33,539
Total transaction accounts	3,020,116	1,863,486
Time deposits	216,030	277,713
Total deposits	$ 3,236,146	$ 2,141,199

Deposits - Additional Informati

Deposits - Additional Information (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Deposits [Abstract]
Time deposits in denominations of $250,000 or more	$ 135,500,000	$ 113,200,000
Aggregate amount of demand time deposits overdrafts	31,000	40,000
Deposits received from related parties	$ 16,000,000	$ 19,000,000

Deposit - Schedule Maturities o

Deposit - Schedule Maturities of time deposit (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Maturities of Time Deposits [Abstract]
2023	$ 181,926
2024	28,578
2025	2,971
2026	1,567
2027 and thereafter	988
Time deposits	$ 216,030	$ 277,713

Income Taxes - Summary of Provi

Income Taxes - Summary of Provision for Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Current income tax expense									$ 5,759	$ 3,439
Deferred income tax benefit									(1,250)	(380)
Income tax expense as reported	$ 1,802	$ 1,495	$ 604	$ 608	$ 133	$ 617	$ 955	$ 1,354	$ 4,509	$ 3,059	$ 3,495

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income tax provision expense	$ 1,802	$ 1,495	$ 604	$ 608	$ 133	$ 617	$ 955	$ 1,354	$ 4,509	$ 3,059	$ 3,495
Effective tax rate									19.50%	21.10%
Statutory income tax rate										21%

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of Reported Income Tax Expense (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income tax expense computed at statutory rate									$ 4,865	$ 3,042
Stock-based compensation									117	93
Bank-owned life insurance									(276)	(119)
Non-deductible meals, entertainment, and dues									91	57
Tax-exempt income									(283)	(2)
Non-deductible merger costs										2
Other, net									(5)	(14)
Income tax expense as reported	$ 1,802	$ 1,495	$ 604	$ 608	$ 133	$ 617	$ 955	$ 1,354	$ 4,509	$ 3,059	$ 3,495

Income Taxes - Summary of Defer

Income Taxes - Summary of Deferred Taxes (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Allowance for loan losses	$ 6,352	$ 4,046
Organizational and start-up costs	6	18
Accrued expenses	264	1,189
Stock options and restricted stock	114	131
Loan purchase mark-to-mark	62	216
Deposit purchase premium		38
Deferred loan origination fees	1,564	433
Net unrealized loss on securities available for sale	1,271
Non-accrual interest	241	150
Other	118	2
Total deferred tax assets	9,992	6,223
Deferred tax liabilities:
Premises and equipment	2,468	1,161
Goodwill and core deposit intangibles	237	271
Investments	68	66
Net unrealized gain on securities available for sale	0	210
Unrealized gain on derivatives	712	161
Prepaid expenses and other	204	231
Total deferred tax liabilities	3,689	2,100
Net deferred tax asset	$ 6,303	$ 4,123

FHLB Advances and Other Borro_3

FHLB Advances and Other Borrowings - Additional Information (Details) - USD ($)				1 Months Ended	12 Months Ended
	Sep. 10, 2022	Mar. 31, 2022	Mar. 10, 2021	Aug. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Aug. 30, 2021
Federal Home Loan Bank Advances [Line Items]
Revolving line of credit facility					$ 30,875,000	$ 1,000,000
Borrowing capacity available under federal home loan bank stock and real estate loans					719,100,000	450,400,000
Letters Of credit amount issued					290,300,000
Maximum borrowing capacity under federal fund line of credit					36,500,000	50,500,000
FHLB advances outstanding					$ 0	50,000,000
Minimum
Federal Home Loan Bank Advances [Line Items]
Federal home loan bank letter of credit expiration date					2023-01
Maximum
Federal Home Loan Bank Advances [Line Items]
Federal home loan bank letter of credit expiration date					2023-12
Line of Credit
Federal Home Loan Bank Advances [Line Items]
Federal funds					$ 0	$ 0
Senior Secured Promissory Notes
Federal Home Loan Bank Advances [Line Items]
Promissory note			$ 20,900,000		$ 30,900,000
Matured and renewed note amount	$ 30,900,000
Promissory note maturity date	Sep. 10, 2024				Sep. 10, 2022
Interest rate	5%
Frequency of periodic interest payment	Interest is payable quarterly on the 10th day of March, June, September and December through maturity date of September 10, 2024				Interest was payable quarterly on the 10th day of March, June, September and December through maturity date of September 10, 2022
Secured percentage of debt			100%
Revolving line of credit facility			$ 30,900,000
Senior Secured Promissory Notes \| US Prime Rate
Federal Home Loan Bank Advances [Line Items]
Interest rate			4%
Debt instrument, basis spread on variable rate	0.50%
Senior Secured Promissory Notes \| Third Party Lender
Federal Home Loan Bank Advances [Line Items]
Line of credit facility, current borrowing capacity	$ 50,000,000
Revolving line of credit facility			$ 10,000,000
Senior Secured Promissory Note One
Federal Home Loan Bank Advances [Line Items]
Promissory note			$ 10,000,000
Promissory note maturity date			Aug. 31, 2021
Senior Secured Promissory Note Two
Federal Home Loan Bank Advances [Line Items]
Promissory note			$ 10,900,000
Promissory note maturity date			Mar. 10, 2021
Subordinated Promissory Note One
Federal Home Loan Bank Advances [Line Items]
Promissory note				$ 2,000,000
Promissory note maturity date				Sep. 27, 2022
Debt instrument fixed interest rate							6%
Frequency of periodic interest payment					Quarterly interest payments for the $2.0 million note were due on the 27th day of March, June, September and December.
Subordinated Promissory Note Two
Federal Home Loan Bank Advances [Line Items]
Promissory note				$ 11,000,000			$ 11,000,000
Promissory note maturity date				Jul. 29, 2022
Debt instrument fixed interest rate							6%
Frequency of periodic interest payment					Quarterly interest payments for the $11.0 million note were due on the 29th day of March, June, September and December.
Subordinated Notes due 2032
Federal Home Loan Bank Advances [Line Items]
Promissory note maturity date					Apr. 01, 2032
Debt instrument fixed interest rate		5.50%			5.50%
Frequency of periodic interest payment					the Company will pay interest on the Notes semi-annually in arrears on April 1 and October 1 of each year, commencing on October 1, 2022, at a fixed interest rate of 5.500% per annum.
Subordinated notes aggregate principal amount		$ 82,300,000
Unamortized debt issuance costs		$ 2,100,000			$ 1,900,000
Outstanding principal					$ 82,300,000
Amortization period for debt issuance costs					10 years
Deb instrument, redemption price					100%
Debt redemption start date					Apr. 01, 2027
Subordinated notes description					The floating interest rate will be reset quarterly, and the interest rate for any Floating Rate Period shall be equal to the then-current Three-Month Term Secured Overnight Financing Rate (“SOFR”) plus 315 basis points for each quarterly interest period during the Floating Rate Period. Interest payable on the Notes during the Floating Rate Period will be paid quarterly in arrears on January 1, April 1, July 1 and October 1, of each year, commencing on July 1, 2027. Notwithstanding the foregoing, in the event that Three-Month Term SOFR is less than zero, then Three-Month Term SOFR rate shall be deemed to be zero.
Subordinated notes variable interest rate percentage					plus 315 basis points
Subordinated notes commencement date					Oct. 01, 2022
Debt instrument purchasers price equal to face amount		100%

FHLB Advances and Other Borro_4

FHLB Advances and Other Borrowings - Summary of Contractual Maturities of FHLB Advances and Other Borrowings (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Federal Home Loan Banks [Abstract]
2024	$ 30,875
Senior Debt Borrowings, Total	30,875	$ 1,000
Subordinated Debt Borrowings, 2027 and thereafter	80,348
Subordinated Debt Borrowings, Total	$ 80,348

Stock Options and Warrants - Ad

Stock Options and Warrants - Additional Information (Details)			1 Months Ended	12 Months Ended
	May 20, 2021 shares	Jan. 01, 2020 shares	Jul. 31, 2018 shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares	Dec. 31, 2020 USD ($) $ / shares	Sep. 30, 2022 $ / shares shares	Jul. 01, 2022 $ / shares	Jan. 01, 2021 shares	May 29, 2019 shares	Dec. 31, 2017 shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expiration period		10 years
Exchange ratio		0.89
Vested options outstanding		109,908
Converted options of common stock		97,821
Remaining available for grant for future awards				0
Risk-free interest rate minimum				1.45%	0.70%	0.47%
Risk-free interest rate maximum				4.168%	1.48%	1.85%
Dividend yield rate				0%	0%	0%
Estimated volatility rate					10%	10%
Estimated volatility rate, minimum				10%
Estimated volatility rate, maximum				38%
Expected lives of options				7 years 6 months	7 years 6 months	7 years 6 months
Stock-based compensation expense \| $				$ 646,000	$ 552,000	$ 275,000
Unrecognized compensation costs related non-vested stock \| $				2,200,000
Total intrinsic value of outstanding in-the-money stock options \| $				2,100,000	5,800,000
Intrinsic value outstanding in-the-money exercisable stock options \| $				1,800,000	3,000,000
Intrinsic value of stock options exercised \| $				236,000	506,000	139,000
Stock options exercised \| $				$ 672,000	$ 995,000	$ 385,000
Weighted average remaining contractual life of outstanding stock warrants				6 years 9 months
Preferred stock, par value \| $ / shares				$ 1
Common stock, par value \| $ / shares				$ 1	$ 1			$ 1
Fair value of warrants included in additional-paid-in capital \| $				$ 380,000
Weighted-average grant date fair value of options granted during the period \| $ / shares				$ 6.80	3.15	$ 2.65
Weighted Average Grant Date Fair Value 'Vested during the period \| $ / shares				3.07	3.17	$ 3.58
Series B Preferred Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Preferred stock, par value \| $ / shares				1	1
Private Placement Offering
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrants to purchase							175,000
Warrant exercise price of common stock per share \| $ / shares				$ 22.50			$ 22.50
Private Placement Offering \| Series B Preferred Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Preferred stock, par value \| $ / shares							1
Private Placement Offering \| Non-Voting Common Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock, par value \| $ / shares							$ 1
Directors, Executive Officers and Other Key Employees
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expiration period				10 years
Vesting period				5 years
Other Key Employees \| IPO
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Granted exercise price \| $ / shares					$ 26.68
RSAs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Contractual term				10 years
Stock-based compensation expense \| $				$ 629,000	$ 106,000
Fair value of shares vested \| $				342,000	0	$ 0
Total unrecognized compensation cost related to nonvested restricted stock awards \| $				$ 1,400,000
Warrants Expiring July 1, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average remaining contractual life of outstanding stock warrants				6 months
Warrants exercisable year				10 years
Warrants expires date				Jul. 01, 2023
Warrants Expiring September 30, 2029
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrants exercisable year				7 years
Warrants expires date				Sep. 30, 2029
Common Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock options exercised \| $				$ 47,000	$ 83,000	$ 32,000
Minimum \| Directors, Executive Officers and Other Key Employees
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Granted exercise price \| $ / shares				$ 17.11	$ 16.30
Minimum \| RSAs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period				2 years
Maximum \| Directors, Executive Officers and Other Key Employees
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Granted exercise price \| $ / shares				$ 25.76	$ 24
Maximum \| RSAs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period				4 years
2013 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares authorized to grant				500,000
Additional issuance shares										152,750
Remaining available for grant for future awards				0
2019 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Additional issuance shares	800,000
Additional options shares grant in period	500,000
Remaining available for grant for future awards				125,266
2017 Non-Employee Director Stock Option Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares authorized to grant											100,000
Additional options shares grant in period			50,000
Description of the plan				Options are generally granted with an exercise price equal to the market price of the Company’s stock at the date of the grant. Option awards generally vest based on 5 years of continuous service and have 10-year contractual terms for non-controlling participants as defined by the Director Plan. Other grant terms can vary for controlling participants as defined by the Director Plan.
Remaining available for grant for future awards				8,000
2017 Non-Employee Director Stock Option Plan \| Common Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares authorized to grant			150,000
2017 Non-Employee Director Stock Option Plan \| Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares authorized to grant									187,000

Stock Options and Warrants - Su

Stock Options and Warrants - Summary of Stock Option Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock options grant	136,000	788,250
Weighted-average grant date fair value of options granted during the period	$ 6.80	$ 3.15	$ 2.65
Underlying Options Shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding at beginning of period	1,220,428	660,251
Stock options grant	136,000	788,250
Forfeited during the period	(105,167)	(144,903)
Exercised during the period	(47,333)	(83,170)
Outstanding at the end of period	1,203,928	1,220,428	660,251
Options exercisable at end of period	527,658	361,758
Outstanding at beginning of period	$ 17.83	$ 14.37
Granted during the period	21.15	20.22
Forfeited during the period	21.18	17.55
Exercised during the period	14.38	13.48
Outstanding at the end of period	18.05	17.83	$ 14.37
Options exercisable at end of period	15.51	13.59
Weighted-average grant date fair value of options granted during the period	$ 6.80	$ 3.15

Stock Options and Warrants - Sc

Stock Options and Warrants - Schedule of Weighted Average Remaining life (Details) - Underlying Options Shares - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options Outstanding	1,203,928	1,220,428	660,251
Weighted Average Remaining Life (years)	7 years 21 days	8 years 1 month 9 days
Options Exercisable	527,658	361,758
$10.00 - $12.99
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Exercise Price, Lower Range Limit	$ 10
Exercise Price, Upper Range Limit	$ 12.99
Options Outstanding	146,553	162,223
Weighted Average Remaining Life (years)	1 year 11 months 15 days	5 years 1 month 24 days
Options Exercisable	146,553	162,223
$13.00 - $16.99
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Exercise Price, Lower Range Limit	$ 13
Exercise Price, Upper Range Limit	$ 16.99
Options Outstanding	435,175	496,955
Weighted Average Remaining Life (years)	6 years 5 months 12 days	7 years 5 months 23 days
Options Exercisable	280,905	199,535
$17.00 - $26.99
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Exercise Price, Lower Range Limit	$ 17
Exercise Price, Upper Range Limit	$ 26.99
Options Outstanding	622,200	561,250
Weighted Average Remaining Life (years)	8 years 8 months 8 days	9 years 6 months 7 days
Options Exercisable	100,200

Stock Options and Warrants - _2

Stock Options and Warrants - Schedule of Nonvested Share Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Payment Arrangement [Abstract]
Shares Nonvested at January 1,	858,670	262,670
Shares Granted during the period	136,000	788,250
Shares Vested during the period	(219,900)	(72,500)
Shares Forfeited during the period	(98,500)	(119,750)
Shares Nonvested at end of period	676,270	858,670	262,670
Weighted Average Grant Date Fair Value Nonvested at January 1	$ 3.15	$ 3.04
Weighted Average Grant Date Fair Value Granted during the period	6.80	3.15	$ 2.65
Weighted Average Grant Date Fair Value 'Vested during the period	3.07	3.17	3.58
Weighted Average Grant Date Fair Value Forfeited during the period	3.70	2.88
Weighted Average Grant Date Fair Value Nonvested at end of period	$ 3.82	$ 3.15	$ 3.04

Stock Options and Warrants - _3

Stock Options and Warrants - Schedule Of Stock Warrant Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Warrants Expiring September 30, 2029
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares Underlying Warrants Outstanding at beginning of period	4,285
Shares Underlying Warrants Granted	175,000
Shares Underlying Warrants Outstanding at end of period	179,285	4,285
Shares Underlying Warrants Exercisable at end of period	179,285
Weighted Average Exercise Price, Outstanding at beginning of period	$ 11
Weighted Average Exercise Price, Granted	22.50
Weighted Average Exercise Price, Outstanding at end of period	22.23	$ 11
Weighted Average Exercise Price, Exercisable at end of period	$ 22.23
Warrants Expiring July 1, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares Underlying Warrants Outstanding at beginning of period	4,285	6,000
Shares Underlying Warrants Exercised		(1,715)
Shares Underlying Warrants Outstanding at end of period		4,285
Shares Underlying Warrants Exercisable at end of period		4,285
Weighted Average Exercise Price, Outstanding at beginning of period	$ 11	$ 11
Weighted Average Exercise Price, Exercised		11
Weighted Average Exercise Price, Outstanding at end of period		11
Weighted Average Exercise Price, Exercisable at end of period		$ 11

Stock Options and Warrants - _4

Stock Options and Warrants - Summary of Activity for Nonvested RSAs (Details) - RSAs - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares Nonvested at beginning of period	49,750
Shares Granted during the period	54,424	49,750
Shares Vested during the period	(18,580)
Shares Forfeited during the period	(9,500)
Shares Nonvested at the end of period	76,094	49,750
Weighted Average Grant Date Fair Value, Nonvested at beginning of period	$ 24
Weighted Average Grant Date Fair Value, Granted during the period	21.81	$ 24
Weighted Average Grant Date Fair Value, Vested during the period	24
Weighted Average Grant Date Fair Value, Forfeited during the period	24.67
Weighted Average Grant Date Fair Value, Nonvested at the end of period	$ 22.35	$ 24

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Lessee, Lease, Description [Line Items]
Operating lease ROU asset	$ 17,872
Lease liability - operating leases	$ 18,209
Weighted average discount rate	4.05%
Weighted average remaining lease term	9 years 8 months 12 days
Operating lease expense	$ 3,400	$ 1,600	$ 1,200
Minimum
Lessee, Lease, Description [Line Items]
Operating leases term	5 months
Maximum
Lessee, Lease, Description [Line Items]
Operating leases term	144 months

Leases - Schedule of Lease Cost

Leases - Schedule of Lease Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating lease cost	$ 2,804	$ 1,605	$ 1,154
Short-term lease cost	607
Total lease cost	$ 3,411	$ 1,605	$ 1,154

Leases - Contractual Maturity f

Leases - Contractual Maturity for Operating Leases (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Leases [Abstract]
2023	$ 2,516
2024	2,944
2025	2,957
2026	3,027
2027 and thereafter	16,917
Total undiscounted lease liability	28,361
Discount on cash flows	(3,920)
Lease signed, but not yet commenced	(6,232)
Total operating lease liability	$ 18,209

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details)	Dec. 31, 2022
Minimum
Lessee, Lease, Description [Line Items]
Operating leases term	5 months
Maximum
Lessee, Lease, Description [Line Items]
Operating leases term	144 months

Financial Instruments With Of_3

Financial Instruments With Off Balance Sheet Risk - Schedule of Financial Instruments Outstanding Whose Contract Amounts Represent Credit Risk (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Fair Value Off Balance Sheet Risks Disclosure Information [Line Items]
Total	$ 1,169,740	$ 620,304
Standby Letters of Credit
Fair Value Off Balance Sheet Risks Disclosure Information [Line Items]
Total	21,728	14,144
Commitments to Extend Credit
Fair Value Off Balance Sheet Risks Disclosure Information [Line Items]
Total	$ 1,148,012	$ 606,160

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Impaired loans with carrying value	$ 19,715,000	$ 15,372,000
Valuation allowances	1,600,000	307,000
Net fair value	18,100,000	15,100,000
Foreclosed asset	0
Fair value, assets, transfers between levels	0	0
Fair value, liabilities, transfers between levels	$ 0	$ 0

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Financial Assets and Financial Liabilities Measured at Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Securities available for sale:
Total investment securities available for sale	$ 176,067	$ 26,432
State and Muncipal Securities
Securities available for sale:
Total investment securities available for sale	417	1,094
Mortgage-Backed Securities and Other Agency Obligations
Securities available for sale:
Total investment securities available for sale	22,881	811
U.S. Treasury Bonds
Securities available for sale:
Total investment securities available for sale	98,518
Corporate Bonds
Securities available for sale:
Total investment securities available for sale	54,251	24,527
Fair Value, Recurring
Securities available for sale:
Total investment securities available for sale	176,067	26,432
Asset derivatives:
Asset derivatives	$ 9,213	$ 389
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Fair Value Hedge Assets	Fair Value Hedge Assets
Liability derivatives:
Liability derivatives	$ 9,221	$ 389
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Fair Value Hedge Liabilities	Fair Value Hedge Liabilities
Fair Value, Recurring \| State and Muncipal Securities
Securities available for sale:
Total investment securities available for sale	$ 417	$ 1,094
Fair Value, Recurring \| Mortgage-Backed Securities and Other Agency Obligations
Securities available for sale:
Total investment securities available for sale	22,881	811
Fair Value, Recurring \| U.S. Treasury Bonds
Securities available for sale:
Total investment securities available for sale	98,518
Fair Value, Recurring \| Corporate Bonds
Securities available for sale:
Total investment securities available for sale	54,251	24,527
Fair Value, Recurring \| Interest Rate Swaps
Asset derivatives:
Asset derivatives	9,213	389
Liability derivatives:
Liability derivatives	9,213	389
Fair Value, Recurring \| Risk Participation Agreements
Liability derivatives:
Liability derivatives	8
Fair Value, Recurring \| Level 2 Inputs
Securities available for sale:
Total investment securities available for sale	176,067	26,432
Asset derivatives:
Asset derivatives	9,213	389
Liability derivatives:
Liability derivatives	9,221	389
Fair Value, Recurring \| Level 2 Inputs \| State and Muncipal Securities
Securities available for sale:
Total investment securities available for sale	417	1,094
Fair Value, Recurring \| Level 2 Inputs \| Mortgage-Backed Securities and Other Agency Obligations
Securities available for sale:
Total investment securities available for sale	22,881	811
Fair Value, Recurring \| Level 2 Inputs \| U.S. Treasury Bonds
Securities available for sale:
Total investment securities available for sale	98,518
Fair Value, Recurring \| Level 2 Inputs \| Corporate Bonds
Securities available for sale:
Total investment securities available for sale	54,251	24,527
Fair Value, Recurring \| Level 2 Inputs \| Interest Rate Swaps
Asset derivatives:
Asset derivatives	9,213	389
Liability derivatives:
Liability derivatives	9,213	$ 389
Fair Value, Recurring \| Level 2 Inputs \| Risk Participation Agreements
Liability derivatives:
Liability derivatives	$ 8

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Foreclosed Assets Remeasured and Recorded at Fair Value (Details) $ in Thousands	Dec. 31, 2021 USD ($)
Foreclosed assets remeasured subsequent to initial recognition:
Carrying value of foreclosed assets prior to remeasurement	$ 1,676
Fair value of foreclosed assets remeasured subsequent to initial recognition	$ 1,676

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Estimated Fair Values and Carrying Values of Financial Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Financial assets
Cash and cash equivalents	$ 332,014	$ 327,025
Interest bearing time deposits in other banks		131
Investment securities available for sale	176,067	26,432
Non-marketable securities	15,405	7,527
Accrued interest receivable	18,340	10,228
Bank-owned life insurance	60,761	26,528
Total assets	3,773,148	2,499,412
Loans, including held for sale, net	3,077,200	2,049,429
Financial liabilities
Deposits	3,236,146	2,141,199
Accrued interest payable	2,545	437
FHLB advances		50,000
Total liabilities	3,391,368	2,200,405
Carrying Value \| Level 2 Inputs
Financial assets
Cash and cash equivalents	332,014	327,025
Interest bearing time deposits in other banks		131
Investment securities available for sale	176,067	26,432
Non-marketable securities	15,405	7,527
Accrued interest receivable	18,340	10,228
Bank-owned life insurance	60,761	26,528
Derivative instruments assets	9,213	389
Total assets	611,800	398,260
Financial liabilities
Deposits	3,236,146	2,141,199
Accrued interest payable	2,545	437
FHLB advances		50,000
Notes payable	111,223	1,000
Derivative instrument liabilities	9,221	389
Total liabilities	3,359,135	2,193,025
Carrying Value \| Level 3 Inputs
Financial assets
Loans, including held for sale, net	3,077,200	2,049,429
Estimated Fair Value \| Level 2 Inputs
Financial assets
Cash and cash equivalents	332,014	327,025
Interest bearing time deposits in other banks		131
Investment securities available for sale	176,067	26,432
Non-marketable securities	15,405	7,527
Accrued interest receivable	18,340	10,228
Bank-owned life insurance	60,761	26,528
Derivative instruments assets	9,213	389
Total assets	611,800	398,260
Financial liabilities
Deposits	3,238,857	2,141,999
Accrued interest payable	2,545	437
FHLB advances		50,000
Notes payable	111,223	1,000
Derivative instrument liabilities	9,221	389
Total liabilities	3,361,846	2,193,825
Estimated Fair Value \| Level 3 Inputs
Financial assets
Loans, including held for sale, net	$ 2,920,213	$ 2,023,761

Significant Group Concentrati_2

Significant Group Concentrations of Credit Risk - Additional Information (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Risks and Uncertainties [Abstract]
Federal funds sold	$ 2,150,000	$ 292,000
Uninsured deposit	$ 179,300,000	$ 189,700,000

Employee Benefit Plans - Additi

Employee Benefit Plans - Additional Information (Details) - USD ($)		12 Months Ended
	Jul. 01, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Postemployment Benefits [Abstract]
Estimated fair value of cash obligation			$ 2,300,000
Increase in fair value of ESOP shares			$ 317,000
Number of shares held by ESOP	149,461		113,306
Unallocated shares			0
Plan released shares committed			10,826
Fair value of shares committed to be released			$ 284,000
Number of shares repurchased from ESOP			8,211
Repurchased shares from ESOP			$ 167,000
Contributions to ESOP		$ 1,400,000	936,000	$ 645,000
Administrative expenses related to ESOP		$ 59,000	$ 41,000	$ 16,000
Stock issued during period, shares	400,000
Common stock, par value	$ 1	$ 1	$ 1

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Related Party Transactions [Abstract]
Aggregate amounts of loans to related parties	$ 1,491,000	$ 569,000
Loan originations to related parties	1,344,000
Repayments from related party loans	422,000
Related party unfunded commitments	587,000	0
Deposits received from related parties	$ 16,000,000	$ 19,000,000

Shareholders' Equity and Regula

Shareholders' Equity and Regulatory Matters - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands						2 Months Ended	6 Months Ended	12 Months Ended
	Sep. 30, 2022	Jul. 01, 2022	Nov. 17, 2021	Nov. 09, 2021	Aug. 27, 2021	Aug. 27, 2021	Jun. 30, 2021	Dec. 31, 2022	Dec. 31, 2021
Subsidiary, Sale of Stock [Line Items]
Preferred stock, shares authorized								1,000,000
Preferred stock, par value								$ 1
Repayments of long-term debt								$ 32,500
Share issued and sold		400,000
Senior Debt
Subsidiary, Sale of Stock [Line Items]
Repayments of Senior Debt								$ 19,500
Debt due date								Sep. 10, 2022
Subordinated Debt One
Subsidiary, Sale of Stock [Line Items]
Repayments of Subordinated Debt								$ 11,000
Debt due date								Jul. 29, 2022
Subordinated Debt Two
Subsidiary, Sale of Stock [Line Items]
Repayments of Subordinated Debt								$ 2,000
Debt due date								Sep. 27, 2022
Series A Convertible Non-cumulative Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Preferred stock, shares authorized								69,400	69,400
Preferred stock, par value								$ 1	$ 1
Series B Convertible Perpetual Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Preferred stock, shares authorized								69,400	69,400
Preferred stock, par value								$ 1	$ 1
Director and Officers [Member] \| Series A Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Purchase of preferred stock shares	$ 2,700
Private Placement Offering
Subsidiary, Sale of Stock [Line Items]
Liquidation preference per share	$ 1,000
Warrant exercise price of common stock per share	$ 22.50							$ 22.50
Gross proceeds before deducting placement fees and offering expenses	$ 69,400
Placement fees and offering expenses	3,200
Net proceeds after deducting placement fees and offering expenses	$ 66,200
Issuance and sale of common stock					2,937,876	2,710,569	227,307
Proceeds from issuance and sale of common stock					$ 70,500	$ 65,100	$ 5,400
Private Placement Offering \| Series A Convertible Non-cumulative Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Preferred stock, shares authorized	69,400
Preferred stock, par value	$ 1
Private Placement Offering \| Series B Convertible Perpetual Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Preferred stock, par value	$ 1
IPO
Subsidiary, Sale of Stock [Line Items]
Share issued and sold				4,025,000
Shares issued, price per share				$ 25
Aggregate gross proceeds				$ 100,600
Aggregate net proceeds from issuance of common stock				92,000					$ 92,043
Underwriting discounts and offering expenses				$ 8,600
IPO \| RSAs
Subsidiary, Sale of Stock [Line Items]
Share issued			49,750
Over-Allotment Option
Subsidiary, Sale of Stock [Line Items]
Share issued and sold			525,000

Shareholders Equity and Regulat

Shareholders Equity and Regulatory Matters - Schedule of comparison of the actual capital amounts and ratios (Details) $ in Thousands		Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Banking Regulation, Tier 1 Risk-Based Capital [Abstract]
Total capital (to risk weighted assets), Actual, Amount		$ 496,222	$ 288,022
Total capital (to risk weighted assets), Actual, Ratio		0.138	0.135
Total capital (to risk weighted assets), For Capital Adequacy Purposes, Amount	[1]	$ 377,782	$ 223,444
Total capital (to risk weighted assets), For Capital Adequacy Purposes, Ratio	[1]	0.105	0.105
Total capital (to risk weighted assets), To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount		$ 359,793	$ 212,804
Total capital (to risk weighted assets), To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio		0.100	0.100
Tier I capital (to risk weighted assets), Actual, Amount		$ 465,871	$ 268,727
Tier I capital (to risk weighted assets), Actual, Ratio		0.129	0.126
Tier I capital (to risk weighted assets), For Capital Adequacy Purposes, Amount	[1]	$ 305,824	$ 180,883
Tier I capital (to risk weighted assets), For Capital Adequacy Purposes, Ratio	[1]	0.085	0.085
Tier I capital (to risk weighted assets), To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount		$ 287,834	$ 170,243
Tier I capital (to risk weighted assets), To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio		0.080	0.080
Tier I capital (to average assets), Actual, Amount	[2]	$ 465,871	$ 268,727
Tier I capital (to average assets), Actual, Ratio	[2]	0.131	0.123
Tier I capital (to average assets), For Capital Adequacy Purposes, Amount	[1],[2]	$ 142,188	$ 87,602
Tier I capital (to average assets), For Capital Adequacy Purposes, Ratio	[1],[2]	0.040	0.040
Tier I capital (to average assets), To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount	[2]	$ 177,734	$ 109,503
Tier I capital (to average assets), To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio	[2]	0.050	0.050
Common equity tier 1 (to risk weighted assets), Actual, Amount		$ 465,871	$ 268,727
Common equity tier 1 (to risk weighted assets), Actual, Ratio		0.129	0.126
Common equity tier 1 (to risk weighted assets), For Capital Adequacy Purposes, Amount	[1]	$ 251,855	$ 148,962
Common equity tier 1 (to risk weighted assets), For Capital Adequacy Purposes, Ratio	[1]	0.070	0.070
Common equity tier 1 (to risk weighted assets), To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount		$ 233,865	$ 138,322
Common equity tier 1 (to risk weighted assets), To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio		0.065	0.065

[1] Percentages represent the minimum capital ratios plus, as applicable, the fully phased-in 2.5 % CIT1 capital buffer under the Basel III Capital Rules. The Tier 1 capital ratio (to average assets) is not impacted by the Basel III Capital Rules; however, the Federal Reserve and the FDIC may require the Bank to maintain a Tier 1 capital ratio (to average assets) above the minimum required.

Shareholders' Equity and Regu_2

Shareholders' Equity and Regulatory Matters - Schedule of comparison of the actual capital amounts and ratios (Parenthetical) (Details)	Dec. 31, 2022	Dec. 31, 2021
Banking Regulation, Tier 1 Risk-Based Capital [Abstract]
CITI Capital Buffer Rate	2.50%	2.50%

Earnings Per Common Share - Sch

Earnings Per Common Share - Schedule Of Earnings Per Share Basic And Diluted (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Earnings Per Share [Abstract]
Net income	$ 7,525	$ 6,770	$ 2,277	$ 2,087	$ 354	$ 2,385	$ 3,589	$ 5,096	$ 18,659	$ 11,424	$ 12,115
Less dividends declared, Preferred Series A stock									1,418
Net income available to common shareholders									$ 17,241	$ 11,424	$ 12,115
Weighted-average shares outstanding for basic earnings per common share									13,465,196	7,874,110	6,232,115
Dilutive effect of stock compensation									289,414	264,714	97,645
Weighted-average shares outstanding for diluted earnings per common share									13,754,610	8,138,824	6,329,760

Derivative Financial Instrume_3

Derivative Financial Instruments - Additional Information (Details) - USD ($)		1 Months Ended	12 Months Ended
	Feb. 18, 2021	Jul. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain on terminated of hedge recognized	$ 945,000	$ 3,000,000
Cash Flow Hedges
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Term of swap agreement		5 years
Notional amount		$ 200,000,000
Pay fixed interest rate swap	$ 100,000,000
Contract maturity date		Jul. 09, 2027	Sep. 04, 2025
Reduction of interest expense			$ 401,000
Fair Value Hedges
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative liabilities			9,200,000
Collateral for derivative financial instruments			$ 730,000	$ 730,000

Derivative Financial Instrume_4

Derivative Financial Instruments - Schedule of Outstanding Notional Balances and Fair Values of Outstanding Derivative Positions (Details) - Fair Value Hedges - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021
Risk Participation Agreements Purchased
Derivatives Fair Value [Line Items]
Outstanding Notional Balance		$ 10,621
Receive Rate	[1]	4.87%
Remaining Term	[2]	2 years 2 months 12 days
Risk Participation Agreements Sold
Derivatives Fair Value [Line Items]
Outstanding Notional Balance		$ 29,360
Liability Derivative Fair Value		$ 8
Receive Rate	[1]	5.54%
Remaining Term	[2]	4 years 2 months 12 days
Commercial Loan Interest Rate Swaps
Derivatives Fair Value [Line Items]
Outstanding Notional Balance		$ 335,101	$ 155,174
Asset Derivative Fair Value		9,213	389
Liability Derivative Fair Value		9,221	389
Commercial Loan Interest Rate Swaps \| Loan Customer Counterparty \| Not Designated as Hedging Instrument
Derivatives Fair Value [Line Items]
Outstanding Notional Balance		147,560	77,587
Liability Derivative Fair Value		$ 9,213	$ 389
Receive Rate	[1]	4.77%	4.21%
Remaining Term	[2]	4 years 6 months	7 years 7 months 6 days
Commercial Loan Interest Rate Swaps \| Financial Institution Counterparty \| Not Designated as Hedging Instrument
Derivatives Fair Value [Line Items]
Outstanding Notional Balance		$ 147,560	$ 77,587
Asset Derivative Fair Value		$ 9,213	$ 389
Pay Rate	[1]	4.77%	4.21%
Remaining Term	[2]	4 years 6 months	7 years 7 months 6 days

[1] Weighted average rate. Weighted average life (in years).

Core Deposit Intangibles, Net -

Core Deposit Intangibles, Net - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 162,000	$ 162,000	$ 162,000
Core Deposits
Finite-Lived Intangible Assets [Line Items]
Weighted average life	7 years

Core Deposit Intangibles, Net_2

Core Deposit Intangibles, Net - Schedule of Amortization of Core Deposit Intangibles (Details) - Core Deposits $ in Thousands	Dec. 31, 2022 USD ($)
Finite-Lived Intangible Assets [Line Items]
2023	$ 162
2024	162
2025	162
2026	162
2027 and thereafter	483
Total	$ 1,131

Business Combinations - Additio

Business Combinations - Additional Information (Details) - USD ($) $ in Millions	Jul. 01, 2022	Jan. 01, 2020
Business Acquisition [Line Items]
Stock issued during period, shares	400,000
Heritage Bancorp Inc
Business Acquisition [Line Items]
Fair value of loans acquired		$ 259.6
Contractual balance		$ 263.3

Business Combinations - Schedul

Business Combinations - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Assets of acquired bank:
Goodwill	$ 18,034	$ 18,034

Parent Company Financial Stat_3

Parent Company Financial Statements - Schedule of Condensed Balance Sheets (Details) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Assets [Abstract]
Cash and cash equivalents	$ 332,014	$ 327,025
Other assets	12,146	7,553
Total assets	3,773,148	2,499,412
LIABILITIES AND SHAREHOLDERS' EQUITY
Other liabilities	14,024	7,380
Total liabilities	3,391,368	2,200,405
Commitments and contingencies - ESOP-owned shares		2,300
Shareholders' equity:
Series A Convertible Non-Cumulative Preferred Stock	69
Common stock	13,610	13,482
Additional paid-in capital	318,033	249,202
Retained earnings	53,270	36,029
Accumulated other comprehensive (loss) income	(2,103)	1,393
Treasury stock: at cost	(1,099)	(1,099)
Total shareholders' equity	381,780	299,007
Total liabilities & shareholders' equity	3,773,148	2,499,412
Parent
Assets [Abstract]
Cash and cash equivalents	8,752	8,707
Investment in subsidiary	482,933	289,446
Other assets	3,795	1,856
Total assets	495,480	300,009
LIABILITIES AND SHAREHOLDERS' EQUITY
Other borrowings	111,223	1,000
Other liabilities	2,477	2
Total liabilities	113,700	1,002
Shareholders' equity:
Series A Convertible Non-Cumulative Preferred Stock	69
Common stock	13,610	13,482
Additional paid-in capital	318,033	249,202
Retained earnings	53,270	36,029
Accumulated other comprehensive (loss) income	(2,103)	1,393
Treasury stock: at cost	(1,099)	(1,099)
Total shareholders' equity	381,780	299,007
Total liabilities & shareholders' equity	$ 495,480	$ 300,009

Parent Company Financial Stat_4

Parent Company Financial Statements - Schedule of Condensed Statements of Income and Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Interest expense:
Total interest expense	$ 19,000	$ 11,747	$ 4,771	$ 1,974	$ 2,041	$ 2,397	$ 2,717	$ 2,907	$ 37,492	$ 10,062	$ 14,360
Noninterest expense:
Legal and professional									6,987	5,293	3,962
Other									4,117	1,919	1,845
Total noninterest expense	22,627	22,728	22,773	20,181	20,087	17,641	17,779	15,518	88,309	71,025	47,403
Income tax benefit	(1,802)	(1,495)	(604)	(608)	(133)	(617)	(955)	(1,354)	(4,509)	(3,059)	(3,495)
Net income	$ 7,525	$ 6,770	$ 2,277	$ 2,087	$ 354	$ 2,385	$ 3,589	$ 5,096	18,659	11,424	12,115
Comprehensive income									15,163	12,538	12,394
Parent
Interest expense:
Interest on notes payable									4,605	1,091	1,615
Total interest expense									4,605	1,091	1,615
Noninterest expense:
Legal and professional									302	680	1,233
Other									230	23	37
Total noninterest expense									532	703	1,270
Loss before income tax expense and equity in undistributed earnings of subsidiaries									(5,137)	(1,794)	(2,885)
Income tax benefit									1,087	359	384
Loss before equity in undistributed earnings in subsidiaries									(4,050)	(1,435)	(2,501)
Equity in undistributed earnings of subsidiaries									22,709	12,859	14,616
Net income									18,659	11,424	12,115
Comprehensive income									$ 15,163	$ 12,538	$ 12,394

Parent Company Financial Stat_5

Parent Company Financial Statements - Schedule of Condensed Statements of Cash Flows (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income	$ 18,659	$ 11,424	$ 12,115
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Amortization of subordinated debt issuance costs	154
Net cash provided by (used in) operating activities	21,791	4,584	(3,654)
Cash flows from investing activities:
Net cash used in investing activities	(1,239,530)	(500,062)	(500,009)
Cash flows from financing activities:
Net (repayment of) proceeds from subordinated notes payable - related party		(13,000)	5,000
Net proceeds from (repayment of) line of credit -senior debt	29,875	(19,875)	(1,500)
Net proceeds from subordinated debt issuance	80,194
Dividends paid on Series A preferred stock	(221)
Proceeds from stock options exercised	672	995	385
Net redemption of treasury stock		(121)	(38)
Net cash provided by financing activities	1,222,728	618,943	611,158
Increase in cash and cash equivalents	4,989	123,465	107,495
Cash and cash equivalents at beginning of period	327,025	203,560	96,065
Cash and cash equivalents at end of period	332,014	327,025	203,560
Parent
Cash flows from operating activities:
Net income	18,659	11,424	12,115
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Equity in undistributed net income of subsidiaries	(22,709)	(12,859)	(14,616)
Amortization of subordinated debt issuance costs	154
Net change in other assets	(1,938)	(359)	501
Net change in other liabilities	1,278	(150)	(320)
Net cash provided by (used in) operating activities	(4,556)	(1,944)	(2,320)
Cash flows from investing activities:
Capital investments in subsidiaries	(173,000)	(125,800)
Net cash used in investing activities	(173,000)	(125,800)
Cash flows from financing activities:
Net (repayment of) proceeds from subordinated notes payable - related party		(13,000)	(5,000)
Net proceeds from (repayment of) line of credit -senior debt	29,875	(19,875)	(1,500)
Net proceeds from subordinated debt issuance	80,194
Net proceeds from issuance of preferred stock	66,225
Proceeds from issuance of common stock	856	163,199	536
Dividends paid on Series A preferred stock	(221)
Proceeds from stock warrants exercised		19
Proceeds from stock options exercised	672	995	385
Net redemption of treasury stock		(121)	(38)
Net cash provided by financing activities	177,601	131,217	4,383
Increase in cash and cash equivalents	45	3,473	2,063
Cash and cash equivalents at beginning of period	8,707	5,234	3,171
Cash and cash equivalents at end of period	$ 8,752	$ 8,707	$ 5,234

Quarterly Financial Data (UNA_3

Quarterly Financial Data (UNAUDITED) - Summary of Quarterly Financial Information (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]
Interest income	$ 51,151	$ 43,102	$ 32,509	$ 27,184	$ 26,660	$ 24,399	$ 23,931	$ 25,625	$ 153,946	$ 100,615	$ 82,241
Interest expense	19,000	11,747	4,771	1,974	2,041	2,397	2,717	2,907	37,492	10,062	14,360
Net interest income	32,151	31,355	27,738	25,210	24,619	22,002	21,214	22,718	116,454	90,553	67,881
Provision for loan losses	1,950	2,900	3,350	4,000	6,100	2,323		1,500	12,200	9,923	7,550
Net interest income after provision for loan losses	30,201	28,455	24,388	21,210	18,519	19,679	21,214	21,218	104,254	80,630	60,331
Noninterest income	1,753	2,538	1,266	1,666	2,055	964	1,109	750	7,223	4,878	2,682
Noninterest expense	22,627	22,728	22,773	20,181	20,087	17,641	17,779	15,518	88,309	71,025	47,403
Net income before income tax expense	9,327	8,265	2,881	2,695	487	3,002	4,544	6,450	23,168	14,483	15,610
Income tax expense	1,802	1,495	604	608	133	617	955	1,354	4,509	3,059	3,495
Net income	$ 7,525	$ 6,770	$ 2,277	$ 2,087	$ 354	$ 2,385	$ 3,589	$ 5,096	$ 18,659	$ 11,424	$ 12,115